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Stellingen behorende bij het proefschrift
APPLICATIONS OF HYALURONAN IN ABDOMINAL SURGERY
AN EXPERIMENTAL STUDY
- Humane mesotheelcellen, verkregen uit omentum, alsook uit peritoneaalvocht 
zijn geschikt voor het opkweken van cellijnen, zonder verlies van specifieke 
eigenschappen, zelfs na bevroren opslag. (D it proefschrift)
- Cellen van het monocyten-macrophagensysteem moduleren de fibrinolytische 
capaciteit van humane peritoneale mesotheelcellen en interfereren met de 
hualuronzuur-geassocieerde veranderingen in de mesotheliale fibrinolytische 
capaciteit. (D it proefschrift)
- Hyaluronzuur gel vermindert intra-abdominale adhesies en abcesvorming 
niet in een experimenteel peritonitismodel. (D it proefschrift)
- Met gelabelde liposomen is het mogelijk om zowel adhesies als abcessen te 
detecteren. (D it proefschrift)
- Een gecombineerde mesh van polypropyleen met hyaluronzuurmembraan 
benadert de ideale mesh voor herniaherstel het meest in een dierexperimenteel 
model. (D it proefschrift)
- Hyaluronzuur heeft geen uitgesproken remmend effect op intraperitoneale 
tumor implantatie en groei in een diermodel. (D it proefschrift)
- De immense populariteit van sociale netwerken zoals facebook en hyves 
staat in sterk contrast met de angst voor schending van de privacy door 
introductie van het landelijk EPD.
- Een goed arts neemt zijn patiënten en werk zeer serieus, zichzelf niet al te.
- Het goedkoopst is zelden synoniem met kwalitatief het beste. Toch wordt de 
indruk gewekt dat dit fenomeen in de zorg geen opgeld doet.
- Men moet patiënten niet opereren op hun sterfdag (uit De Heelmeesters, 
Abraham Verghese)
- Mensen die niets te bieden hebben, bieden hoop. (Arnon Grunberg)
- Sommige vragen zijn zo goed dat het jammer zou zijn ze met een antwoord 
te verknoeien. (Harry Mulisch)
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General introduction
GENERAL INTRODUCTION
I n t r a -a b d o m in a l  a d h e s io n  a n d  a bsc ess  f o r m a t io n ;
CLINICAL IMPACT AND PATHOPHYSIOLOGY
Abdominal surgery inevitably leads to peritoneal trauma. Peritoneal trauma, 
how insignificant it may seem, can lead to the formation of adhesions. 
Adhesions are responsible for considerable morbidity and even mortality and 
have an enormous impact on the health care burden. Adhesions are the main 
cause of intestinal obstruction in the Western world, accounting for 40% of cases 
and are responsible for over two thirds of the readmissions for small bowel 
obstruction1. After conventional colorectal surgery, approximately 20% of 
patients is readmitted within 4 years after the operation, for reasons directly or 
indirectly related to adhesions2. Other, well-known and frequent complications 
of adhesions are chronic abdominal and pelvic pain, secondary infertility in 
women and inadvertent enterotomy during relaparotomy3-5.
Adhesions arise from peritoneal trauma, which can be induced by surgery, 
trauma or inflammation. Mesothelial cells are loosely interconnected and easily 
detach from their basal membrane, even after delicate trauma. Subsequently an 
inflammatory response activates the coagulation cascade, resulting in a cascade 
of events in order to achieve reepithelialization. On the damaged areas a fibrin 
matrix is formed. Under normal circumstances the fibrinolytic system will eventually 
lyse the fibrin deposits and new mesothelial cells will reepithelialize the denuded 
areas within a week6, 7.
Beside activation of the coagulation cascade, surgery and infection will reduce 
fibrinolysis, mainly due to increased plasminogen activator inhibitor type-1 
(PAI-1) levels and decreased tissue-type plasminogen activator (tPA) levels7-11. 
When fibrin deposits are not lysed, the clots are invaded by fibrocollagenous 
tissue, thus forming fibrous adhesions.
In case of intra-abdominal infection, bacteria can be caught in fibrin clots, 
protecting microorganisms against the immunologic defenses in the abdomen. 
These contaminated fibrin clots can act as a nidus for abscess formation. Intra­
abdominal abscesses are a frequent complication of peritonitis and carry a high 
morbidity. Dense adhesions occur around abscesses, which makes early surgical 
interventions hazardous. In severe cases of peritonitis, multiple relaparotomies 
and the use of temporary closure devices may be necessary. These reinterventions 
aggravate the formation of adhesions and carry a high risk of complications 
such as serosal bleeding, inadvertent enterotomy and fistula formation5. So, 
adhesion formation after intra-abdominal sepsis is a major problem complicating 
future surgery.
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Adhesion related complications underline the urge for optimal adhesion 
prevention during abdominal surgery. Nevertheless the interest in this topic is 
limited since the magnitude of the problem is often underestimated, the 
knowledge on the subject is limited and the efficacy of preventive measures 
is negligible. The awareness about the consequences of adhesions is also 
hampered because surgeons are seldom confronted with these complications in 
their own patients because most complications are acute and present some 
time after the initial procedure.
HYALURONAN
Although the majority of adhesions will have no clinical implications, the 
incidence and the severity of complications caused by adhesions are much 
too high to ignore. Many studies have focused on prevention of adhesions 
and intra-abdominal abscesses. Apart from good surgical technique and 
avoiding adhesiogenic foreign materials, much attention is paid to the use of 
antiadhesive agents. Until now, hyaluronan-based antiadhesive agents are 
among the most intensive studied products, and probably are the most 
successful as well.
Hyaluronan is a polysaccharide of repeating disaccharide units of sodium 
glucuronate and N-acetyl-glucosamine linked by glycosidic bonds. Initially 
it was described as hyaluronic acid, a polysaccharide isolated from the vitreous 
fluid of the eye (hyalos) that contained uronic acid12. Later the name hyaluronan 
was more generally used13. Hyaluronate is another frequently used synonym. 
Hyaluronan is found in almost all tissues and fluids of vertebrates, especially in 
connective tissue14. Hyaluronan is generally known to be associated with tissue repair 
and wound healing. In healing tissues the concentration of hyaluronan is high15' 16. 
Its biological functions appear to be the result of both its physicochemical properties 
and its biological interactions17. Hyaluronan is a hygroscopic macromolecule, which 
makes hyaluronan solutions highly osmotic and important for water homeostasis. 
Hyaluronan can modulate the inflammatory respons by influencing cytokine 
production, and facilitation of adhesion of cytokine-activated lymphocytes. In a next 
phase cell migration and proliferation are facilitated17-19. Hyaluronan also plays 
a role in the downregulation of the inflammatory response. Its free-radical scavenging 
and antioxidant properties and its supposed inhibiting effect on proteinases, seem to 
be responsible for this downregulation, stabilizing the granulation tissue during the 
healing process. These processes and the influence of hyaluronan on these processes 
are complex and much is still unclear. This is equally true for the role of hyaluronan 
in adhesion and abscess prevention.
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Despite the widespread use of hyaluronan-based antiadhesive agents, there 
is much debate on the exact mechanism of action of hyaluronan in adhesion 
prevention. Mechanical separation of traumatized peritoneal surfaces is probably 
one of the most important mechanisms. Hyaluronan solutions are thought to 
create a pool in which the intestines float, keeping them separated from each 
other as well as from the peritoneal lining of the abdominal cavity. Due to this 
"hydroflotation", uninterrupted healing of the mesothelial lining is possible. 
The short half-life of hyaluronan solutions, however seems to interfere with 
optimal adhesion prevention. Hyaluronan-based gels and membranes have 
been developed to solve this problem. Membranes create a mechanical barrier, 
whereas the mechanism of gels is probably between creation of hydroflotation 
and creating a barrier.
Apart from the mechanical explanation, hyaluronan has a biological mechanism 
of action in adhesion prevention. Hyaluronan increases the proliferation of 
mesothelial cells in vitro20, 21. Part of the adhesion reducing capacity of hyaluronan 
might thus be explained by its ability to accelerate peritoneal healing due 
to stimulation of mesothelial cell proliferation. The impact of hyaluronan on 
fibrinolysis has been subject of many studies, but yet its influence is still unclear. 
In vitro, hyaluronan has shown to increase the fibrinolytic response of mesothelial 
cells, due to a decrease of PAI-1 release and an increase of the intracellular tPA 
concentration22. However, other in vitro and in vivo studies showed contradicting 
results23-25. Detailed information on the topic of hyaluronan and its effects on 
intra-abdominal adhesion and abscess formation was already described by 
Reijnen26. Although its working mechanism is not completely understood, hyaluronan 
is well-known for its antiadhesive properties, as stated above27-33. In clinical 
studies hyaluronan reduces the incidence, severity and extent of adhesions after 
abdominal surgery. However, the incidence of intestinal obstruction is not 
reduced. Two recent reviews support these conclusions34, 35.
H y a lu r o n a n  a n d  in fec t io n
Reijnen et al. were among the first to describe the use of hyaluronan in a 
peritonitis model in rats36, 37. Hyaluronan membrane failed to show a favourable 
effect, whereas hyaluronan solution reduced the severity of adhesions and the 
incidence of abscesses. High volumes of 0.2% and 0.4% hyaluronan solution 
proved to be most effective, suggesting that the "hydroflotation effect" was an 
important factor as well. In a similar experiment, Tüzüner et al. found similar 
results showing that hyaluronan solution was superior to hyaluronan membrane38. 
Hyaluronan solution reduced both incidence and severity of adhesions, whereas
11
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hyaluronan membrane reduced only the severity. No differences were found 
with regard to morbidity or abscess formation. Unfortunately, withdrawal of the 
used hyaluronan solution from the market prohibits further research.
Tzianabos et al. proved that hyaluronan membrane is safe when used in rats 
with generalized peritonitis39. In a second experiment they used a modified 
hyaluronan membrane with glycerol in rats with generalized peritonitis and 
found no negative effects on morbidity and mortality. In contrast with these 
outcomes, ferric hyaluronan gel was found to have serious adverse events. 
In rats with generalized peritonitis, application of ferric hyaluronan gel resulted 
in almost 100% mortality compared to 49% in controls. Possible explanations 
pointed at presumed negative properties of iron under these circumstances. 
Unfortunately the effect on adhesion formation was not evaluated. Ghellai et al. 
described a trend towards increased abscess formation, using hyaluronan 
membrane in generalized peritonitis in rats40. Hyaluronan did not affect the 
amount or strength of adhesions after cecal ligation or cecal ligation and 
puncture in this study. Kayaoglu et al. also studied the earlier mentioned 
modified hyaluronan membrane, with glycerol added41. Its use resulted in 
increased adhesion formation during bacterial peritonitis. Uchida et al. used 
hyaluronan membrane in an experimental study in rats using a cecal ligation 
and puncture model42. Use of hyaluronan, did not show significant differences 
in serum inflammatory cytokine levels.
Several clinical studies using hyaluronan in the presence of contamination or 
overt infection have been performed. Tang et al. used ferric hyaluronan gel in 
patients undergoing elective colorectal surgery43. The study was terminated 
prematurely due to an increase of anastomotic leaks in the intervention group. 
Cohen et al. applied the hyaluronan/ glycerol membrane in patients undergoing 
restorative proctocolectomy and ileal pouch-anal anastomosis31. The hyaluronan/ 
glycerol membrane reduced the incidence, extent and severity of adhesions, 
but increased incidence of infectious complications. Vrijland et al. used hyaluronan 
membrane in a randomized controlled trial in patients who underwent a 
Hartmann procedure for sigmoid diverticulitis or obstruction28. 81% of patients 
had a peritonitis. Hyaluronan membrane did reduce the severity of adhesions, 
although the incidence was not significantly altered. Uchida et al. studied 
patients who underwent surgery for colorectal cancer42. The patients were 
retrospectively divided into two groups: in one group hyaluronan membrane 
was applied just before abdominal wall closure. In the other group no hyaluronan 
membrane was used. No adverse events were found in the hyaluronan group.
In conclusion, there are only limited data on hyaluronan and infection. 
The adverse results of the few studies preclude definite statements on the
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effectiveness of hyaluronan, regarding adhesion and abscess prevention, under 
infectious conditions.
H y a lu r o n a n  a n d  t u m o r
In abdominal surgery, a considerable amount of procedures is performed for 
malignant disease. Little is known about the effect of the application of 
hyaluronan during oncologic surgical procedures32, 42, 44. Although no negative 
side effects have been mentioned up to now, both positive and negative effects 
of hyaluronan on tumor anchorage and growth are imaginable. On one hand, 
hyaluronan may promote anchorage, independent growth, and invasiveness of 
cancer cells as described by Toole45, 46. On the other hand, the antiadhesive 
properties of hyaluronan and its presumed influence on peritoneal healing can 
support a theory of prevention of tumor adherence and growth. In conclusion, 
the data on the application of hyaluronan during oncologic surgical procedures 
are too scarce to draw any conclusions.
A im  o f  th e s t u d ies
As described above, hyaluronan has acknowledged antiadhesive properties. 
Nevertheless the studies focusing on its use under the most challenging 
conditions with regard to adhesion prevention are scarce. Use of hyaluronan 
under inflammatory and infectious conditions warrants further research, 
focusing both on descriptive basal studies, as well on interventional studies. 
In chapter two we reviewed the use of hyaluronan-based antiadhesive agents in 
abdominal surgery.
Mesothelial cells play a central role in the the (patho)biology of the peritoneal 
cavity, in the maintenance of the peritoneal membrane, and in tissue repair. 
To study the effects of hyaluronan on mesothelial cells, in vitro studies are 
inevitable. Cultures of human cells are usually used for this purpose. However, 
little is known about the differences between mesothelial cells isolated from 
different sources. This and the effects of cell propagation and storage at low 
temperatures were the objectives of the study in chapter three. Effects of 
different stimuli and hyaluronan were studied.
The balance between fibrinolysis and coagulation after peritoneal trauma and 
infection is decisive in the development of adhesions and eventually abscesses. 
In chapter four, an in vitro study is described, focusing on the fibrinolytic response 
of human peritoneal mesothelial cells, after stimulation with lipopolysaccharide. 
Especially the influence of monocytes, macrophages and hyaluronan were evaluated.
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Some of the earlier interventional studies showed a beneficial effect of hyaluronan 
solutions under contaminated conditions. In chapter five, a hyaluronan-based gel 
was compared to saline, in order to determine if a gel, that remains longer in the 
abdominal cavity, gives better results with respect to adhesion and abscess 
formation in a peritonitis model in rats.
Evaluation of the adhesion and abscess reducing capacities of antiadhesive 
agents is of utmost importance. Most data come from experimental studies. 
In human clinical studies, therapy evaluation is a problem. The study in chapter 
six investigated whether it was possible to use a new diagnostic technique, 
using 99mTc-PEG-liposomes, to detect adhesions and abscesses. Again a peritonitis 
model in rats was used and the earlier positive experiences with hyaluronan 
could now be evaluated once more, potentially even using a non-invasive 
technique.
Incisional hernias occur in 10-15% after laparotomy. Mesh repair is the preferred 
treatment of these hernias. These prosthetic materials generate a local inflammatory 
response that ultimately results in adhesion formation. The inflammatory respons 
depends on the chemical and physical properties of the meshes. The study in 
chapter seven focuses on adhesion formation after mesh repair and the potential 
prevention of adhesions by hyaluronan. Both combinations of antiadhesives with 
mesh and composite meshes were studied, again with a central role for hyaluronan. 
The pathways of adhesion and abscess formation are, as stated earlier, 
common, resulting from an inflammatory cascade after injury. The mechanism 
of tumor implantation on the peritoneum after oncologic bowel surgery is 
presumed to be dominated by factors involved in wound healing and adhesion 
formation as well. Although use of hyaluronan during oncologic resections is 
controversial, the presumed similarities of these pathways, resulted in the 
hypothesis that the antiadhesive agent hyaluronan could reduce peritoneal 
tumor implantation. In the study in chapter eight we investigated the influence 
of hyaluronan membrane on tumor cell implantation in the abdomen of mice 
and rats. The study was not primarily designed to answer the question whether 
hyaluronan can be used safely during oncologic abdominal surgery, but 
focused on a possible "tumor implantation diminishing" effect.
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Chapter 2
A bstract
Postsurgical intra-abdominal adhesions cause significant morbidity and mortality, 
with small bowel obstruction being the most common complication. The urge 
to prevent adhesion formation has resulted in multiple experimental and 
clinical trials and the development of numerous antiadhesive agents. Through 
the years, hyaluronan-based antiadhesives have proved to be successful in 
the reduction of adhesion formation. Despite the obvious effectiveness of 
hyaluronan, there is still much debate on its clinical use and mechanisms of 
action. Various hyaluronan-containing products have been introduced and 
withdrawn from the market. The application of hyaluronan in combination with 
meshes for hernia repair appears to be a promising concept. Not all different 
applications of hyaluronan are well-known and its use in patients with a 
malignancy or abdominal infection remains controversial. Here an overview is 
given on the effects of hyaluronan-based antiadhesive agents in abdominal 
surgery, its use in infectious conditions, and its oncologic repercussions. The 
most important mechanism of action appears to be the mechanical separation 
of damaged peritoneal surfaces. However, the biological effects of hyaluronan, 
such as modulation of cell proliferation and peritoneal biology, might also be of 
influence.
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I n t r o d u c t io n
Peritoneal trauma during abdominal surgery and abdominal infection can lead 
to intra-abdominal adhesion formation (Fig. 1). Adhesions, especially when 
excessive, can cause severe complications and are responsible for considerable 
morbidity and mortality. Adhesions are the main cause of intestinal obstruction 
in the developed world and account for approximately 70% of readmissions for 
small bowel obstruction1. After conventional colorectal surgery, one out of five 
patients is readmitted for reasons directly or indirectly related to adhesions 
within 4 years after the operation2. The relative risk of adhesion-related 
complications in this group is 29.7 per 100 initial procedures over 4 years time. 
Furthermore, adhesions account for 15% to 20% of cases of secondary 
infertility in women and are associated with chronic abdominal and pelvic 
pain 3, 4. Relaparotomies are complicated by the presence of adhesions as well; 
procedures are longer and the risk of inadvertent enterotomy is approximately 
2 0 % , which in turn is associated with a higher incidence of postoperative 
complications, an increased risk of admission to intensive care units, and 
prolonged hospital stays5. Complication rates may be even higher when 
adhesions are accompanied by abdominal infection and abscess formation. 
The high incidence of adhesion-related complications, their severity, and the 
obvious impact on the health care burden urge attention for the prevention of 
postsurgical adhesion formation.
Mechanical separation of adhesiogenic wound surfaces during the first phase of 
peritoneal healing - which takes 5 days to 7 days - is the most common 
concept of adhesion prevention. During the last decades, several mechanical 
barriers have been developed. Membranes of oxidized regenerated cellulose or 
expanded polytetrafluoroethylene have been demonstrated to decrease the 
incidence of adhesion formation6-9. However, oxidized regenerated cellulose 
was less effective in the presence of blood. Expanded polytetrafluoroethylene 
may not be the ideal antiadhesive, as it is a permanent device; it remains in situ 
on the injured site where it is placed, prone for device-related complications. 
Hyaluronan (HA) is a polysaccharide made up of repeating disaccharide units 
of sodium glucuronate and N-acetyl-glucosamine linked by glycosidic bonds 
(Fig. 2). In 1934, Meyer and Palmer were the first to describe hyaluronic acid, 
a polysaccharide isolated from the vitreous fluid (hyalos) that contained uronic 
acid10. Later, the name hyaluronan was introduced11. The intraperitoneal 
application of HA derivates was considered a promising concept for the 
reduction of adhesions. Today HA is well-known for its antiadhesive properties 
and has been studied extensively. Currently, HA-based agents are the most
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Figure 1. (a) Intra-abdominal adhesion between small bowel loops. (b) Intra-abdominal adhesion 
between omentum and the abdominal wall.
22
Hyaluronan-based antiadhesive agents in abdominal surgery
Figure 2. Hyaluronan is a polysaccharide made up of repeating disaccharide units of sodium 
glucuronate and N-acetyl-glucosamine linked by glycosidic bonds.
frequently used antiadhesive agents worldwide with an undisputed adhesion 
reducing effect. Use of HA under contaminated or infectious conditions and 
during oncologic procedures is described as well. However, its use under these 
conditions is still controversial. In this chapter, an overview is given on the role 
of HA-based antiadhesive agents in abdominal surgery, with attention for different 
application forms, mechanisms of action, results, and oncologic repercussions.
H y a l u r o n a n -ba sed  a n t ia d h e s iv e  a g en ts
1. Sodium Hyaluronan Carboxymethylcellulose Membrane
The hyaluronan-carboxymethylcellulose (CMC) antiadhesive barrier, known 
as Seprafilm® (Genzyme, Cambridge, MA, USA), is a sterile, bioresorbable 
membrane (Fig. 3). The US Food and Drug Administration (FDA) approval of the 
agent was obtained in 1996. The membrane is applied to injured peritoneal 
spots, thereby acting as a physical barrier to separate traumatized peritoneal 
layers during the first phase of peritoneal wound healing. It is composed of two 
polysaccharides - sodium HA and CMC - and turns into a gel within 24 hours 
to 48 hours, remaining at the site of placement in this gel form for up to 7 days. 
Experimental studies concerning the use of this HA-CMC membrane are 
numerous. The report from Burns et al. in 1997 first describes its adhesion- 
reducing capacity in a rat cecal abrasion and sidewall injury model12. 
Hellebrekers et al. studied various antiadhesive barriers in a rat model, with 
HA-CMC showing superior results9. In another study by Kutlay et al., the HA-CMC 
membrane was more effective than heparin and aprotinin in a cecal abrasion 
model in rats13. Any presumed fibrinolytic activity of the HA-CMC membrane 
could not be supported by experimental studies from Reijnen et al. and Tarhan 
et al.14, 15.
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Figure 3. Application of the HA-CMC membrane in open surgery for digestive disease. A dry 
white Tyvek® sleeve, in which the transparant HA-CMC membrane is supplied, is used to position 
the membrane in the abdomen. The Tyvek® sleeve is removed once the hydrophilic HA-CMC 
membrane has been properly positioned. (Image kindly provided by Genzyme)
In a randomized clinical trial, Becker et al. studied the effect of the HA-CMC 
membrane in patients with ulcerative colitis or familial polyposis who were 
scheduled for ileal pouch-anal anastomosis with diverting-loop ileostomy1 6. 
The included patients were randomized into two groups: in one group, the 
HA-CMC membrane was placed under the midline incision prior to closure; 
and in the other group, no antiadhesive agent was applied. Adhesions were 
evaluated laparoscopically at the time of ileostomy closure 8 weeks to 12  weeks 
later. The data of 1 75 patients were analyzed. Only 5 (6% ) of 90 control 
patients were free of adhesions versus 43 (51%) of 85 patients treated with the 
HA-CMC membrane (p < 0.001). The mean percent of incision length involved 
with adhesions was also significantly greater in the control group (63% versus 
23%, p < 0.001). Furthermore, the percentage of patients with dense adhesions 
was significantly higher in the control group (58% versus 15%, p < 0.001). 
The use of the HA-CMC membrane was not related to an increased incidence 
of adverse events.
24
Hyaluronan-based antiadhesive agents in abdominal surgery
In another randomized trial, Diamond studied the effect of the HA-CMC 
membrane in women undergoing uterine myomectomy i 7. The 127 patients 
included in the trial were randomized to treatment with the HA-CMC 
membrane or to no adjunctive antiadhesive treatment at the end of the 
procedure. Adhesions were assessed during second-look laparoscopy. The 
mean number of sites adherent to the uterine surface was significantly lower in 
the HA-CMC membrane treated group (4.98 sites ± 0.52 sites) compared with 
the no-treatment group (7.88 sites ± 0.48 sites), as were the mean uterine 
adhesion severity scores (1.94 ± 0.14 versus 2.43 ± 0.10; all values treatment 
versus no treatment, respectively), mean extent scores (1.23 ± 0.12 versus 
1.68 ± 0.10), and the mean area of adhesions (13.2 cm2 ± 1.67 cm2 versus 
18.7 cm2 ± 1.66 cm2). Again, the use of the HA-CMC membrane was not 
associated with an increase in postoperative complications.
Vrijland et al. assessed the applicability of the HA-CMC membrane in patients 
requiring a Hartmann's procedure for sigmoid diverticulitis or obstructed 
rectosigmoid18. Patients were randomized to either HA-CMC membrane 
placement in the pelvis and under the midline incision or no additional 
antiadhesive treatment. Adhesions were evaluated laparoscopically at second- 
stage surgery for restoration of bowel continuity. In that study of 42 patients, 
although the incidence of adhesions did not differ significantly between groups, 
the severity of the adhesions was significantly reduced in the group treated with 
the HA-CMC membrane. There was no correlation between the use of the 
HA-CMC membrane and the incidence of postoperative complications.
In a worldwide trial focusing on the incidence of bowel obstruction, Fazio et al. 
recently reported on the efficacy of the HA-CMC membrane in patients who 
underwent intestinal resection19. Patients were randomized to be treated with 
the HA-CMC membrane, which was applied on adhesiogenic areas, or no 
treatment. The mean follow-up time was 3.5 years. Although the overall rate of 
bowel obstruction was similar in both groups, the incidence of adhesive small- 
bowel obstruction requiring reoperation was significantly lower in the group 
treated with the HA-CMC membrane: 1.8% versus 3.4% (p < 0.05). Two other 
randomized studies have shown the value of the HA-CMC membrane in 
reducing peristomal adhesions, facilitating early closure, and in reducing 
postoperative adhesions in pediatric patients20, 21.
In a safety study by Beck et al., the use of this membrane was not associated 
with an increased incidence of abdominal or pelvic abscess, pulmonary 
embolism, or foreign-body reaction22. However, wrapping the suture or staple 
line of a bowel anastomosis with the HA-CMC membrane should be avoided, 
as this might increase the risk of detrimental sequelae associated with 
anastomotic leaks.
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2. Glycerol Sodium Hyaluronan Carboxymethylcellulose Membrane
The HA-CMC membrane has been modified by adding glycerol (G). G-HA-CMC 
membrane, also known as Seprafilm II® (Genzyme) was developed to improve 
the handling characteristics of the HA-CMC membrane. The HA-CMC 
membrane is known to be brittle and sometimes it can be technically difficult 
to apply; contact of the membrane with an area other than the desired one can 
lead to a sticky mass, which is hard to replace. Moreover, the HA-CMC 
membrane is difficult to use in laparoscopic procedures due to its characteristics. 
The addition of glycerol made the membrane easier to apply. However, only a 
few studies evaluated its efficacy and safety.
Kayaoglu et al. studied the use of the G-HA-CMC membrane in a rat adhesion 
model under clean conditions and during peritonitis23. Surprisingly, the use of 
the membrane did not reduce adhesion formation under clean circumstances 
and even caused increased adhesion formation in bacterial peritonitis. 
Recently, a clinical trial by Cohen et al. reported on the use of the G-HA-CMC 
membrane in patients undergoing restorative proctocolectomy and ileal pouch­
anal anastomosis with diverting loop ileostomy24. Indications for surgery were 
ulcerative colitis and familial polyposis. The evaluation of adhesions was 
performed during ileostomy closure by means of laparoscopy. A significant 
reduction in incidence, extent, and severity of adhesions was observed in 
patients treated with the G-HA-CMC membrane. However, an increased 
incidence of infectious complications was noted, possibly due to the glycerol 
application. Further production and marketing was then stopped by the 
manufacturers.
3. Hyaluronan Solution
The use of solutions of HA to prevent adhesions was already described in the 
early 1990s. In this group of agents, Sepracoat® (Genzyme) is probably one of 
the best known products. It is a sterile-filtered, nonpyrogenic 0.4% solution of 
sodium HA in phosphate buffered saline.
Solutions containing HA have been studied extensively for their adhesion- 
reducing capacity. Burns et al. performed one of the most extensive experimental 
studies on this topic25. They described the adhesion-reducing capacity of different 
concentrations of HA solution in a rat cecal abrasion model. The use of the HA 
solution resulted in a reduced severity of adhesions, with 0.4% HA solution 
being most successful.
Only one clinical prospective randomized trial has been published to our 
knowledge describing the use of 0.4% HA solution for the reduction of 
postsurgical adhesion formation. Diamond assessed the use of 0.4% HA solution
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in women who underwent various gynecologic procedures via laparotomy26. 
During the procedure, the peritoneum was repeatedly coated with the 0.4% 
HA solution or with phosphate-buffered saline, acting as a placebo. After 
40 days, adhesions were assessed during second-look laparoscopy. The data 
of 277 women were available for safety evaluations and of 245 women 
for efficacy studies. The group treated with the 0.4% HA solution had a 
significantly lower incidence of adhesions when compared with the placebo 
group. The proportion of sites involved was lower (0.23 ± 0.02 versus 0.30 ± 0.02, 
respectively) and the percentage of patients without de novo adhesions was 
higher (13.1% versus 4.6%, respectively). Furthermore, the use of the 0.4% HA 
solution resulted in a significantly reduced adhesion extent and severity. In that 
study, no obvious adverse effects of 0.4% HA solution were described. 
Nevertheless, in 1997 the FDA panel voted that Sepracoat® was not yet 
approvable due to the lack of proven clinical effectiveness. Further studies and 
evaluation were suggested. However, based upon market dynamics at the time 
the manufacturers chose not to pursue US market approval. This led to the 
complete withdrawal of the product from all markets due to business 
economics (personal communication).
4. 0.5% Ferric Hyaluronan Gel
In the abdominal cavity, an HA solution has a very short residence time and 
may disappear within hours after placement. Therefore, modifications of the 
HA solution have been brought to the market to increase its viscosity and 
prolong its residence time. Crosslinking of HA with ferric ions has resulted in 
the production of 0.5% ferric HA gel (Gynecare Intergel®, Ethicon, Somerville, 
NJ, USA), a sterile, nonpyrogenic, viscous solution. Initially, this gel was brought 
to the market under the name of Lubricoat®.
Few experimental studies on the use of 0.5% ferric HA gel have been 
published. In 1997, Johns et al. reported on an experimental study on various 
test formulations applied as peritoneal instillates in a sidewall and uterine horn 
model in rabbits27. Adhesion formation was assessed at 7 days and at 14 days. 
HA that was not ionically crosslinked was ineffective in reducing adhesions in 
these models even when applied at high viscosity, whereas the ionically 
crosslinked formulations of HA with trivalent iron were highly effective. 
Efficacy improved with increased levels of ionic crosslinking. In contrast, in 
more recent experimental studies the use of 0.5% ferric HA gel has shown no 
convincing adhesion-reducing effects in a laparoscopic adhesion model in 
rabbits and in rats28, 29.
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Thornton et al. assessed the safety and efficacy of 0.5% ferric HA gel in 
reducing adhesions in patients undergoing abdominal surgery by laparotomy 
with a planned second-look laparoscopy30. Women desirous of fertility, aged 
from 24 to 41, were randomized to receive either 300 ml of 0.5% ferric HA gel 
or lactated Ringer's solution at the completion of the procedure. Treated 
patients had significantly fewer intra-abdominal adhesions and the adhesions 
that did form in this group were significantly less extensive and less severe. 
Lundorff et al., who randomized patients undergoing a laparotomy for various 
gynecological procedures including myomectomy, ovariectomy, salpingostomy 
and adhesiolysis, performed a similar study31. Women were aged 18 to 46 and 
adhesions were evaluated at 24 sites at second-look laparoscopy 6 weeks to 
12 weeks later. The ferric HA group had significantly fewer adhesions and again 
the adhesions that formed despite the use of ferric HA were significantly less 
extensive and less severe compared with controls. The American Fertility Society 
score for adnexal adhesions was reduced by 69% in the treatment group 
compared to controls. In a larger clinical trial by Johns et al., 281 women were 
randomized with 143 women in the treatment arm and 138 in the control 
arm32. Results were similar to the results in the other two studies. The American 
Fertility Society score for adnexal adhesions was now reduced by 59%. In all 
three studies, no obvious adverse effects of the use of the ferric HA solution 
were noted. However, a recently published trial conducted by Tang et al. 
examining the efficacy and safety of 0.5% ferric HA gel in colorectal resections 
had to be suspended because of high morbidity in the treatment group, mainly 
due to anastomotic dehiscence and prolonged postoperative ileus33.
In 2003, the manufacturers withdrew Intergel® from the market. The product 
was intended to be used in conventional gynecological surgery to reduce 
postsurgical adhesions as an adjunct to good surgical technique. The voluntary 
withdrawal was conducted to complete an assessment of information obtained 
during post-marketing experience with the device, including adverse events 
associated with off-label use in laparoscopy and laparoscopic procedures such 
as hysterectomies. The post-market reports included late-onset postoperative 
pain and repeat surgeries following the onset of pain, noninfectious foreign 
body reactions, and tissue adherence (information provided by the FDA and 
manufacturers).
5. Hyaluronan Carboxymethylcellulose Gel
As described above, the HA-CMC membrane proved to be effective in adhesion 
reduction. However, as mentioned its handling characteristics may not be 
optimal, especially in laparoscopic surgery, where application of the membrane
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can be difficult. Laparoscopic use of a solution or gel is much easier. HA-CMC 
gel (Sepragel®, Genzyme) was developed as an alternative to the HA-CMC 
membrane.
In 1996, Burns et al. described the use of HA-CMC gel for the prevention of 
adhesions in adhesion models in rats and rabbits34. Treatment with the gel 
resulted in an increased number of animals without adhesions by 70% in a rat 
cecal abrasion model and over 90% in a rabbit sidewall defect-bowel abrasion 
model. Leach et al. showed a reduction of adhesions using the HA-CMC gel in 
a rabbit uterine horn model35. The uterine horn model was shown to be 
adhesiogenic, with 29 (70%) of 42 untreated uterine horns found to have 
adhesions. After treatment with HA-CMC gel, 22 (55%) of 40 uterine horns 
were free of adhesions compared with 12 (30%) of 42 uterine horns in controls. 
Postsurgical adhesion formation was significantly reduced in animals treated 
with HA-CMC gel when compared with controls (p < 0.05). Separate analysis 
for extent, severity, and density showed significant differences for adhesion 
severity and density (p < 0.05). Clinical trials studying the safety and efficacy 
of HA-CMC gel have not yet been performed to our knowledge. HA-CMC gel 
has not been submitted for regulatory review in the United States or the 
European Union and is therefore not available for clinical use. According to 
the manulacturers, this is a clinical development project that is still under 
investigation (personal communication).
6. Auto-Crosslinked Hyaluronan Gel
Another novelty in the field of HA-based instil lates was the development of 
auto-crosslinked HA gel (Hyalobarrier® gel, Fidia Advanced Biopolymers, 
Abano Terme, Italy). This highly viscous gel was obtained by means of an 
internal crosslinking reaction of pure HA in the absence of any chemical 
substance foreign to the native HA structure. The commercially offered auto­
crosslinked HA gel had a concentration of 4 %  and a prolonged residence time 
in the abdominal cavity was claimed by the manufacturers.
De Iaco et al. described the use of auto-crosslinked HA gel in a laparoscopic 
adhesion model in rabbitsi 6. Use of auto-crosslinked HA gel resulted in a 
significant reduction of adhesion formation: 35% of the treated animals had 
severe adhesions versus 66%  in the control group. Furthermore the mean 
adhesion score was significant lower in the treated group. In a subsequent 
study, auto-crosslinked HA gel appeared to be effective in reducing adhesions 
in the presence of inadequate hemostasis as well37. In a rat model of laparotomy 
and uterine horn injury, Koçak et al. managed to reduce adhesions using auto­
crosslinked HA gel38. Belluco et al. used an adhesion model in rabbits with
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different concentrations of the gel39. Again, the adhesion-reducing effect was 
obvious, with the 4 %  concentration being the most efficient.
The only available clinical data to our knowledge come from studies in women 
undergoing abdominal surgery for gynecological indications; Acunzo et al. 
used the auto-crosslinked HA gel in women following hysteroscopic intrauterine 
adhesiolysis40. After 3 months, a significantly lower rate of intrauterine adhesions 
was observed in the auto-crosslinked HA treated group (n = 43) compared with 
controls (n = 41; 14% versus 32%, p < 0.05). Patients in the treated group 
showed significantly lower adhesion scores at follow-up in comparison with 
those in the control group (2.0 ± 0.0 versus 5.3 ± 0.2, p < 0.001). When an 
intrauterine adhesion staging was performed according to the American Fertility 
Society, all auto-crosslinked HA gel treated patients had mild (Stage I) 
adhesions. Among control patients, only 25% had mild adhesions and 75% had 
moderate (Stage II) adhesions. The same research group has performed a 
comparable study in women with a single surgically remediable intrauterine 
lesion41. Again, a significantly lower rate of intrauterine adhesions was 
observed in the auto-crosslinked HA gel treated group (n = 67) compared with 
controls (n = 65; 10% versus 26%, p < 0.05). The mean adhesion score was 
significantly lower as well (2.42 ± 0.78 versus 3.83 ± 0.98, p < 0.05). 
The adhesion severity according to the American Fertility Society demonstrated 
a significantly decreased adhesion severity in the treated group (86%  mild 
adhesions, 14% moderate adhesions) compared with controls (24% mild, 76% 
moderate). No adverse gel-related effects were detected in the auto-crosslinked 
HA gel treated group.
In a recent study by Pellicano et al., the gel proved useful for reducing the 
incidence of postsurgical adhesions after laparoscopic myomectomy42. Auto­
crosslinked HA gel-treated patients (n = 18) had a significantly lower rate of 
postsurgical adhesions in comparison with controls (n = 18; 28% versus 78%, 
p < 0.01). The rate of adhesions was significantly higher (p < 0.05) in patients 
treated with interrupted "figure-eight" sutures than in subjects treated with 
subserous sutures. Four out of nine patients (44%) in the auto-crosslinked 
HA gel-treated group and eight out of nine patients (89%) in the control group 
who were treated with so-called interrupted "figure-eight" sutures developed 
postoperative adhesions, whereas one out of nine (1 1 % ) auto-crosslinked 
HA gel-treated patients and six out of nine (67%) control patients who were 
treated with subserous sutures developed postoperative adhesions. No side 
effects of the applied gel were reported.
Currently, the auto-crosslinked HA gel is also no longer available for clinical use. 
It was withdrawn from the market after it failed to show its effectiveness in adhesion 
reduction on a large scale after clinical research (personal communication).
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7. Other Hyaluronan-Based Products
A few other crosslinked HA products have been described in recent years. 
Haney et al. studied a barrier composed of chemically crosslinked HA (Incert®, 
Anika Therapeutics, Woburn, MA, USA)43. The product was used in a murine 
uterine horn model. Fewer adhesions were present when excision injuries were 
separated by the barrier (43% versus 88%), whereas the number of adhesions 
was unchanged after electrocautery injuries (54% versus 65%, N.S.). Despite 
human pilot trials to test the safety and effectiveness of this product for 
prevention of adhesions after spinal surgery, no trials studying the abdominal 
use are available to our knowledge. Until now, the barrier has not been 
approved by the FDA for use in the United States.
Jackson et al. focused on the use of a paclitaxel-loaded crosslinked HA film - 
HA crosslinked with water-soluble carbodiimide and containing 10% glycerol 
and 1% or 5 %  paclitaxel44. In a rat cecal abrasion model, both 1% and 5%  
paclitaxel film effectively reduced the formation of adhesions, with the 5%  
paclitaxel film being the most effective. However, this product led to excess 
fluid in the abdominal cavity at necropsy. No further studies have been reported 
at this time.
Li et al. described the development of a crosslinked HA hydrogel that contained 
a covalently bound derivative of the antiproliferative drug mitomycin C 
(MMC)45. The hydrogel was tested with 0.5% MMC and 2 %  MMC in vitro and 
in vivo. In vitro HA film loaded with 0.5% MMC inhibited proliferation when 
incubated with human T31 tracheal scar fibroblasts, whereas the 2 %  MMC 
films were cytotoxic. In vivo, the MMC films were implanted intra-abdominally 
in rats; the HA-MMC films reduced the thickness of fibrous tissue formed 
surrounding it. In a second study by the same group, HA-MMC films and gels 
were evaluated in a uterine horn model in ratsi6. Both films and gels were 
tested in several concentrations and were highly efficient in reducing 
adhesions. The results of the HA-MMC films were dose-dependent. The efficacy 
of the gels was highly correlated to the concentration, with the HA 0.625% 
MMC gel being the most effective. The use of this novelty is not yet described 
in clinical studies to our knowledge.
H er n ia  r epa ir  a n d  h y a lu r o n a n  c o n t a in in g  m esh es
Stimulated by the adhesion-reducing properties of HA in abdominal surgery, 
other applications have recently been explored, including its use in hernia 
repair. Adhesion reduction after abdominal wall reconstruction using prosthetic 
meshes is challenging. Incisional hernia after abdominal surgery is a common
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complication and tension-free repair is considered a prerequisite for successful 
treatment. This requires the use of a prosthetic mesh. To allow optimal ingrowth 
and to prevent reherniation, the mesh should be macroporous and nonsoluble. 
Polypropylene is the most commonly used biomaterial for this purpose. 
However, a major drawback is the propensity of adhesion formation at the 
peritoneal side of this mesh, introducing the risk of bowel obstruction, fistula 
formation, and inadvertent enterotomy at relaparotomy. Experimental studies 
have shown a successful reduction of mesh-related adhesions using a com3 
bination of polypropylene mesh with a separate HA-CMC membrane47-49. 
To improve the handling characteristics, a polypropylene mesh was covered on 
one side with sodium HA-CMC (Sepramesh®, Genzyme). Greenawalt et al. 
were the first to describe results of this antiadhesive mesh50.
The use of the composite mesh resulted in a reduction of mesh-related 
adhesions compared with a polypropylene mesh or polypropylene/ePTFE mesh 
in a rabbit model of incisional hernia. Van 't Riet et al. performed experiments 
in a rat incisional hernia model, comparing several antiadhesive meshes or 
combinations of mesh with antiadhesive agents51. The composite HA-CMC 
mesh was the most effective in adhesion reduction. This superior behavior with 
regard to adhesion reduction compared with other meshes was confirmed by a 
recent experimental study by Sikkink et al.52. Adhesion reduction was obtained 
without compromising reherniation and infection rates. Felemovicius et al. 
studied the use of the polypropylene HA-CMC mesh and polypropylene 
HA-CMC mesh combined with an additional HA-CMC membrane in a rat 
hernia model53. Polypropylene HA-CMC mesh reduced adhesions by roughly 
three-quarters compared to polypropylene mesh. The combination of the 
polypropylene HA-CMC mesh with the membrane nearly eliminated adhesion 
formation. Building on these successes, human studies should now further 
enlighten the clinical value of the polypropylene HA-CMC mesh.
Recently, the polypropylene HA-CMC mesh has been further developed into a 
polypropylene mesh co-knitted with polyglycolic acid (PGA) fibers (Sepramesh® 
IP, Genzyme) (Fig. 4). The PGA surface is coated with a bioresorbable, 
chemically modified sodium HA, CMC, and polyethylene glycol-based hydro­
gel. The co-knitting of polyglycolic acid in this mesh provides for a stronger 
bond between the permanent polypropylene mesh and the temporary adhesion 
barrier component as compared to the previous generation. A literature search 
does not reveal any clinical or preclinical data on this second generation 
product at this time, although the manufacturers claim the same level of benefit 
as the first generation product with substantially better handling characteristics 
and easier use in laparoscopic procedures (Fig. 5).
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Figure 4. Polypropylene mesh co-knitted with polyglycolic acid fibers, coated with a HA-CMC 
polyethylene glycol based hydrogel. (Image kindly provided by Genzyme)
Figure 5. Handling characteristics of the polypropylene polyglycolic acid HA-CMC polyethylene 
glycol mesh: flexible and well-suited for laparoscopic procedures. (Image kindly provided by 
Genzyme)
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T he u se  o f  h y a lu r o n a n  in  in f e c t io u s  c o n d it io n s
The use of HA-based antiadhesives under infectious conditions remains 
controversial. The majority of the available data at this time results from 
experimental studies and presents contradicting outcomes. Reijnen et al. 
described the use of the HA-CMC membrane in a peritonitis model in rats54. 
Although the contrary was hypothesized, the HA-CMC membrane did not 
reduce adhesions under these conditions. Tzianabos et al. stated that adhesion 
reduction devices might even potentiate intra-abdominal infection55. In a rat 
model, they used HA-CMC and G-HA-CMC membranes after the insertion of a 
bacterial inoculum in the peritoneal cavity. Both membranes did not increase 
abscess rates. Mortality data were only available for HA-CMC membrane, 
which did not increase mortality. In this study, the effect of the membranes on 
adhesion formation was not evaluated. Ghellai et al. described use of the 
HA-CMC membrane after cecal ligation and puncture or cecal ligation alone in 
rats56. Again, the HA-CMC membrane did not reduce the number or tenacity of 
adhesions. A trend toward increased abscess formation was associated with the 
use of the HA-CMC membrane in the cecal ligation group. Again using a cecal 
ligation and puncture model in rats, Tüzüner et al. found no differences 
between the control and HA-CMC membrane-treated groups regarding 
mortality, abdominal abscess formation, and median adhesion scores57. On the 
contrary, the use of the HA-CMC membrane led to significantly less dense 
adhesions. The increased adhesion formation after use of the G-HA-CMC 
membrane in bacterial peritonitis in the study of Kayaoglu et al. was already 
mentioned earlier in this chapter23. The only clinical prospective study that we 
are aware of describing the use of HA-CMC membrane in patients suffering 
from peritonitis is the above mentioned study of Vrijland et al.18. In this study, 
81% of the patients treated with the HA-CMC membrane were diagnosed to 
have sigmoid diverticulitis with signs of peritonitis. Although the number of 
patients in this study was small, it is interesting to note that although the 
incidence of adhesions did not differ between groups, the severity of adhesions 
was reduced by the HA-CMC membrane.
In the above mentioned experimental study of Reijnen et al. showing no 
beneficial effect of the HA-CMC membrane, the 0.4% HA solution proved to 
reduce the incidence of adhesions and abscesses in a peritonitis model54. 
The median severity of adhesions was significant lower using the HA solution at 
Day 7 and at Day 21 postoperatively. At Day 21, none of the rats treated with the 
HA solution had an intra-abdominal abscess, in contrast to 4 out of 12 (33%) rats 
in the control group. These results were confirmed by a second, larger study on
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this topic showing high volumes of 0.2% and 0.4% HA to be most effective, 
which may suggest a "hydroflotation" effect of the HA solution58. These superior 
results of HA solution compared to the HA-CMC membrane under infectious 
conditions were confirmed by the quoted study of Tüzüner et al.57. Unfortunately, 
withdrawal of Sepracoat® from the market has prohibited further clinical studies. 
There are no clinical data available on the use of ferric HA gel under contaminated 
and infectious conditions. The study of Tzianabos et al. describes the use of a 
preparation of ferric HA gel in an intra-abdominal model of infection in rats55. 
This study focused on a potential propagation of the device on intra-abdominal 
infection. The use of ferric HA gels potentiated bacterial peritonitis and led to 
significantly increased mortality rates of 90% to 100%, compared to 49% in 
controls. This could be explained by the known increase in virulence of 
bacterial species by iron. Furthermore, some virulent strains of human 
pathogens are able to use iron for the survival and replication of the organism. 
Sikkink et al. studied the use of auto-crosslinked HA gel in a rat peritonitis 
model59. Bacterial peritonitis was induced using a cecal ligation and puncture 
model, and the animals were randomized to receive 4 %  auto-crosslinked 
HA gel or phosphate buffered saline. Different amounts of the gel were used 
and the effects on adhesion and abscess formation were evaluated at different 
time points. In this study, a trend toward increased mortality due to fecal 
peritonitis with subsequent sepsis in the auto-crosslinked HA gel treated groups 
was observed. There were no significant differences in median total adhesion 
scores and abscess rates between groups.
O n c o l o g ic  r e p e r c u s s io n s  o f  h y a lu r o n a n
Little is known at this time about the use of HA during oncologic surgical 
procedures. Nevertheless, experimental studies have documented a critical role 
for HA in tumor growth and metastasis, as it interacts with cell behavior in 
various ways. The physical properties of HA contribute to tissue biomechanics. 
Furthermore, it acts as a template for the assembly of other pericellular 
macromolecules and interacts directly with cell surface receptors that transduce 
intracellular signals. Consequently, HA may promote anchorage, independent 
growth, and invasiveness of cancer cells as described by Toole60, 61.
Haverlag et al. studied the influence of HA solution on tumor cell adhesion62. 
In vitro, mesothelial cells were cultured in monolayers and the effect of 
HA solution on adhesion of tumor cells evaluated. The use of HA solution 
showed an inhibitory effect on tumor adhesion. In a uterine abrasion model in 
rats, HA solution tended to increase tumor load. In a laparotomy model, the
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mean total tumor scores did not differ significantly. Underwood et al. examined 
the effect of the HA-CMC membrane on tumor cell implantation at surgical 
wound and laparoscopic trocar sites in a hamster model63. It was concluded 
that the HA-CMC membrane neither had a protective nor an adverse effect on 
tumor implantation or growth. On the contrary, Tan et al. demonstrated that the 
HA solution significantly increased tumor cell proliferation and motility in 
vitro64. In vivo, a significantly higher total tumor nodule count was noted when 
using the HA solution in a rat model. Hubbard et al. examined the effect of the 
HA-CMC membrane on cancer cell growth and metastasis in a mouse model65. 
The HA-CMC membrane did not affect tumor metastasis. However, the 
placement of the membrane on nontraumatized peritoneum led to increased 
local tumor growth. It was concluded that not the HA but the traumatic 
placement of the membrane was responsible for local increased tumor growth. 
Pucciarelli et al. studied the effect of auto-crosslinked HA gel, native HA, and 
HA-CMC membrane on experimental intraperitoneal tumor implantation in 
mice66. Human HT29 colorectal cells were used, and the antiadhesives showed 
no negative impact on survival or tumor implantation. In an experimental 
laparoscopic study in mice by Sasaki et al., a protective effect of the HA-CMC 
membrane on port site metastasis was suggested67. Sikkink et al. recently 
studied the influence of the G-HA-CMC membrane on intraperitoneal tumor 
implantation and growth in a mouse and rat model of peritoneal traumai8. 
No major effects were found. However, a uniform conclusion cannot be drawn 
from these contradictory experimental results.
Human studies are even more scarce. Kusunoki et al. already described the use 
of the HA-CMC membrane in 1999 for the reconstruction of the pelvic floor 
after abdominoperineal rectal excision for oncologic reasons in three 
patients69. No remarks were made about the safety of HA in these cases. In a 
retrospective study in patients with colorectal excisions and short follow-up, 
Oikonomakis et al. found no adverse effects of the HA-CMC membrane70. 
More recently, Kusunoki et al. showed in a prospective randomized study that 
the use of the HA-CMC membrane had no adverse effects in a group of patients 
with rectal carcinoma who were treated with radiation therapy, two-stage 
surgery, and chemotherapy71. The median follow-up period was 43.6 months. 
The treatment with the HA-CMC membrane reduced adhesions in this 
chemoradiated group. Meanwhile, no other prospective randomized human 
studies have been performed to our knowledge.
Thus far, manufacturers have not promoted the use of HA-based agents in 
patients with malignancies. The product information for 0.5% ferric HA (Intergel®) 
clearly states that the product was not studied and is not recommended for
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use in patients with cancer. The same accounts for other products, such 
as HA solution (Sepracoat®), HA-CMC membrane (Seprafilm®), G-HA-CMC 
membrane (Seprafilm II®), polypropylene HA-CMC mesh (Sepramesh®), and poly­
propylene polyglycolic acid HA-CMC polyethylene glycol mesh (Sepramesh® IP).
M e c h a n ism s  o f  a c t io n  o f  h y a lu r o n a n
HA-based antiadhesive agents have proved to be effective in reducing intra­
abdominal adhesions in both experimental and clinical studies. Although the 
use of these products is widespread, there is still much debate on the exact 
mechanisms of action. Mechanical separation of injured peritoneal surfaces is 
probably the most important. Once these surfaces have healed after a period of 
approximately five days, no de novo adhesions will form. HA-CMC membranes 
create a mechanical barrier between the adhesiogenic wound surfaces. This 
allows the peritoneal lining to heal without adherence to the adjacent 
structures. HA solutions create a medium in which the bowel floats (the 
hydroflotation hypothesis), thus separating the intestines and thereby allowing 
adhesion-free repair of the mesothelial lining. The mechanical mechanism of 
the action of gels is probably somewhere between acting as a barrier and 
creating hydroflotation.
Apart from these mechanical mechanisms, biological mechanisms of action 
may be involved as well. Present in virtually all tissues and body fluids of 
vertebrates and with a profound role in cell biology, HA might improve 
peritoneal healing and enhance fibrinolysis72.
The relation between HA synthesis and cell proliferation has been studied 
thoroughly. The concentration of HA in healing tissues is high73, 74. Furthermore, 
HA synthesis facilitates cell detachment, mitosis, and locomotion75-79. An 
HA-rich environment provides an open, hydrated matrix that facilitates cell 
migration80,81. Exogenous HA may be beneficial in wound healing82, 83. Rapid, 
undisturbed restoration of the mesothelial lining of the traumatized peritoneum 
after surgery or infection should prevent adhesions, as stated previously. This 
concept is supported by the adhesion-reducing effect of intraperitoneal seeding 
of mesothelial cells or mesenchymal stem cells84, 85. Several studies have 
shown that HA increases the proliferation rate of mesothelial cells in vitro86, 87. 
This process implies that part of the adhesion-reducing capacity of HA may partly 
be explained by its ability to improve peritoneal healing due to the stimulation 
of mesothelial cell proliferation.
Abdominal surgery and peritonitis are known to disturb the equilibrium between 
the coagulation cascade and the fibrinolytic system, resulting in decreased
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peritoneal fibrinolytic capacity and subsequently enhanced adhesion 
formation. The influence of HA on peritoneal fibrinolysis despite several studies 
is not completely clear. HA increases the fibrinolytic response of human 
peritoneal mesothelial cells, mainly by decreasing PAI-1 transcription and 
release but also by increasing the intracellular tPA concentration in vitroi8. 
However, in vivo HA-based membrane and solution did not affect tissue tPA 
antigen or its activity in rat peritoneal biopsies after colonic surgery, with and 
without peritonitis i 4. Reijnen et al. discussed several explanations for these 
contradicting results in an earlier review89. However, a more recent in vitro 
study by Sikkink et al. did not show a significant effect of HA on the production 
of tPA by mesothelial cells either90. This study showed that cells of the 
monocyte-macrophage system modulate the fibrinolytic capacity of lipopoly- 
saccharide-treated human peritoneal mesothelial cells by increasing PAI-1 and 
tPA. HA solution decreased PAI-1 production by mesothelial cells, an effect that 
was ameliorated by the presence of monocyte-like cells. Two other studies did 
not add clarity to this subject, as the use of HA showed no effect on tPA and PAI 
levels in one and even resulted in a decrease of tPA in the other15, 91. Perhaps 
sequential biopsies from the peritoneum in human studies could further 
enlighten the role of HA in fibrinolysis, although the harvesting of successive 
biopsies would not be feasible in humans. Other sampling techniques, 
including the use of a peritoneal chamber or microdialysis, might overcome 
this in the near future92.
C o n c l u s io n s
HA-based antiadhesive agents have proven to be effective reducers of postsurgical 
adhesions in both experimental and clinical studies. Unfortunately, several 
products have been withdrawn form the market before larger clinical trials 
could be initiated. The application of HA in composite meshes for the repair of 
abdominal wall hernia appears to be worthwhile as well. Data on the use of HA 
under infectious conditions are scarce and do not allow conclusions about its 
preventive potential and clinical safety under these conditions. However, the 
use of HA solution appears to be beneficial in experimental models. Data on 
oncologic repercussions using HA are also scarce and contradictory, troubling 
conclusions on the use of HA-based agents in patients with a malignancy. 
Widespread use of HA should therefore be restricted to noninfectious and 
benign conditions. Further elucidation of the involved mechanisms and the 
clinical application of HA in patients with peritonitis and patients with 
abdominal malignancies are challenges for future trials.
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A bstract
Background: Mesothelial cells are involved in a variety of biological processes 
among which the formation of peritoneal adhesions. Cultures of human 
peritoneal mesothelial cells comprise an important tool to investigate behaviour 
and functions of mesothelial cells. Very little is known about differences 
between mesothelial cells isolated from different sources and of changes in 
specific functions as caused by cell propagation in vitro  or resulting from 
storage of cells at low temperatures. The current study aims to characterize 
two particular cellular activities relevant for tissue repair, the expression of 
ICAM-1 and the gelatinase activity, and to assess the effect of hyaluronan, an 
antiadhesive agent, on these cellular activities.
Methods: Viable cell lines were established from both omentum and peritoneal 
lavage fluid from seven patients. ICAM-1 expression, by ELISA, and matrix 
metal loproteinase (MMP) bioactivity, by zymography, were measured in the 
second and fourth passage, the latter also after freezing and storage of cells in 
liquid nitrogen. The effects of IL-1 ß, TNF-a, phorbol myristate acetate (PMA) 
and hyaluronan were analysed.
Results: ICAM-1 was constitutively expressed and stimulated by IL-1 ß, TNF-a 
PMA. All cell lines produced both MMP-2 and MMP-9. Only the latter activity 
was affected by TNF-a and, especially so, PMA. Differences were found 
between the second and fourth passage, and between cells of different lineage, 
mostly so if the relative stimulation by the various agents was compared. 
Addition of sodium hyaluronate either to control cultures or to cultures together 
with any of the three stimuli examined did not significantly change either 
ICAM-1 expression or gelatinase activity. Freezing and storage of cells did not 
affect their functions.
Conclusions: Both the human omentum and peritoneal lavage fluid are good 
sources to establish mesothelial cell lines which can be propagated, also after 
freezing, without qualitative changes in their ability to express ICAM-1 and produce 
the gelatinases. For omental cells there is a differential effect of stimulation 
depending on whether the cells have been passaged 2 or 4 times. The presence 
of hyaluronan did not affect the expression of ICAM-1 or the gelatinases.
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I n t r o d u c t io n
Mesothelium lines the peritoneal, pleural and pericardial cavities, with visceral 
and parietal surfaces covering the internal organs and body wall, respectively. 
The peritoneal mesothelium consists of a monolayer of specialised epithelial- 
like mesothelial cells that rests on a basement membrane supported by connective 
tissue. In recent years it has been shown that mesothelial cells are involved in 
a variety of biological processes, including antigen presentation, tumor cell 
adhesion and growth, and inflammation and healing 1 . Thus, the peritoneal 
mesothelial cells play a central role in the (patho)biology of the peritoneal 
cavity, in the maintenance of the peritoneal membrane, and in peritoneal tissue 
repair including coagulation and fibrinolysis2. Importantly, mesothelial cells are 
involved in the formation of intra-abdominal adhesions, which are a common 
complication following laparotomy3. Also, it has been suggested that regulation 
of mesothelial cell functions may be pivotal in the optimal management of 
patients with peritonitis4.
The mesothelial cells are loosely attached to the submesothelial layer and are 
easily removed or damaged due to peritoneal infection, pelvic inflammation, or 
tissue trauma induced during surgical procedures or peritoneal dialysis. They 
participate in initiating and resolving intraperitoneal inflammation and repair. 
In this respect, mesothelial cell intercellular adhesion molecule-1 (ICAM-1) expression 
and matrix metalloproteinase (MMP) activity are of interest. ICAM-1 expression 
facilitates the influx of leukocytes from the vascular compartment into the serosal 
space5 while the MMPs, including the gelatinases MMP-2 and MMP-9, are 
involved in matrix homeostasis6, 7. Since peritoneal injury will lead to high local 
concentrations of inflammatory cytokines2, 8 9, any of their effects on these mesothelial 
cell functions will constitute a potential regulatory mechanism.
Research on specific functions of human peritoneal mesothelial cells is usually 
performed either with primary cultures obtained from omental tissue or with 
immortalized cell lines, the latter by definition phenotypically altered10, 11. 
It has also been suggested that peritoneal lavage fluid would be a superior source 
of mesothelial cells10. However, little is known about differences between 
mesothelial cells isolated from different sources and of changes in specific 
functions as caused by cell propagation in vitro or resulting from storage of cells 
at low temperatures. Such knowledge is necessary for performing studies on 
isolated cells in such a way that culture conditions do least affect the cellular 
phenotype.
Hyaluronan is a high molecular weight polyanionic polysaccharide and part of 
the extracellular matrix. There is considerable evidence that hyaluronan has
49
Chapter 3
a beneficial influence on wound healing of several tissues. Besides a direct 
involvement in wound repair, hyaluronan is an important regulatory molecule 
in the inflammatory response12-14, and modifies cell migration and attachment 
by interaction with cell surfaces15. Hyaluronan reportedly reduces intra­
abdominal adhesion formation16-19.
The current study aims to characterize two particular cellular activities relevant 
for repair, the expression of ICAM-1 and the gelatinase activity, as they depend 
on a variety of conditions mentioned above. The effect of hyaluronan on the 
expression of ICAM-1 and the gelatinase activity was assessed in addition.
M et h o d s  
M aterials
Culture medium M199 (containing 25 mM HEPES, Earl's salts and L-glutamate), 
foetal bovine serum, penicillin-streptomycin, trypsin, ethylenediaminetetraacetic 
acid (EDTA) were obtained from Life Technologies, Breda, The Netherlands. 
Hydrocortisone, phorbol myristate acetate (PMA), gelatin (Type A: From Porcine 
Skin) and p-amino-phenylmercuric acetate (APMA) were purchased from Sigma 
Chemical (St Louis, MO, USA). Recombinant human interleukin-1 ß (IL-1 ß) and 
tumor necrosis factor-a (TNF-a) were from Peprotech (Rocky Hill, NY, USA). 
Sodium hyaluronate was from Genzyme (Cambridge, MA, USA). Human 
recombinant MMP-2 and MMP-9 were from Oncogene Research Products, 
Cambridge, MA, USA. A crude fraction of endothelial cell growth factors (ECGF) 
was kindly provided by the Department of Paediatrics, University Medical 
Center, Nijmegen, The Netherlands; heparin was obtained from Leo pharmaceutical 
products (Weesp, The Netherlands). Mouse anti-human cytokeratin 18 (M7010), 
rabbit anti-human von Willebrand factor (A082), FITC-labelled goat anti-mouse 
(F479), swine anti-rabbit (F205), horseradish peroxidase-conjugated goat-anti- 
mouse and orthophenyl diamine were from DAKO A/S, Glostrup, Denmark; 
mouse anti-human cytokeratin 19 (C7159) was from Sigma. Mouse anti-human 
ICAM-1 (clone HM-1) was from Hycult biotechnology (Uden, The Netherlands).
Isolation of cells
Source material for peritoneal mesothelials cells was obtained, after informed 
consent, from seven patients who underwent elective open abdominal surgery 
for non-infectious and non-tumorous conditions.
Peritoneal lavage fluid was obtained, immediately after opening of the peritoneal 
cavity, by distributing approximately 500 ml (37°C) saline solution and aspirating 
100 ml fluid after 2 min. The fluid was centrifuged for 10 min at 350xg (4°C). The
50
Intercellular adhesion molecule-1 and gelatinase expression
sediment was washed twice in cold culture medium (see below) and finally 
resuspended and seeded onto 75 cm2 tissue culture flasks.
From each patient approximately 5 g omental tissue was excised and collected 
in phosphate buffered saline (PBS). The tissue was washed twice with PBS and 
cells were detached by incubated under rotation in 16 ml of a solution 
containing 0.5 mg/ml trypsin and 0.2 mg/ml EDTA for 30 min at 37°C. 
Thereafter 16 ml culture medium was added, the resulting tissue was removed 
and the remaining suspension was centrifuged for 10 min at 350 x g (4°C), 
washed twice again with culture medium and the resulting cells were seeded 
onto 75 cm2 tissue culture flasks. Institutional ethical board approval was 
obtained for this study.
Cell culture and identification
The cells were propagated in a humified incubator at 37°C under 5%  CO2/95% 
air atmosphere. The medium consisted of M199 completed with 20% (v/v) foetal 
bovine serum albumin, 100 U/ml penicillin, 100 Mg/ml streptomycin, 0.5 Mg/ml 
hydrocortisone, 150 Mg/ml crude ECGF and 14U/ml heparin. One day after seeding 
or passage, and then every three days the cultures were replenished with fresh 
medium. Confluent cultures were passaged by brief (2-3 min) trypsinization 
(0.5 mg/ml trypsin and 0.2 mg/ml EDTA) until approximately 80% cell detachment 
was observed by light microscopy. For both lavage and omentum isolates cells 
were denominated as passage 1 (P1) after their first trypsinization from the 75 cm2 
tissue culture flasks. All cell lines were cultured up to passage 4 (P4). For propagation 
of cells a split ratio of 1:2.5 was applied. Typically, cells were seeded at a density 
of 1-1.5 x 104/cm2. Cell functions were examined in the second and fourth passage. 
A batch of cells from passage 2 (P2) was frozen in liquid nitrogen and after 
storage propagated until P4 for comparison with cells that had not been 
through a cyclus of freezing/thawing.
The purity of isolated cells and their mesothelial phenotype were evaluated by phase- 
contrast microscopy of the monolayer morphology and by immunohistochemistry. 
For the purpose of the latter, cultures were grown to confluency in 24-well plates, 
fixed in 95% ethanol and processed for immunofluerescence as described10. 
Cells were treated with antibodies to the specific endothelial markers cytokeratin 
18 and 19 and the endothelial marker von Willebrand factor. Characteristic 
staining was visualized after incubation with a second fluoresecent (FITC labelled) 
antibody.
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Cell functions: ICAM-1 expression and gelatinase activity
Cells were seeded (5 x 103 cells/well) in gelatin-coated 96 well plates in 
complete medium and grown to confluence in 5 days. The medium was 
changed at the first and third day after seeding. On day 5 cells were washed 
and incubated for 24 h with culture medium containing only 0.1% (v/v) 
albumin in the presence of various agents (n=6 for each condition) such as 
IL-1 ß (0.1 and 10 ng/ml), TNF-a (0.1 and 10 ng/ml), PMA (25 ng/ml) and 
sodium hyaluronate (0.08%). Thereafter, cultures were analysed immediately 
for ICAM-1 expression and the medium from 6 wells was pooled and stored at 
-80°C for subsequent measurement of gelatinase activity.
The expression of ICAM-1 was determined by a modified ELISA20. Briefly, the 
cultures were washed with serum-free M199 to remove serum components, 
and fixed with a 0.025% glutaraldehyde solution in PBS. The tissue culture 
plates were then pre-incubated for 1 h at 37°C with murine monoclonal anti- 
ICAM-1 (clone HM2, 1:1000) in ELISA buffer (0.5% bovine serum albumin in 
PBS). After 4 washing steps, specific binding was detected by incubation with 
horseradish peroxidase-conjugated goat-anti-mouse (1:1000) for 1 h at 37°C, 
and enzyme activity was analysed by using orthophenyl diamine substrate and 
measuring the optical density at 490 nm on a Bio-Rad 550 plate reader.
The activity of the gelatinases MMP-2 and MMP-9 was measured by quantitative 
gelatin zymography, as decribed previously21. Briefly, pooled medium was mixed 
with an equal volume of sample buffer, containing 0.125 M Tris-HCl, pH 6.8, 
17.4% (w/v) glycerol, 4%  sodium dodecylsulphate (SDS) and 0.01% bromophenol 
blue. Five pl aliquots were loaded on a 7.5% (w/v) standard Laemmli SDS- 
polyacrylamide gel containing 2 mg/ml gelatin as a substrate. Quantification of 
the proteinase activities, which were expressed as arbitrary units on the basis 
of lysed area, was performed using a Sharp JX-330 scanner and Imagemaster 
ID software (Amersham Pharmacia Biotech, Uppsala, Sweden). In-between 
comparison of values obtained on different gels was performed using an internal 
standard. The presence of true MMP activity was confirmed by adding 10 mM 
EDTA or 1 mM 1,10'phenanthroline, both MMP inhibitors, to the buffers used after 
electrophoresis. Human recombinant MMP-2 (1 ng/lane) and MMP-9 (0.5 ng/lane) 
were added to compare their localisation with endogenous activities. Activation of 
recombinant MMPs was achieved by incubation with 1mM p-amino-phenylmercuric 
acetate (APMA) (Sigma, St. Louis, MO, USA).
Statistical analysis
The tests used, mostly a two-sided paired t-test, are mentioned where appropriate. 
Differences between groups are considered significant if p<0.05.
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R esults
Establishment of cultures
Omental biopsies and lavage fluid were obtained from all patients and viable 
cell lines were established from all, with the exception of one sample of lavage 
fluid. The growth rate of cell lines from both sources, from P1 onwards, was 
similar. During cell propagation cells were routinely screened by light 
microscopy and all retained typical polygonal (cobblestone) morphology. 
Contrast microscopy failed to disclose any evidence of contamination by 
fibroblasts, endothelial cells or smooth muscle cells. Cells stained positive for 
cytokeratin 18 and 19 with sharply delineated cell boundaries and stained 
negative for von Willebrand factor. The opposite was true for cultures of human 
umbilical vein endothelial cells, used as negative controls. Propagation until 
the 10th passage was possible without any apparent changes in morphology as 
observed by light microscopy. Mesothelial cell lines that had been stored in 
liquid nitrogen showed features being equal to those of their counterparts that 
had not gone through this procedure.
ICAM-1 expression
Both omental and lavage cells from P2 constitutively expressed ICAM-1, but 
expression in the control medium was significantly higher in the cells cultured 
from lavage fluid (figure 1). Expression was increased by incubation with IL-1 ß, 
TNF-a and PMA for both cell sources, but more clearly so in the omental cells. 
In the lavage cells, average values after incubation with 0.1 ng/ml IL-1 ß or 
TNF-a, or PMA, were higher than in controls but not significantly so. As a 
consequence, the degree of stimulation by the various agents was significantly 
higher in omental than in lavage cells.
Figure 2 shows that the basal ICAM-1 expression in P4 omental cells was 
significantly higher than in P2 cells. Although expression in P4 was still enhanced 
(p<0.05) by both IL-1 ß and TNF-a, the relative increase was significantly less 
than in P2 for all stimuli examined. Such a difference was not observed in 
lavage cells (data not shown): cells in P4 reacted in a similar fashion as those in 
P2 (figure 1B).
Cells that had been propagated after storage in liquid nitrogen (and thus could only 
be evaluated in P4) did behave similarly to the corresponding cells that not had been 
frozen. This is illustrated in figure 3 for the omental cells. Here, the stimulation by 
10 ng/ml IL-1 ß seemed even more explicit in the cells cultured from frozen samples. 
Addition of sodium hyaluronate either to control cultures or to cultures together with 
any of the three stimuli examined did not significantly change ICAM-1 expression.
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Figure 1. ICAM-1 expression on mesothelial cells from the second passage. Average (+SD) expression 
in omental (A) and lavage (B) cells in control medium and in media with IL-1 ß (0.1 and 10 ng/ml), 
TNF-a (0.1 and 10 ng/ml) or PMA (25 ng/ml). Panel C represents the relative expression with respect to 
control medium (100%) for both omental (black bars) and lavage (open bars) cells. * p<0.05 vs control 
(two-tailed paired t-test); # p<0.05 omentum vs lavage (unpaired t-test with welch correction).
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Figure 2. ICAM-1 expression on mesothelial cells from omentum: effect of passage. Average (+SD) 
absolute expression in control medium C (left axis) for P2 (black bars) and P4 (open bars) cells. 
Relative expression (right axis) with respect to control medium (100%) for media with IL-1 ß 
(0.1 and 10 ng/ml), TNF-a (0.1 and 10 ng/ml) or PMA (25 ng/ml). * p<0.05 vs control; # p<0.05 P2 
vs P4 (both: two-tailed paired t-test).
MMP-2 and MMP-9 activity
All cell lines produced both the gelatinases MMP-2 and MMP-9: Figure 4 shows 
typical examples demonstrating the presence only of the pro-enzymes and not 
the activated (lower molecular weight) forms. The secreted activity of MMP-2 
was far higher than that of MMP-9 and mean activities in all cell lines appeared 
the same, independent of either passage or origin (table 1). In cells from the 
lavage lineage, MMP-9 activity was significantly lower in P4 than in P2.
Table 1. GELATINASE ACTIVITY IN MESOTHELIAL CELLS
MMP-2 MMP-9
Omentum P2 97 ± 42 (7) 2.36 ± 1.34 (7)
P4 82 ± 39 (7) 2.46 ± 1.27 (7)
Lavage P2 93 ± 52 (6) 2.39 ± 0.84 (6)*
P4 72 ± 38 (6) 1.38 ± 0.68 (6)
MM P activity in the culture medium from unstimulated cells is expressed in arbitrary units and shown as mean ± SD. 
* P2 vs P4, p<0.05, unpaired t-test.
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In none of the cell lines did incubation with IL-1 ß, TNF-a or PMA lead to 
significant changes in MMP-2 activity. This is illustrated in figure 4 and further 
quantified for P2 in figure 5. Addition of hyaluronic acid to any of the 
incubation media did not affect activity (data not shown).
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Figure 3. ICAM-1 expression on mesothelial cells from omentum: effect of freezing. Average (+SD) 
absolute expression in P4 in control medium C (left axis) for cells which had been frozen (black bars) 
and those which had remained unfrozen during propagation (open bars). Relative expression (right 
axis) with respect to control medium (100%) for media with IL-1 ß (0.1 and 10 ng/ml), TNF-a (0.1 and 
10 ng/ml) or PMA (25 ng/ml). * p<0.05 vs control; (#) p= 0.07 P2 vs P4 (both: two-tailed paired t-test).
Figure 4. Zymogram. Typical examples of gelatinases produced by two different omental cell lines 
in P2 and P4, both in control medium and after stimulation with TNF-a and PMA.
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Figure 5. MMP-2 activity in mesothelial cells from the second passage. Average (+SD) activity in 
P2 cells from omentum (black bars) and lavage cells (open bars). Results are given as relative 
activity vs control medium (100%) in media incubated with IL-1 ß (10 ng/ml), TNF-a (10 ng/ml) or 
PMA (25 ng/ml).
The MMP-9 activity was affected by TNF-a and, especially so, by PMA (figure 6). 
In cells from the second passage the relative stimulation was significantly 
higher in omental cells than in lavage cells (figure 6). In P4 this difference only 
existed for stimulation by TNF-a, although the average stimulation in omental 
cells of 44% failed to reach significance. When comparing the relative activities 
in P4 to those in P2, no significant differences were found (two-tailed paired 
t-test). As with MMP-2, addition of sodium hyaluronate to any of the incubation 
media did not affect MMP-9 activity at all.
D is c u s s io n
Viable human mesothelial cell cultures can easily be established with cells obtained 
both from omentum and lavage fluid. The two cell functions investigated, ICAM-1 
expression and gelatinase activity, are largely retained after propagation into the 
fourth passage. The differences observed appear to be quantitative only: stimulation 
by mediators remains intact, though in the case of omental cells to a lesser degree. 
Although the primary function of the mesothelium is to act as a protective non­
adhesive surface, mesothelial cells are also actively involved in a variety of 
processes such as antigen presentation, inflammation and repair, coagulation 
and fibrinolysis and tumor cell adhesion. Peritoneal mesothelial cells play a key 
role in peritoneal healing processes and adhesion formation22. Thus, their
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Figure 6. MMP-9 activity in mesothelial cells. Average (+SD) activity in P2 (A) and P4 (B) cells 
from omentum (black bars) and lavage cells (open bars). Results are given as relative activity vs 
control medium (100%) in media incubated with IL-1 ß (10 ng/ml), TNF-a (10 ng/ml) or PMA 
(25 ng/ml). * p<0.05 and (*) p=0.06 vs control; # p<0.05 and (#) p=0.07 omentum vs lavage 
(all: two-tailed paired t-test).
functions are increasingly studied in culture under conditions thought to mimic 
e.g. repair after surgery, pelvic inflammatory disease, peritonitis or peritoneal 
dialysis. The expression of ICAM-1 and the production of gelatinases are two 
cellular functions that are thought to be generally involved in repair after a variety 
of insults.
While the most explicit stimulation of cell functions in the present study is seen 
with omental cell lines in P2, significant stimulation of ICAM-1 expression by 
both IL1-ß and TNF-a is still observed in P4, also if cell lines had been deep- 
frozen. The latter result would suggest that mesothelial cells obtained from one 
patient can be harvested, propagated and stored, to be used at any suitable time 
for study of cellular functions. This would greatly facilitate studies on the 
properties of human mesothelial cells. However, one should realize that results
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may depend on the passage number. In our study for example ICAM-1 
expression in P2 omental cells was significantly higher than in P4 cells, even 
though ICAM-1 expression remained high in all conditions tested.
If investigated in P2, the earliest moment after harvesting considered practical 
for the purpose of studies into multiple cellular functions, cells from the lavage 
lineage appear to be less responsive to stimuli than omental cells. Both ICAM-1 
expression and MMP-9 activity are significantly stronger increased in the latter 
by the various mediators investigated. Still, lavage cells are responsive and 
remain so during further propagation. It has been reported that mesothelial cells 
from lavage fluid and omentum are also similar with respect to their production 
of components from the fibrinolytic system10. Thus, lavage fluid appears to be a 
feasible alternative as a source for mesothelial cells if insufficient omental tissue 
would be available. Still, it should be kept in mind that the mesothelial cells 
found in the lavage fluid may be either somehow damaged and thereby 
detached or recruited from the mesothelial lining for a purpose. It has been 
shown recently that free-floating mesothelial cells attach to injured serosal 
surfaces, proliferate and incorporate into the regenerating mesothelium23. They 
thus may have an essential role in peritoneal healing and therefore certain 
functional differences between these free-floating cells and cells present in the 
mesothelial lining may be expected.
It has been well established that mesothelial cells constitutively express ICAM-1. 
Expression of this adhesion molecule represents an important function of the 
mesothelial cell. For instance, ICAM-1 is essential in the peritoneal immune 
response against invading pathogens24, 25 and is involved in the adhesion of 
tumor cells during the development of peritoneal metastases26. The cell lines 
described in the present study all express ICAM-1. Also, they consistently show 
upregulation of ICAM-1 expression by both IL-1 ß and TNF-a.
MMP expression appears to be another important function of the mesothelial cell. 
A certain amount of matrix degradation is intrinsic to tissue repair. Thus, MMPs 
are involved in healing processes in general and it has been demonstrated that 
mesothelial cells have the capacity to produce MMPs, although data are relatively 
scarce, certainly those obtained on non-transformed cells. Pleural mesothelial 
cells have been found to constitutively express MMP-1,2,3 and -9 activity7' 27. 
With regard to human peritoneal cells, an immortalized cell line has been found 
to produce both MMP-2 and MMP-9 activity28, while cell lines grown from 
omentum and analysed in the second or third passage expressed MMP-2 and 
MMP-3 constitutively, but MMP-9 only after incubation with IL1-ß29. In our 
hands, mesothelial cells always express MMP-2, but incubation with IL-1 ß, TNF-a 
or PMA does not affect the activity found in the culture medium. MMP-9 is also
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invariably found, though at a far lower activity. There is very little stimulation 
by TNF-a and none with IL-1 ß, while PMA strongly stimulates the production 
of MMP-9. Each time, only the (inactive) proform of MMP-9 is found. Thus, while 
our data represent consistent findings in separate cell lines obtained from 
7 different subjects, they do not completely agree with the few reports published 
so far. Possibly, this emphasizes the fact that some cellular functions may vary 
strongly depending on cellular culture and propagation conditions. This implicates 
that results from in vitro experiments may be affected by specific culture and 
propagation conditions. Testing with various cell lines and origins may reduce this 
possibility.
W e have also investigated the effects of hyaluronan on ICAM-1 expression and 
gelatinase activity. Hyaluronan synthesis and degradation are thought to be 
involved in mesothelial repair30 and to influence the wound healing processes 
and inflammation in general. Hyaluronan-based agents reduce the formation of 
postsurgical adhesions, most likely due to both physical and biological 
properties22. Hyaluronan has been shown to modulate the fibrinolytic response 
of peritoneal mesothelial cells to TNF-a31, 32 and to affect both MMP-2 and 
MMP-9 release into the medium of cultured cells such as macrophages33 and 
tumor cells34. Hence, in neither of the cell lines examined here, did sodium 
hyaluronate affect ICAM-1 expression under any of the conditions investigated. 
This result is in accordance with a very recent report investigating its potential 
for therapeutic intervention in mesothelial-tumor adhesion3 5. In addition, in 
none of the cell lines, sodium hyaluronate changed M M P activity, either in the 
presence or absence of the various other agents added as potential stimuli. Thus 
it appears that both cellular repair functions investigated will remain unchanged 
by fluctuations in hyaluronan levels.
To our knowledge, there are hardly any studies reporting in a comprehensive 
manner on mesothelial cell functions as affected by culture and propagation 
conditions. Experiments on isolated cells are mostly done on primary cultures 
or immortalized cell lines. In the latter case, it is often unclear to what extent 
these cells retain their original characteristics. The current study emphasizes 
the fact that omental tissue is probably the best source for the isolation and 
culturing of human mesothelial cells since, in some respects, they remain more 
responsive than cells obtained from peritoneal lavage fluid from the same 
subject. For omental cells there is a differential effect of stimulation depending 
on whether the cells have been passaged 2 or 4 times. It is important to realize 
that isolated cells may be stored in liquid nitrogen and propagated again 
without any apparent loss of the functions studied here. The use of such cultures 
might limit the need to collect tissue from human subjects.
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A bstract
Objective: To determine whether the presence of cells of the monocyte- 
macrophage system affects the fibrinolytic response of peritoneal mesothelial cells 
to lipopolysaccharide (LPS) in presence and absence of sodium hyaluronate. 
Design: Controlled laboratory experiment.
Setting: Cell cultures in an academic laboratory research environment.
Cells: Human peritoneal mesothelial cells were harvested from patients undergoing 
a laparotomy for non-infectious reasons and cultured in vitro. Co-cultures were 
formed by adding U-937 human monocyte-like cells to a monolayer of mesothelial 
cells.
Interventions: After 24 hours, cultures were treated with 10 ng/ml LPS and sodium 
hyaluronate was added in a final concentration of 0.2%. Controls received 
medium without sodium hyaluronate.
Main outcome measures: After 24 hours incubation, tissue Plasminogen Activator 
(tPA), urokinase Plasminogen Activator (uPA) and Plasminogen Activator Inhibitor-1 
(PAI-1) levels were determined in medium and cell lysates using ELISA techniques. 
Results: In medium of co-cultures, tPA and PAI-1 concentrations were significantly 
increased compared to monocultures (p<0.05 and p<0.005, respectively), 
while uPA concentration was significantly decreased (p<0.01). In cell lysates of 
co-cultures, PAI-1 concentration was significantly increased compared to 
monocultures (p<0.01), while tPA and uPA were unaffected. Treatment with 
sodium hyaluronate significantly decreased PAI-1 (p<0.05) and uPA (p<0.01) 
concentrations in medium of monocultures, but decreased uPA concentration 
only in medium of co-cultures (p<0.01), compared to controls.
Conclusion: Cells of the monocyte-macrophage system modulate the fibrinolytic 
capacity of LPS treated human peritoneal mesothelial cells and interfere in the 
hyaluronan associated changes in mesothelial fibrinolytic capacity.
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I n t r o d u c t io n
Intra-abdominal infection, caused by perforation of viscera or leakage of a 
bowel anastomosis, is a critical and potential lethal condition. Peritonitis elicits 
an inflammatory response, accompanied by the production and release of a 
broad spectrum of biologically active proteins and exudation of protein rich 
fluid. The peritoneal exudate contains large amounts of fibrinogen. The activated 
coagulation cascade will result in the formation of thrombin that triggers 
conversion of fibrinogen into fibrin.
Under normal circumstances, fibrin is lysed by the fibrinolytic system. After 
abdominal surgery and infection, however, the equilibrium between coagulation 
and fibrinolysis is disturbed, in favor of the coagulation system1-3. Thus, fibrin 
will form deposits that are a matrix for ingrowth of fibrocollagenous tissue. 
Moreover, fibrin clots protect bacteria against the immunological defense of the 
abdominal cavity. Following this pathway, intra-abdominal fibrin may eventually 
lead to adhesion and abscess formation1, 2 4.
By producing both plasminogen activators and inhibitors mesothelial cells are 
decisive in the genesis of adhesions and abscesses. Tissue-type plasminogen 
activator (tPA) is the main plasminogen activator. A second, but less potent 
plasminogen activator is urokinase-type plasminogen activator (uPA), which 
also may play a role in tissue remodeling processes5. Their activity is restricted 
by plasminogen activating inhibitors, predominantly type 1 (PAI-1).
The monocyte-macrophage system may influence peritoneal fibrinolysis by the 
production of a variety of cytokines. Cytokines have been reported to alter the 
production of both plasmin activators and its inhibitors by mesothelial cells. 
Cells of the monocyte-macrophage system are attracted to the abdominal cavity 
48 to 72 hours cells after bacterial infection by inflammatory mediators, and 
thus might alter mesothelial cell functions. These inflammatory cells are 
triggered by bacterial compounds, including lipopolysaccharide (LPS), which 
are released during colorectal surgery and peritonitis.
Hyaluronan is a substance of the extracellular matrix, which influences wound 
healing processes and inflammation6-9. Hyaluronan reportedly reduces intra­
abdominal adhesion formation10-12. Moreover it may reduce the incidence of 
intra-abdominal abscesses in experimental peritonitis13, 14. W e have earlier 
demonstrated that sodium hyaluronate modulates the fibrinolytic response of 
peritoneal mesothelial cells to TNF-a15.
W e hypothesized that cells of the monocyte-macrophage system affect the 
fibrinolytic response of human peritoneal mesothelial cells, and that effects of 
hyaluronan might differ in the presence and absence of these cells.
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M a t er ia ls  a n d  M et h o d s  
Cell culturing
Human peritoneal mesothelial cells were isolated from peritoneal lavage 
performed in 5 patients undergoing colorectal surgery for non-infectious 
reasons, according to Ivarsson et al.16. Meticulous hemostasis during opening 
of the abdomen prevented blood spill in the lavage fluid. Lavage fluids were 
transferred into 50 ml tubes and centrifuged at 650 g at 20°C for ten minutes. 
The supernatant was withdrawn and the pellet resuspended in 5 ml culture 
medium. Cells were cultured at 37°C in 5 %  CO2 in air with a humidity of 
80-90%, in tissue culture flasks (25cm2) (Sarstedt, Newton, NC, USA) in 
medium which consisted of E199 (Sigma, St.Louis, MO, USA), with the addition 
of L-glutamine 1.1 mmol/l (Sigma), penicillin-streptomycin 30 I.E./ml (Sigma), 
fetal bovine serum 20% (Sigma), endothelial cell growth factor 150 pg/ml 
prepared according to Maciag17, heparin 14 IU/ml (Lövens Läkemedel, Malmö, 
Sweden) and 0.5 pg/ml hydrocortisone (Sigma). Cells were passaged two 
times at the most. The mesothelial origin from the cells was controlled by their 
typical cobblestone appearance in phase contrast microscopy and by 
immunohistochemistry, as previously described16. In addition, the presence of 
cytokeratin 18 and 19, typically expressed by mesothelial cells, was verified 
using a mouse anti-human cytokeratin 18 antibody (DAKO A/S, Glostrup Denmark, 
M7010, diluted 1:20), and a mouse anti-human cytokeratin 19 antibody (DAKO 
A/S, M0888, diluted 1:20) that were FITC-labeled.
U-937 human monocyte-like cells (ATCC, Rockville, MD, USA) were cultured 
in medium that consisted of RPMI 1640 (Sigma) with the addition of L-glutamine
1.1 mmol/l (Sigma), penicillin-streptomycin 30 I.E./ml (Sigma) and 10% fetal 
bovine serum (Sigma), as specified by the manufacturer.
The experiments were approved by the Institutional Review Board of the Sahlgrenska 
University Hospital/Östra, Göteborg University, Göteborg, Sweden, and informed 
consent was obtained prior to the cell harvesting.
Study design
Mesothelial cells were cultured until a complete monolayer was formed. 
In order to form co-cultures U-937 cells were added to half of the cultures one 
day prior to the experiments in a final concentration of 106 U-937 cells/well. 
Medium of both mono- and co-cultures consisted of 50% E199 medium and 
50% RPMI 1640 medium. Pilot studies have demonstrated that this composition 
of medium is optimal for the growth of both cell types (data not published).
To mimic the clinical situation of colorectal surgery and bacterial peritonitis,
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all cultures were treated with 10 ng/ml LPS (Sigma, St.Louis, MA, USA). For each 
study group eight cultures were used (n=8). Four experimental groups were 
created;
1. Mesothelial cells with regular medium.
2. Co-cultures of mesothelial cells and U-937 cells with regular medium.
3. Mesothelial cells with medium containing 0.2% (w/v) sodium hyaluronate 
(Genzyme Corporation, Cambridge, MA, USA).
4. Co-cultures of mesothelial cells and U-937 cells with medium containing 
0.2% (w/v) sodium hyaluronate.
After 24 hours incubation, medium was collected and stored in aliquots at 
-80°C until measurements. Fresh medium was added to the cells and they were 
lysated by freezing and thawing three times. Cell lysates were stored in aliquots 
at -80°C until assayed.
Biochemical assays
Determinations of plasminogen activators and inhibitors were done using 
commercially available ELISA-kits. Levels of tPA-antigen, and PAI-1-antigen 
were assessed using imulyse kits from Biopool (Umeâ, Sweden) and uPA- 
antigen using a kit from Monozyme (Horsholm, Denmark).
Statistics
Values are given in box plots (median, interquartile range and 10th and 90th 
percentiles) in several figures. Analysis of differences was performed using the 
Mann-Whitney U test. Statistical significance was set at P<0.05. All tests were 
2-tailed.
R esults
tPA-antigen
The presence of U-937 cells significantly increased tPA concentration in the 
media of cultures not treated with hyaluronate (group 1 vs. group 2, p<0.05) 
(Fig. 1). The addition of sodium hyaluronate to the medium ameliorated the 
effect of the U-937 cells (group 3 vs. group 4).
Treatment with sodium hyaluronate did not affect tPA concentrations in the 
media of both mono- and co-cultures (group 1 vs. group 3 and group 2 vs. group 4, 
respectively).
There was no significant difference between tPA concentrations measured in 
cell lysates of mono- and co-cultures (group 1 vs. group 2 and group 3 vs. group 4, 
respectively) (Fig. 2).
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Treatment with sodium hyaluronate did not significantly affect tPA concentration 
measured in cell lysates of both mono- and co-cultures (group 1 vs. group 3 and 
group 2 vs. group 4, respectively).
Figure 1. Levels of tPA-ag in medium of monocultures and co-cultures. Results are illustrated 
as median (horizontal line) interquartile range (boxes) and 10th and 90th percentiles (error bars). 
+ = p<0.05 monocultures versus co-cultures.
Figure 2. Levels of tPA-ag in cell lysates of monocultures and co-cultures. Results are illustrated 
as median (horizontal line) interquartile range (boxes) and 10th and 90th percentiles (error bars).
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uPA-antigen
The presence of U-937 cells significantly decreased uPA concentrations in the 
media of cultures not exposed to sodium hyaluronate (group 1 vs. group 2, 
p<0.01) and the media of cells treated with sodium hyaluronate (group 3 vs. 
group 4, p<0.01) (Fig. 3).
Figure 3. Levels of uPA-ag in medium of monocultures and co-cultures. Results are illustrated 
as median (horizontal line) interquartile range (boxes) and 10th and 90th percentiles (error bars). 
+ = p<0.01, monocultures versus co-cultures, * = p<0.01 sodium hyaluronate (HA) versus control.
Sodium hyaluronate significantly decreased uPA concentration measured in 
medium of both monocultures (group 1 vs. group 3, p<0.01) and co-cultures 
(group 2 vs. group 4, p<0.01).
There was no significant difference in uPA concentrations measured in cell 
lysates of monocultures and co-cultures, regardless the presence or absence of 
sodium hyaluronate (group 1 vs. group 2 and group 3 vs. group 4) (Fig. 4). 
Treatment with sodium hyaluronate did not have a significant effect on uPA 
concentration in cell lysates of both monocultures and co-cultures (group 1 vs. 
group 3 and group 2 vs. group 4, respectively).
PAI-1-antigen
PAI-1 concentration in medium was significantly increased in co-cultures 
compared to monocultures in both media from cultures not treated with 
sodium hyaluronate (group 1 vs. group 2, p<0.005) and media from cells 
exposed to sodium hyaluronate (group 3 vs. group 4, p<0.005) (Fig. 5).
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Figure 4. Levels of uPA-ag in cell lysates of monocultures and co-cultures. Results are illustrated 
as median (horizontal line) interquartile range (boxes) and 10th and 90th percentiles (error bars).
Figure 5. Levels of PAI-1-ag in medium of monocultures and co-cultures. Results are illustrated 
as median (horizontal line) interquartile range (boxes) and 10th and 90th percentiles (error bars). 
+ = p<0.005, monoculture versus co-culture. * = p<0.05, sodium hyaluronate (HA) versus control.
Treatment with sodium hyaluronate significantly decreased PAI-1 concentration 
in medium of monocultures (group 1 vs. group 3, p<0.05). In contrast, exposure 
to sodium hyaluronate did not affect PAI-1 levels in media of co-cultures (group 2 
vs. group 4).
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In cell lysates, the PAI-1 concentration was significantly increased in co-cultures 
compared to monocultures, both in the absence and presence of sodium 
hyaluronate (group 1 vs. group 2, p<0.01 and group 3 vs. group 4, p<0.05, 
respectively) (Fig. 6).
Treatment with sodium hyaluronate did not affect PAI-1 concentration in cell 
lysates of both mono- and co-cultures (group 1 vs. group 3 and group 2 vs. group 4, 
respectively).
Figure 6. Levels of PAI-1-ag in cell lysates of monocultures and co-cultures. Results are illustrated 
as median (horizontal line) interquartile range (boxes) and 10th and 90th percentiles (error bars). 
+ = p<0.01, ++ = p<0.05 monoculture versus co-culture.
D is c u s s io n
In the present study we have demonstrated that cells of the monocyte-macrophage 
system have a significant influence on the fibrinolytic response of human 
peritoneal mesothelial cells exposed to LPS and that the effect of sodium 
hyaluronate on this response differs in presence or absence of monocyte-like cells. 
The occurrence of U-937 cells in the cultures increased both tPA and PAI-1 in 
medium, while the uPA levels decreased. Monocytes/macrophages can produce 
a broad scale of inflammatory cytokines, including TNF-a and TGF-ß18, 19. Both 
cytokines are known regulators of peritoneal fibrinolysis, mainly by increasing 
the production of PAI-1 by mesothelial cells1 6, 20. It seems unlikely that the 
U937 cells themselves have contributed to the increased PAI-1 levels since 
these cells do not seem to produce PAI-121.
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If the U937 cells have contributed to the increased tPA levels cannot be 
concluded from the present study. However, previous experiments of our group 
have shown that these cells do not produce detectable amounts of tPA under 
these conditions (data not published). The presence of U-937 cells in the 
cultures did not seem to affect the intracellular storage of tPA in mesothelial 
cells. This may indicate that the monocytes mainly affect tPA release from 
mesothelial cells.
The U-937 cells decreased the secretion of uPA into the medium, but did not 
affect its intracellular storage. This suggests that the reduced expression of uPA 
in the media may not be an effect of internalization of uPA, but rather a 
decreased synthesis.
In peritonitis the peritoneal fibrinolytic capacity is depressed2, 3. Experimental 
data have demonstrated that the period of hypofibrinolysis is followed by a 
phase of increased activity after several days22, 23. This is in accordance with the 
time period wherein cells of the monocyte-macrophage system invade the 
peritoneal cavity. The increased tPA concentrations found in co-cultures suggest 
that monocyte-like cells might be involved in this rebound phenomenon, either 
by stimulating mesothelial tPA production or by producing it themselves. 
However, in the presence of monocyte-like cells, the PAI-1 expression was 
equally increased, which will rapidly inactivate the surplus of tPA by forming 
one-on-one complexes. The role of monocyte-like cells in peritoneal repair 
mechanisms therefore requires further investigation.
Several studies have demonstrated that intra-peritoneal treatment with 
hyaluronan-based agents reduces postsurgical adhesion formation10-12. Moreover, 
it is reported to reduce abscesses in experimental peritonitis13, 14. The principle 
mode of action of hyaluronan agents is considered to be separation of injured 
serosal layers and protection of the peritoneal surface from surgical damage. 
Hyaluronan, however, has also documented biological functions2. We previously 
demonstrated that hyaluronan modulates the fibrinolytic capacity of human 
peritoneal mesothelial cells treated with TNF-alpha, mainly by decreasing the 
production of PAI-115.
In the present study sodium hyaluronate also decreased PAI-1 levels produced 
by mesothelial cells exposed to LPS, most likely due to a decreased synthesis. 
This observation gives further support to the notion that sodium hyaluronan 
may, in part, reduce adhesions and abscesses through increased peritoneal 
fibrinolysis. The presence of monocyte-like cells, however, abolished the 
reduction in PAI-1, indicating that hyaluronan may become less efficient when 
cells of the monocyte-macrophage system have already invaded the abdominal 
cavity.
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The presence of LPS has profound influence on mesothelial cell fibrinolysis. 
It decreases tPA and increases PAI-1 expression of these cells16. Moreover, it 
stimulates the production of various cytokines by monocyte-like cells that, in 
turn, also have an effect on mesothelial fibrinolysis. Both monocytes and 
mesothelial cells carry hyaluronan binding surface receptors, including CD44 
and ICAM-1 7, 24, 25. Binding of hyaluronan to the CD44 receptor modulates the 
cytokine expression of the monocyte, which might have changed the production 
of fibrinolytic factors by mesothelial cells in our study. The mechanisms 
involved in this system are complex though and require additional studies.
The presence of monocyte-like cells in the cultures increased both the release 
of PAI-1 and its intracellular pool, which suggests either an enhanced synthesis 
or a diminished degradation of PAI-1. High levels of PAI-1 have been correlated 
with various clinical situations, including adhesion formation and cancer cell 
invasion and angiogenesis26, 27. Peritonitis, caused by a perforated colorectal 
carcinoma, is correlated with a poor prognosis. In this clinical situation large 
amounts of inflammatory cells are present in the peritoneal cavity, which is 
associated with high PAI-1 levels. Increased PAI-1 concentrations, subsequently, 
might affect the intraperitoneal behavior of colorectal tumor cells. This, however, 
warrants further research.
It is concluded that monocyte-like cells modulate the fibrinolytic activity of 
human peritoneal mesothelial cells by increasing both tPA and PAI-1. Sodium 
hyaluronate decreased PAI-1 production by mesothelial cells, which effect was 
ameliorated by the presence of monocyte-like cells.
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A bstract
Background: Prevention of adhesion and abscess formation would decrease 
mortality and morbidity after peritonitis. In this study the effect of a new 
antiadhesive, auto-cross-linked hyaluronic acid polysaccharide (ACP) gel, on 
adhesion and abscess formation was studied in a rat peritonitis model.
Study Design: In experiment 1, bacterial peritonitis was induced in 24 Wistar 
rats, using a cecal ligation and puncture model. Animals were randomized to 
receive 4ml ACP gel (4%) or 4 ml phosphate buffered saline (PBS). After two 
weeks animals were killed and adhesions and abscesses were scored. In 
experiment 2, 72 rats underwent the same procedure but were randomized to 
receive 2 ml ACP gel, 4 ml ACP gel or 4 ml PBS. After one and three weeks, 
respectively, half of the animals in each group were killed and adhesions and 
abscesses were scored.
Results: The median total adhesion score was 12 (range 3-20) in the ACP group 
and was 9 (range 6-12) in the PBS group (not significant) in experiment 1. 91% 
of rats in the ACP group developed abscesses, versus 90% in the control group. 
There were no significant differences in abscess size or number of abscesses. In 
experiment 2, total adhesion scores in the 2 ml ACP group, 4 ml ACP group and 
PBS group were 4 (range 2-20), 6 (range 1-11) and 6 (range 1-18) respectively 
(not significant) after one week and 3.5 (range 1-8), 5 (range 2-15) and 4 (range 
0-9), respectively (not significant) after three weeks. All rats in the 2 ml ACP 
group and the PBS group and 83% of the 4 ml ACP group had developed 
abscesses after one week. After three weeks these percentages were 80, 75 and 
73, respectively. There were no significant differences in size or number of 
abscesses between groups both after one and three weeks.
Conclusion: Auto-cross-linked hyaluronic acid polysaccharide does not reduce 
adhesion and abscess formation in a rat peritonitis model.
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I n t r o d u c t io n
Secondary peritonitis is a common and serious problem in surgical practice 
associated with high morbidity and mortality. Its most severe causes are bowel 
perforation and intestinal anastomotic dehiscence. Emergency surgery is required 
and potentially life saving. Surgery is frequently complicated by abscess formation 
requiring percutaneous drainage or relaparotomy. In severe cases of peritonitis, 
more than one laparotomy and the use of temporary closure devices are 
inevitable. These relaparotomies may easily be complicated by severe adhesion 
formation and dissection of the adhesions may cause serosal bleeding, inadvertent 
enterotomy and fistula formation1' 2. Diffuse adhesion formation is reason to 
postpone restoration of intestinal continuity or abdominal wall reconstruction in 
these patients for six to twelve months. Prevention of adhesions and abscesses, 
which share a pathophysiological pathway of formation, would be of great help to 
reduce mortality and morbidity after peritonitis.
In the last years, numerous antiadhesives have been studied, most, however, 
in elective surgery and non-infectious conditions3-6. It is notable that adhesion 
prevention after peritonitis is hardly studied, whereas peritonitis and subsequent 
surgery are the ultimate challenge for testing the effectiveness of antiadhesives. 
Some antiadhesives are not registered for infectious conditions or even 
aggravate infection, which in part explains the paucity of data7.
Hyaluronic acid (HA) membrane reduces adhesions in experimental and 
clinical studies3-6. The adhesion reducing capacity of HA seems to be the result 
of being a physical barrier limiting tissue approximation and biological effects 
on peritoneal repair mechanisms8-11. W e previously reported beneficial effects 
of HA solution in experimental peritonitis8, 10. Liquid HA was used to assure 
spreading of the antiadhesive throughout the abdomen. Drawback of the HA 
solution was the short residence time. An antiadhesive agent that spreads 
through the whole abdomen and remains for a period long enough to allow 
peritoneal healing would be most ideal and a new hyaluronic acid derivate 
(auto-cross-linked polysaccharide (ACP) gel (Hyalobarrier® gel) seemed to meet 
these demands.
ACP is a highly viscous suspension in sterile distilled water of pure hyaluronic 
acid, which has been internally cross-linked without use of foreign molecules. 
ACP gel reduces intra-abdominal adhesion formation in experimental adhesion 
models12-15.
Following the previous experiences with HA solution it was the aim of this 
study to evaluate the effect of a viscous pure hyaluronic acid derivate on 
adhesion and abscess formation in a rat model of secondary peritonitis.
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M a t er ia ls  a n d  M et h o d s  
Study design
The effect of ACP gel on adhesion and abscess formation was studied in an 
experimental model of peritonitis in rats, closely mimicking the clinical situation. 
In the first experiment ACP was compared to control (PBS). In the second 
experiment two volumes of ACP were used and results were scored on two time 
points. The study protocol was approved by the Animal Ethics Review 
Committee of the Faculty of Medicine, Radboud University Nijmegen, the 
Netherlands
Animals
Male Wistar rats (Harlan Nederland, Zeist, The Netherlands), weighing between 
260 and 320 gram were housed at 21 ° Celsius with a day-night cycle of 12 hours. 
They had free access to water and standard rodent chow (Hope Farms BV, 
Woerden, The Netherlands).
Antiadhesive agent
Auto-cross-linked polysaccharide (ACP) gel (Hyalobarrier® gel, Fidia Advanced 
Biopolymers, Abano Terme, Italy) is a highly viscous gel, based on pure 
hyaluronic acid. ACP is obtained by means of an intern cross-linking reaction of 
pure hyaluronic acid, in the absence of any chemical substance foreign to the 
native hyaluronic acid structure. The commercially available ACP gel has a 
concentration of 4%.
Experiment 1: Effect of ACP gel on adhesion and abscess formation in a rat 
peritonitis model
A cecal ligation and puncture (CLP) procedure was done to induce bacterial 
peritonitis in 24 rats. This is a well-elaborated model in our laboratory with 
mortality rates between 5 and 30 percent mimicking the clinical situation of 
secondary perforation peritonitis and subsequent surgical source control, and 
postoperative intra-abdominal adhesion and abscess formation8, 10. Food was 
withheld from the animals 12 hours before the first operation. On day zero, rats 
were weighed and anaesthetized with a fluothane, nitrous-oxide-oxygen 
mixture. Before operation the abdomen was shaved and disinfected with 70% 
alcohol. Via a 3 cm midline laparotomy, the cecum was dissected without 
damaging the vascularization and was filled backwards with feces. The rat 
cecum has a saccular shape extending below the level of the ileocecal valve. 
The cecum was ligated just distal to the ileocecal valve, with a 3.0 polyglactin
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suture (Vicryl®, Ethicon, Norderstedt, Germany), without interfering with the 
passage of stools from the ileum to the colon. The antimesenterial site of the 
cecum was punctured once with a 19-Gauge needle. The abdominal wall was 
closed in 2 layers with a 3.0 polyglactin suture. Immediately after operation, 
rats received a single dose of gentamicine sulfate (Centrafarm Services BV, 
Etten-Leur, The Netherlands), 6mg/kg, intramuscularly and buprenofine hydrochloride 
(Temgesic®, Reckitt & Colman Products Ltd., Amstelveen, The Netherlands), 
0.1 mg/kg, subcutaneously. All animals were resuscitated with 10 ml of isotonic 
sodium chloride solution administered subcutaneously.
On day one, the abdomen was reopened under anaesthesia, and in half of the 
animals peritoneal fluid samples were taken and collected for culture. The 
abdominal cavity was rinsed with 10 ml of isotonic sodium chloride solution 
and the cecum was resected.
Before closure of the abdomen, animals were randomly assigned to receive 
4 ml ACP gel 4 %  instilled in the abdominal cavity (ACP group; n=12) or 4 ml 
phosphate-buffered saline (PBS group; n=12). After two weeks, the animals 
were weighed and killed using carbon dioxide asphyxiation. Adhesions were 
scored in a blinded manner according to the method of Zühlke et al., whereby 
grade zero means no adhesions and grade IV means very strong adhesions, only 
dissectible with sharp instruments with organ damage almost unavoidable16. Sites 
of adhesions scored included the midline, the upper abdomen (liver), the 
parietal peritoneum, the omentum, and between bowel loops. The total score of 
these five locations was noted as the total adhesion score (0-20). If present, the 
size of abscesses was noted. An abscess was defined as a walled off collection 
containing purulent material. In half of the animals samples were taken from 
the abscesses for microbiological examination.
Experiment 2: Effect of two volumes of ACP gel on adhesion and abscess 
formation in a rat peritonitis model, measured at one and three weeks
Bacterial peritonitis was induced in 72 rats according to the same protocol as 
applied in experiment 1. Animals were randomised into three groups of 24 rats 
and treated with 2 ml ACP gel 4%, 4 ml ACP gel 4 %  or 4 ml PBS (control). After 
one and three weeks, respectively, half of the animals in each group (n=12) 
were killed, and adhesions and abscesses were scored as described above. One 
and three weeks were chosen in conjunction with two weeks in experiment 1 
to control for spontaneous resolution of adhesion and abscess formation in 
time.
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Bacterial cultures
Samples of peritoneal fluid were cultured semiquantitatively in aerobic and 
anaerobic conditions. Colombia III agar with 5 %  sheep blood (Beckton 
Dickinson, Etten-Leur, The Netherlands), Levine eosin-methylene blue agar 
(Oxoid, Haarlem, The Netherlands) and fastidious anaerobic agar (Tapley, Bury, 
UK) with or without kanamycin, were used for cultures. After 24 and 48 hours 
of incubation at 37°, bacteria were identified using standard procedures.
Statistical analysis
Statistical analysis of the data in experiment 1 was performed using the non- 
parametric Mann-Whitney U test and Fisher's exact test. Results of experiment 
2 were analysed using the Kruskal-Wallis test for multiple comparisons, with 
Dunn's post-tests and the Chi-squared test for independence. A p-value < 0.05 
was considered statistically significant.
R esults
Sepsis and mortality
Following the cecal ligation and puncture procedure rats demonstrated symptoms 
of intra-abdominal sepsis, including apathic behaviour, ocular exudates, pilo- 
erection and diarrhoea. These symptoms resolved after 2-3 days after the 
resection of the ligated and punctured cecum and abdominal lavage in most 
rats. Three rats (12%) prematurely died in experiment 1; one in the ACP group, 
two in the PBS group (p=1.00). Death was probably due to inadvertent 
enterotomy during the surgical procedure in one case. Cause of death was 
unclear in two cases. 22 Rats (31%) prematurely died in experiment 2; 9 in the 
2 ml ACP group, 10 in the 4 ml ACP group and 3 in the PBS group (p=0.06). 
Fecal peritonitis with subsequent sepsis seemed to be the cause of death in all 
but one cases.
Cultures
Both in experiment 1 and 2, bacterial cultures taken at the day of cecal 
resection, revealed a mixed aerobic and anaerobic flora of Escherichia co li, 
coagulase negative Staphylococcus, Proteus species, Streptococcus viridans, 
Enterococcus species, (gram-negative and -positive rods), anaerobic gram-negative 
and -positive rods and anaerobic gram-positive cocci. A similar flora was found 
in the abscesses at two weeks in experiment 1.
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Adhesions and abscesses
The median adhesion scores at the five different locations and the total 
adhesion score in experiment 1 are shown in table 1. The quality of adhesions 
did not differ, except for the omentum at which site adhesions were thicker in 
the ACP group (p=0.01). 91% of rats in the ACP group developed abscesses, 
versus 90% in the control group (p=1.00). There was no significant difference in 
abscess size (p=0.22) or number of abscesses (p=0.76) between the ACP and 
PBS group.
Table 1. DEATH, ABSCESS RATE AND  ADHESION SCORES OF RATS TREATED WITH 4 ML ACP 
4% GEL COMPARED TO CONTROLS (PBS). ADHESION SCORES AFTER 2 WEEKS ARE GIVEN 
AS MEDIAN AND RANGE. * P=0.01 ACP 4ML VS PBS 4ML
ACP, 4ml PBS, 4ml
N 12 12
Premature death (N) 1 2
%  of rats with abscess 91 90
Adhesion score midline 3 (0-4) 3 (0-4)
Adhesion score liver 0 (0-4) 0 (0-2)
Adhesion score omentum -4)(0­3 1.5 (0-3)
Adhesion score peritoneum 3 (0-4) 2 (0-3)
Adhesion score bowel loops 4 (0-4) 3 (2-4)
Total adhesion score 12 (3-20) 9 (6-12)
Similarly to experiment 1, differences between groups with regard to adhesion 
scores at one and three weeks in experiment 2 were not significant except for 
the omentum, at which site adhesions were thicker in the 4 ml ACP group at 
three weeks (difference between groups; p=0.02, post tests: p<0.05 ACP 4 ml 
vs PBS) (Table 2). 100% of rats in both the 2 ml ACP group and PBS group and 
83% of the 4 ml ACP group had developed abscesses after one week (p=0.27). 
There were no significant differences in abscess size (p=0.66) or number of 
abscesses (p=0.57). After three weeks, 80% of the 2 ml ACP group, 75% of the 
4 ml ACP group and 73% of the PBS group had developed abscesses (p=0.93). 
Again, both abscess sizes (p=0.34) and number of abscesses were not different 
(p=0.63).
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Table 2. DEATH, ABSCESS RATE AND ADHESION SCORES OF RATS TREATED WITH 2 ML OR 
4 ML ACP 4% GEL, COMPARED TO CONTROLS (PBS). ADHESION SCORES AFTER 1 AND 
3 WEEKS ARE GIVEN AS MEDIAN AND  RANGE. * P<0.05 ACP 4ML VS PBS 4ML
Scores after 1 week Scores after 3 weeks
ACP, 2ml ACP, 4ml PBS, 4ml ACP, 2ml ACP, 4ml PBS, 4ml
N 12 12 12 12 12 12
Premature death (N) 7 6 2 2 4 1
%  of rats with abscess 100 83 100 80 75 73
Adhesion score midline 0 (0-4) 0 (0-1) 1 (0-4) 0 (0-2) 0 (0-4) 0 (0-2)
Adhesion score liver 0 (0-4) 2 (0-4) 0 (0-4) 0 (0-4) 1 (0-4) 0 (0-3)
Adhesion score omentum 1 (0-4) 1 (0-2) 1 (0-3) 1 (0-3) 1.5 (1-3)* 0 (0-2)
Adhesion score peritoneum 2 (0-4) 0 (0-2) 1.5 (0-4) 0 (0-1) 1 (0-4) 0 (0-2)
Adhesion score bowel loops 2 (1-4) 3 (1-4) 2.5 (1-4) 2 (1-4) 1.5 (1-4) 2 (0-4)
Total adhesion score 4 (2-20) 6 (1-11) 6 (1-18) 3.5 (1-8) 5 (2-15) 4 (0-9)
D is c u s s io n
Hyaluronic acid based agents have shown to be successful reducing postsurgical 
adhesions after elective surgery3' 5' 6' 17. Installing hyaluronic acid into an infected 
abdomen or pelvis is far less studied and the effectiveness is unclear. The lack of 
interest in prevention of adhesions in peritonitis or pelvic infection is surprising, 
considering the fact that adhesions after surgery in these conditions cause serious 
problems. First, there is a great risk of serosal bleeding, inadvertent enterotomy and 
fistula formation at dissecting adhesions during relaparotomies1, 2. Second, intra­
abdominal abscess formation, the result of bacterial entrapment in fibrinous 
adhesions, is a major complication frequently encountered after treatment for severe 
peritonitis. Third, diffuse adhesions complicate surgical procedures such as restoration 
of intestinal continuity and secondary closure of the abdominal wall, which often have 
to be postponed for several months in order to deal with 'more friendly' adhesions. 
Finally, there is an association between an increased incidence of adhesive small 
bowel obstruction and emergency abdomino-pelvic surgery for infection. This anti­
adhesive agent with good characteristics for usage in peritonitis was expected to 
prevent diffuse adhesion formation and abscesses in an experimental rat model of 
peritonitis closely mimicking secondary peritonitis caused by bowel perforation. 
However, pure hyaluronic acid cross-linked gel showed no beneficial results.
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There is debate on the optimal application form of an agent in postsurgical 
adhesion prevention. Membranes, sprays, viscous gels and liquid solutions all 
have been propagated. The advantage of a membrane or a spray is the possibility 
to selectively cover adhesiogenic spots and not the uninjured peritoneal tissue 
or "risk areas" of adhesion prevention such as fresh bowel anastomoses18. 
A further advantage is the prolonged residence time of membranes, allowing for 
separation of traumatized surfaces during the period of mesothelial healing, 
estimated to be at least 5 days4, 19. Disadvantage is the technical difficulty using 
membranes in laparoscopic surgery. A spray would overcome this disadvantage 
but is not broadly available. A liquid solution seems more appropriate when 
broader areas of the peritoneum are damaged such as in generalized peritonitis 
and in laparoscopic surgery. Disadvantages, however, are the short residence 
time6, the inability to control for interference with fresh anastomoses, which are 
increasingly made in peritonitis and a potential drawback on wound healing. 
Viscous solution was expected to combine the advantages of both membrane 
and solution; slow spread throughout the whole abdomen and a longer residence 
time in the abdominal cavity, allowing adhesion free peritoneal healing. Despite 
its potential, based on its properties and earlier studies12-15, viscous ACP gel did 
not reduce adhesions or abscesses. In contrast adhesions and abscesses were 
more severe around the omentum and there was a trend towards higher mortality 
due to abdominal sepsis.
W e have previously showed that hyaluronic acid solution reduces adhesions 
and abscesses in the same experimental model8, 10. These results were attributed 
to a 'floating' effect on the abdominal organs and biologic activity of hyaluronic 
acid. The results were remarkable, given the fact that HA solution disappears 
from the abdominal cavity long before peritoneal healing is completed and 
originally was designed to protect peritoneal tissue during surgical trauma6 . 
Hyaluronic acid membrane, another format of HA, did not have a beneficial 
effect in the same peritonitis model and a trend towards increased abscess 
formation has also been observed20. The similarity between the results of the 
membrane and the ACP gel in peritonitis leads to the assumption that the 
format and not the substance itself determines the action in an infected 
abdominal cavity. This is further supported by similar findings with use of other 
HA based antiadhesive gels and gels, viscous solutions and membranes not 
containing hyaluronic acid7, 21.
In adhesion prevention studies under sterile conditions, concentrations of 1, 2, 
4 and 6%  ACP gel were tested14, 15. The concentration and cross-linking level of 
the ACP gel determine its viscosity, with higher viscosity at higher levels of 
these two determinants22. Although all concentrations reduced the number and
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quality of adhesions significantly, 4 %  seemed to be the optimal concentration 
and was chosen in this study.
The negative results may be explained in several ways. First, the gel stays at the 
site of instillation at the right lower abdomen and does not spread throughout 
the abdominal cavity due to its high viscosity in combination with a disturbed 
peritoneal fluid circulation and bowel paralysis during peritonitis. Second, 
compartimentalization of the abdominal cavity by rapid fibrin formation 
disturbs proper distribution of the gel. Third, bacteria are entrapped in the 
viscous gel and growth is relatively unaffected by immune cells and antibiotic 
therapy, resulting in abscess formation. Indeed, at sacrifice of the animals the 
majority of adhesions and abscesses were in the proximity of the cecal 
resection spot surrounded by omentum. In vitro studies would enlighten the 
question whether the substance itself influences bacterial growth or the gel 
physically contains the bacteria in a similar way it is hypothesized for a 
membrane. The containment theory also explains the similar findings with 
different volumes of ACP gel. Finally, the gel obstructs the diaphragmatic pores, 
impeding clearance of pathogens via diaphragmatic lymphatic absorption, 
which is considered an important host defence mechanism in peritonitis23.
The present study raises concern on the safety of ACP gel under contaminated 
conditions in terms of mortality due to abdominal sepsis. Results on safety and 
effectiveness in elective surgery may not automatically be extrapolated to 
contaminated or infectious procedures. The present unexpected safety results, 
increased bacterial infection in particular, should be kept in mind when 
bringing new antiadhesive products to the clinic.
It could be argued that the number of animals in the experiments has influenced 
the negative results as well. We were interested in a clinically relevant reduction 
compatible with at least 50% reduction of adhesions and abscess formation in 
animals. In the control group almost all rats developed adhesions and 
abscesses, so even with these group sizes a strong reduction would have been 
noticed. Furthermore, adhesions and abscesses were scored on several time 
points with similar results. It is known that abscesses induced by peritonitis 
resolve spontaneously in most rats after a certain time period. This implies that 
a possible effect of ACP gel is more easily detected after a short time span and 
a negative effect is more obvious after a longer period. Again, similar abscess 
rates were seen for all time intervals.
It is concluded that ACP gel does not reduce adhesions and abscesses in a 
relevant experimental rat model of peritonitis. Adequate and safe prevention of 
adhesions in contaminated conditions remains a challenge. Seeking for optimal 
viscosity, volume and residence time is crucial in the development of new 
antiadhesive products.
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A bstract
Background: Abdominal adhesions and abscesses are a major source of morbidity 
and mortality after abdominal surgery and peritonitis. Adhesions are hard to 
detect with standard imaging techniques. Liposomes, coated with polyethylene 
glycol (PEG), represent an agent developed for infection imaging. This study 
investigated the capacity of 99mTc-PEG-liposomes to localize early adhesion 
formation after peritonitis. Additionally, the value of 99mTc-PEG-liposomes for 
therapy evaluation of hyaluronan solution, which reduces adhesion and abscess 
formation in experimental peritonitis, was assessed.
Methods: In 24 rats a bacterial peritonitis was induced by performing a cecal 
ligation and puncture procedure. The animals were treated with sodium 
chloride solution or 0.4% hyaluronan solution intra-abdominally. One week 
later, scintigraphy was performed, using 99mTc-PEG-liposomes and abnormal 
focal uptake in the abdomen was scored. Hereafter autopsy was performed and 
adhesions and abscesses were scored.
Results: A significant correlation was found between the total adhesion score 
and the scintigraphic score (p<0.01, r=0.65). Treatment with hyaluronan 
significantly reduced the total adhesion score (p=0.01). The size of abscesses 
significantly correlated with the scintigraphic score (p<0.01, r=0.62). Treatment 
with hyaluronan reduced the size of abscesses (p<0.05).
Conclusion: 99mTc-PEG-liposomes are able to detect early adhesions and abscesses 
and may be used for therapy evaluation of agents that reduce adhesions and 
abscesses.
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In tro d u c t io n
Intra-abdominal adhesions and abscesses are a major source of morbidity and 
mortality. They are mainly caused by abdominal surgery and peritonitis. 
Adhesions are the foremost cause of intestinal obstruction in the Western world 
and account for approximately 70% of readmissions for small bowel obstruction1. 
They are responsible for 15% to 20% of cases of secondary infertility in women 
and are associated with chronic abdominal and pelvic pain2, 3. Moreover, 
adhesions are associated with surgical complications during relaparotomy and a 
higher incidence of postoperative complications, relaparotomies, admissions to 
the intensive care unit, and a prolonged hospital stay4.
Early dense peritoneal adhesion formation is frequent after peritonitis. Adhesion 
networks may entrap bacteria resulting in intra-abdominal abscesses. Prevention 
of these networks might reduce residual abscesses after peritonitis and facilitate 
relaparotomy, which is regularly indicated during treatment of severe peritonitis. 
Computed tomography (CT) scanning and magnetic resonance imaging (MRI) are 
not sufficiently accurate to demonstrate early dense adhesion formation. 
Liposomes, small lipid vesicles coated with polyethylene glycol (PEG) have 
been developed for infection imaging5. PEG-liposomes can be labelled with 
99mTc in a rapid and efficient procedure, providing images of high quality at 
low cost and with low radiation dose6. When injected intravenously the 
liposomes accumulate in areas with an increased vascular permeability such as 
infiltrates and abscesses. Experimental and clinical studies have shown 
excellent targeting in various models of infection and inflammation, including 
the cecal ligation and puncture (CLP) model5-13. PEG-liposomes localizing 
early adhesions following peritonitis have never been investigated.
The first aim of the present study was to evaluate the value of 99mTc-PEG- 
liposomes visualizing early adhesion formation after experimental peritonitis. 
Secondly, the feasibility of 99mTc-PEG-liposomes for evaluation of intra-peritoneal 
treatment with hyaluronate solution in peritonitis was studied. Hyaluronan-based 
agents are known to successfully reduce post-surgical intra-abdominal adhesions 
in both experimental and clinical trials14-17 and adhesion and abscess formation 
in experimental peritonitis18, 19.
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M aterials and  M ethods 
Animal model
All experiments were carried out in accordance with the guidelines of the local 
Animal Welfare Committee. Twenty-four male, randomly bred Wistar rats (Harlan 
Nederland, Zeist, The Netherlands), weighing 270-310 gram, were accustomed to 
laboratory conditions for one week before experimental use. Animals were 
housed at 21°C with a day-night cycle of 12 hours. They had free access to water 
and standard rodent chow (Hope Farms B.V., Woerden, The Netherlands). 
A bacterial peritonitis was induced by CLP, as described by Wichterman et al.20. 
Briefly, the animals were fasted for 12 hours prior to the first operation. On day 
zero, rats were weighed and anaesthetized with a mixture of fluothane (Zeneca, 
Cheshire, United Kingdom), nitrous oxide and oxygen. Prior to the operation the 
abdomen was shaved and disinfected with 70% ethanol. Via a three cm midline 
laparotomy, the cecum was dissected and filled backwards with feces. Thereafter, 
the cecum was ligated just distal of the ileocecal valve, with a 3.0 polyglactin 
Vicryl suture (Ethicon, Norderstedt, Germany) and its antimesenterial site was 
punctured once with a 19-Gauge needle. The abdominal wall was closed in two 
layers with 3.0 Vicryl suture. Immediately after operation, rats received one single 
dose of 6 mg/kg body weight gentamicin (Centrafarm Services B.V., Etten-Leur, 
The Netherlands) intramuscularly, and 0.1 mg/kg body weight buprenorfine 
(Temgesic®, Reckitt & Colman Products Ltd., Amstelveen, The Netherlands) 
subcutaneously for analgesia. For resuscitation, all animals received 10 ml isotonic 
sodium chloride solution subcutaneously. At day one, the abdomen was reopened 
under anaesthesia and peritoneal fluid was taken and collected in a BBL™ 
Port-A-CulTM envelope (Becton Dickinson, Cockeysville, Maryland, USA) for 
microbiological examination. The abdominal cavity was rinsed with 10 ml of 
isotonic sodium chloride solution and the ligated and perforated cecum was 
resected. Before closure of the abdomen, animals were randomly assigned to 
receive 8 mL of isotonic sodium chloride solution (n=12), or 8 mL of 0.4% 
hyaluronate solution (Sepracoat™, Genzyme Corporation, Cambridge, MA, USA) 
(n=12) instilled throughout the whole abdominal cavity. The abdominal wall was 
closed in two layers as described above. Rats received 10 ml isotonic sodium 
chloride solution and 0.1 mg/kg body weight buprenorfine subcutaneously.
Study design
On day 8, seven days after resection of the cecum, rats were injected via the tail 
vein with 15 MBq 99mTc-PEG-liposomes. At 2, 4 and 24 hours, the animals 
were anaesthetised with a mixture of fluothane, nitrous oxide and oxygen, and
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were placed prone on a single headed gamma camera equipped with a parallel­
hole, low-energy collimator. Images (30,000 counts/animal) were obtained and 
stored in a 256 x 256 matrix (Fig. 1). The scintigraphic images were evaluated 
for increased uptake, and the images at 24 hours appeared to show abnormal 
abdominal uptake most obvious. The abnormal uptake in the images at 
24 hours was scored by comparing the activity with other regions, as described 
by Schölmerich et al.21: 0 = no uptake; 1 = less than bone marrow; 2 = more 
than bone marrow, but less than liver; 3 = more or equal to liver.
Figure 1. Scintigraphic images of rats 2, 4 and 24 hours after injection of 99mTc-PEG-liposomes, 
and a schematic drawing of the observations at postmortem investigation. A: rat without 
adhesions or abscesses, B: rat with abscess, C: rat with adhesions.
S = spleen, Bl = bladder, Ab = abscess, Ad = adhesions. Note the physiologic high uptake at the 
spleen and bladder region. The development of adhesions or abscesses is best seen in the images 
24 hours after injection.
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After recording of the final image, rats were killed by carbon dioxide asphyxiation. 
At autopsy, macroscopic abnormalities were assessed without knowledge of the 
imaging results. Adhesions were scored in a blinded manner by one author 
(H.v.G.) according to the method of Zühlke et al.22, whereby grade zero means no 
adhesions and grade IV means firm extensive adhesions that are only dissectable 
with sharp instruments, with organ damage almost unavoidable. Sites of adhesions 
scored included the midline, the upper abdomen (liver), the parietal peritoneum, 
and between bowel loops. Total score of these four locations was noted as the 
total adhesion score (0-16). If present, the size of abscesses was noted. An abscess 
was defined as a walled off collection containing purulent material. Samples were 
taken from the abscesses for microbiological examination. The locations of the 
adhesions and abscesses were noted in a standardized drawing and compared to 
the scintigraphic images.
Radiopharmaceutical
99mTc-PEG-HYNIC-liposomes were prepared as described previously6. The liposomes 
were composed of the polyethyleneglycol-2000 derivative of distearoylphosphatidyl- 
ethanolamine (PEG-DSPE), partially hydrogenated egg-phosphatidylcholine (PHEPC), 
cholesterol and the hydrazino-nicotinamide derivative of distearoylphosphatidyl- 
ethalonamine (HYNIC-DSPE) in a molar ratio of 0.15:1.85:1:0.07. The particle size 
distribution was determined by dynamic light scattering with a Malvern 2000 system 
equipped with a 25 mW Neon laser (Malvern, UK). The mean size of the liposome 
preparations was 80-85 nm with a polydispersity index of < 0.1. Preformed HYNIC- 
PEG liposomes were labelled with 99mTc by adding 0.25 ml liposomes (75 ^mol 
phospholipid/ml) to a mixture of 10 mg N-[Tris(hydroxymethyl)-methyl]glycine 
(Tricine, Fluka), 10 ^g stannous chloride in 0.5 ml saline and 99mTcO4- in saline 
(15 MBq/^mol phospholipid). The mixture was incubated for 15 min at room 
temperature. Without any further purification, labeling efficiency was >95%. Fifteen 
MBq 99mTc-liposomes were injected intravenously per rat.
Bacterial cultures
Samples of peritoneal fluid and abscesses were cultured semiquantitatively in 
aerobic and anaerobic conditions. Colombia III agar with 5 %  sheep blood 
(Becton & Dickinson, Etten-Leur, The Netherlands), Levine Eosin Methylene 
Blue agar (Oxoid, Haarlem, The Netherlands) and fastidious anaerobic agar 
(Tapley, Bury, United Kingdom) with or without kanamycin, were used for 
cultures. After 24 and 48 hours of incubation at 37°C, bacteria were identified 
using standard procedures.
100
Tc-99m-PEG-liposomes
Statistical analysis
Two-tailed statistical analysis of differences between groups was performed 
using the non-parametric Mann-Whitney U test and the Fisher's Exact test. 
Correlation between adhesions or abscesses and focal uptake on the images 
was assessed using the Spearman rank correlation test. A p-value <0.05 was 
considered statistically significant.
R esults
All rats demonstrated symptoms of intra-abdominal sepsis, including apathic 
behaviour, ocular exudates, pilo-erection and diarrhoea following CLP. These 
symptoms resolved within two days after resection of the ligated and perforated 
cecum and peritoneal lavage. There were no differences in body weights 
between groups. One rat, treated with hyaluronan solution, prematurely died 
due to an unknown cause.
Bacterial cultures of the peritoneal fluid, taken at the day of cecal resection, 
revealed a mixed aerobic and anaerobic flora of Escherichia coli, Enterococcus 
species, Proteus species, coliforme gram-negative bacilli, anaerobic gram negative 
and positive rods and Staphylococcus species in concentrations of 105-109 
colony forming units/mL. Cultures from the abscesses revealed a mixed aerobic 
and anaerobic flora, similar to those found on the day of cecal resection, in 
concentrations of 107-1 09 colony forming units/mL
Scintigraphy with 99mTc-PEG-liposomes, adhesions and abscesses
At autopsy 18/23 (78%) rats had adhesions and 12/23(52%) rats had abscesses. 
Nine of twenty-three (39%) had adhesions without abscesses. Two rats had no 
intra-abdominal abscesses or adhesions. Five of eleven (45%) hyaluronan treated 
rats were free of adhesions compared to none of twelve (0%) control rats 
(p=0.01; Fig 2). Four of eleven (36%) hyaluronan treated rats had adhesions 
requiring sharp dissection (grade 3 and 4) compared to eleven of twelve (92%) 
control rats (p<0.01).
The median focal uptake score of 99mTc-PEG-liposomes at 24 hours after 
injection was 1.0 (range 0-3) in rats treated with hyaluronan and 2.5 (range 
0-3) in control rats (p=0.09)( Fig. 3). There was a significant correlation between 
the focal uptake score and the total adhesion score (p<0.01, r=0.65) (Fig.4). 
Analysis of the subgroup of eleven rats, that had no abscesses demonstrated a 
significant correlation between the total adhesion score and the focal uptake 
score (p<0.05, r=0.70) (Fig 5.).
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Figure 2. Total adhesion score one week after cecal ligation and puncture in rats treated with 
0 .4% hyaluronan solution and controls. Points represent adhesion score in individual animals, 
with bars indicating median levels.
Figure 3. The scintigraphic score one week after cecal ligation and puncture in rats treated with 
0 .4% hyaluronan solution and controls. Points represent scintigraphic score in individual animals, 
with bars indicating median levels.
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Figure 4. The relationship between the total adhesion score and focal uptake score (p<0.01, r=0.65).
total adhesion score
Figure 5. The relationship between the incidence of adhesions without abscess formation and 
focal uptake score (p<0.05, r=0.70).
Three of eleven (27%) hyaluronan treated rats had an intra-abdominal abscess 
compared to nine of twelve (75%) control rats (p<0.05; Fig 6). The size of 
abscesses significantly correlated with the total adhesion score (p<0.001, 
r=0.74) (Fig. 7). At scintigraphy, there was a significant correlation between the 
focal uptake score and the size of abscesses (p<0.01, r=0.62) (Fig. 8).
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Figure 6. Mean abscess size one week after cecal ligation and puncture in rats treated with 0.4% 
hyaluronan solution and controls. Points represent abscess size in individual animals, with bars 
indicating median levels.
total adhesion score
Figure 7. The relationship between the total adhesion score and the abscess size (p<0.001, r=0.74).
abscess size
Figure 8. The relationship between the abscess size and focal uptake score (p<0.01, r=0.62).
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D isc u ss io n
It was previously shown that 99mTc-PEG-HYNIC-liposomes are able to detect 
intra-abdominal abscesses in experimental peritonitis10. The present study 
demonstrates the capability to image adhesions without the presence of 
infection as well. Reduction in adhesion and abscess formation by hyaluronate 
solution was apparent by lower focal uptake of the radiopharmaceutical. 
Results of the present study are of importance for several reasons. First, this is 
the first study suggesting a role for 99mTc-PEG-HYNIC-liposomes in the detection 
of early adhesions after generalized peritonitis. This observation may be of 
clinical interest since these adhesions frequently complicate relaparotomies4, 
which are commonly performed in patients suffering from bacterial peritonitis. 
The detection and localization of these early inflammatory adhesions may 
contribute to the safety of these procedures, reducing for example the rate of 
inadvertent enterotomies, a frequent complication of postsurgical adhesions. 
Thusfar, anatomical imaging techniques such as ultrasonography, CT and MRI 
have yielded disappointing results for the detection of intra-abdominal 
adhesions. Ultrasonography may only detect adhesions with the anterior 
parietal peritoneum23, 24 while CT scanning does not seem to be of value in 
the detection of intra-abdominal adhesions. Cine MRI holds promise 
but information especially regarding deeply located adhesions is scarce25. 
An explanation for the accumulation of liposomes in early adhesive tissue is the 
locally increased vascular permeability of the peritoneal tissue after peritonitis. 
Since hyperpermeability and angiogenesis are also present after elective surgery 
it is expected that 99mTc-PEG-HYNIC-liposomes may detect postsurgical 
adhesions as well. Using these liposomes it does not seem to be possible to 
differentiate between early inflammatory adhesions and other infectious 
processes such as abscesses.
Second, 99mTc-PEG-liposomes may be of additional value in abscess imaging. 
Currently, ultrasonography and computed assisted tomography are considered 
the modalities of choice for the detection of intra-abdominal abscesses. These 
techniques, however, fully depend on morphological abnormalities that may be 
absent in early stages of adhesion and abscess formation, or equivocal in 
postoperative patients. Using 99mTc-PEG-liposomes would indicate areas of 
inflammation but the technique is limited by the fact that it is not possible yet 
to differentiate between vascularized early adhesions and early abscesses. 
Third, the use of 99mTc-PEG-liposomes offers an opportunity to evaluate 
adhesion and abscess reducing therapies, such as treatment with hyaluronan- 
based antiadhesives. At present, second look procedures or long follow-up
105
Chapter 6
periods are needed to demonstrate effect of these agents. Scintigraphy after 
99mTc-PEG-liposomes injection may provide a non-invasive method to obtain 
relevant information within a shorter time period. It is noteworthy that 99mTc 
has optimal characteristics for scintigraphic imaging with a half-life of 6 hrs and 
a low radiation burden, which offers the opportunity of several follow-up scans. 
Whether the technique is also useful for the detection of permanent adhesions 
after the period of acute inflammation remains to be elucidated, although 
vascularization and the presence of inflammatory cells in long existing adhesions 
have been described26. Moreover, additional studies on the assessment of early 
adhesions generated using a non-infectious model are warranted.
As demonstrated earlier, hyaluronate solution effectively reduced adhesion and 
abscess formation in experimental fecal peritonitis18, 19. In these previous 
studies, the incidence of adhesions that required sharp dissection was reduced 
by approximately 40%. Moreover, the hyaluronan solution reduced the 
incidence of intra-abdominal abscesses by 50%. In contrast, the use of 
hyaluronan-carboxymethylcellulose membrane demonstrated a trend towards 
increased abscess formation in experimental peritonitis18, 27. The mechanism of 
action is still unclear, but is most likely based on combined physical and 
biological properties of hyaluronan, as previously reviewed28. The potent 
effects of hyaluronan suggest a new implication for clinical practice in patients 
with secondary peritonitis, using it as a lavage solution during surgery. 
Additionally, patients on continuously ambulatory peritoneal dialysis (CAPD) 
might benefit from lavage with hyaluronan when suffering from CAPD 
peritonitis. This type of peritonitis induces intra-abdominal adhesions that, in 
turn, decrease peritoneal surface needed for dialyzing and ultimately may 
cause CAPD failure. Further studies seem warranted to determine the benefit of 
hyaluronan in these clinical conditions.
The high focal uptake of liposomes in infectious foci holds promise for its use 
in abscess and adhesion preventive therapy by means of targeted drug delivery. 
Liposomes may be labelled by technetium-99m for scintigraphic imaging, but 
also agents with an abscess and adhesion reducing capacity may be 
encapsulated such as tissue plasminogen activator (tPA). Intra-abdominal 
application of tPA reduces the formation of adhesions and abscesses in various 
experimental models2 9, 30. It was never tested in a clinical trial since intra­
peritoneal application of tPA during surgery might cause bleeding complications. 
This potential complication may be prevented by intravenous administration as 
tPA-PEG-liposomes. Moreover, liposomes facilitate sequential administrations 
of antiadhesive agents.
It is concluded that Tc-99m-labeled HYNIC-PEG-liposomes may detect early
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adhesion formation and abscesses. It has potential for the evaluation of new 
agents reducing adhesions and abscesses. Further research is warranted to 
evaluate the value of this technique in adhesion formation after non-infectious 
surgery.
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Chapter 7
A bstract
Background: Incisional hernia is a common surgical problem, frequently requiring 
prosthetic mesh repair. The demands of the ideal mesh seem conflicting; ingrowth 
at the mesh-fascia interface, without development of adhesions at the visceral 
mesh surface. Various antiadhesives combined with macroporous mesh and 
composite meshes were studied for prevention of adhesions to mesh and ingrowth 
into the fascia.
Methods: In 60 rats an abdominal wall defect was created and repaired with 
underlay mesh. Rats were divided in six groups and treated with polypropylene 
mesh (PPM, control), PPM with auto-cross-linked polymers gel (ACP), PPM with 
fibrinogen glue (FG), polypropylene/ expanded polytetrafluoroethylene (ePTFE) 
mesh, polypropylene/ sodium hyaluronate/ carboxymethylcellulose (HA/CMC) 
mesh, and polypropylene-collagen/polyethylene-glycol/glycerol (CPGG) mesh. 
Mesh infection was assessed in the postoperative period, adhesions and 
reherniations were scored at sacrifice two months after operation and tensile 
strength of the mesh-tissue interface was measured.
Results: Six rats developed mesh infection, half of them were treated with 
PPM/ePTFE. The PPM/HA/CMC group showed a significant reduction in the 
amount and severity of adhesions. In animals treated with PPM/ACP and PPM/FG, 
severity of adhesions was reduced as well. Reherniation rate in the PPM/ACP 
group was 50% and significant higher than that in other groups. Rats in the 
PPM/HA/CMC had the highest tensile strength.
Conclusion: PPM/HA/CMC approaches the demands of the ideal mesh best, 
having superior antiadhesive properties, no reherniation and no infection in this 
rat model of incisional hernia.
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In tro d u c t io n
Incisional hernias occur in approximately 10-20% of patients after abdominal 
surgery1, 2, causing signs varying from mild discomfort and pain to incarceration 
and strangulation of bowel loops. Prerequisite for successful treatment of 
incisional hernias is tension-free repair, which often demands the use of prosthetic 
meshes to bridge the abdominal wall defect. Polypropylene is the most commonly 
used biomaterial in incisional hernia repair. This macroporous mesh shows good 
anchorage to the fascia by ingrowth of fibroblasts3. Great drawback is the 
propensity of adhesion formation at the peritoneal side of the mesh3-5, introducing 
risk of bowel obstruction and fistula formation. Microporous meshes, like 
expanded polytetrafluoroethylene, were developed to withstand formation of 
adhesions and associated complications. However, ingrowth of fibrocollagenous 
tissue appeared to be reduced in such order that reherniation occurred6, 7.
At present two concepts are elaborated in an attempt to meet the demands of 
an ideal mesh; good fibroblast ingrowth and anchorage at the fascial side and 
no adhesion formation at the peritoneal side. These concepts include a double­
layer mesh, having a macroporous and a microporous or nonporous side, and 
a traditional mesh combined with an antiadhesive agent either incorporated in 
the mesh or added separately in the peritoneal cavity. Double-layer meshes are 
increasingly applied in the clinical situation, but despite very encouraging 
experimental results8, high mesh infection rate9 and decreased tensile strength 
at the mesh-tissue interface3 have been reported as well. Mesh combined with 
antiadhesives has good anchorage and shows significant reduction of adhesions 
in the experimental setting4, 5, 10-12.
We studied various types of antiadhesive agents combined with a macroporous 
mesh and compared adhesion formation, reherniation and infection with standard 
and double-layer meshes in a rat model of large incisional hernia.
M aterials and  M ethods 
Animals
Male Wistar rats (Harlan, Zeist, the Netherlands), weighing between 165 g and 
225 g were housed at 21°C with a day-night cycle of 12 hours. They had free 
access to water and standard rodent chow (Hope Farms BV, Woerden, the 
Netherlands). Study protocols were approved by the Animal Ethics Review 
Committee of the Faculty of Medicine, University of Nijmegen, the Netherlands.
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Meshes
Meshes used were polypropylene mesh (PPM) (Prolene®, Ethicon, Norderstedt, 
Germany), which served as control mesh, polypropylene/ expanded polytetra­
fluoroethylene mesh (PPM/ePTFE) (Bard®Composix®, Bard, New Jersey, USA), 
polypropylene mesh/ sodium hyaluronate/carboxymethylcellulose (PPM/HA/CMC) 
(Sepramesh®, Genzyme Corporation, Cambridge, USA), and polypropylene- 
collagen/polyethylene-glycol/glycerol mesh (PPM-CPGG) (Parietene® Composite, 
Sofradim International, Trévoux, France).
Antiadhesive agents
Antiadhesive agents used were auto-cross-linked polymers (ACP) Gel (Hyalobarrier® 
gel, Fidia Advanced Biopolymers srl, Abano Terme, Italy) and Fibrinogen glue 
(FG) (Tissucol®, Baxter Healthcare Corporation, Deerfield, USA).
Study design
60 rats were anaesthetized with an isoflurane (Abbott Labaratories Ltd., 
Queenborough, UK) nitrous-oxide oxygen mixture. After shaving and disinfection 
of the abdomen, a midline laparotomy was performed. Subsequently a 2,0 x 
3,0 cm full thickness abdominal wall defect was created, which represents 
approximately 25% of the abdominal wall, without excision of the skin7. Rats 
were randomised in 6 treatment groups (Table 1). In group 1 (controls), the 
abdominal hernia was treated by using a polypropylene mesh. In groups 2 and 
3 polypropylene mesh was combined with use of the antiadhesive agents ACP 
gel (group 2) and FG (group 3). In group 4-6, composite meshes were used; a 
mesh having a macroporous and a microporous side, consisting of polypropylene 
combined with ePTFE (group 4), a mesh having a polypropylene layer combined 
with a hyaluronan-based antiadhesive layer (group 5) and a mesh having a 
collagen-based antiadhesive layer added to a polypropylene one (group 6). 
Meshes of 2,5 x 3,5 cm were placed using underlay technique and were 
sutured to the fascia with 8 interrupted, non-resorbable 4/0 polypropylene 
(Prolene®, Ethicon, Norderstedt, Germany) sutures. 4 ml ACP (4%) gel and 2 ml 
of FG was applied over the abdominal organs under the mesh, before the last 
two sutures were tied in group 2 and 3, respectively. The underlay technique 
was chosen because of claimed superiority preventing reherniation above inlay 
or onlay techniques13. Skin was closed using staples.
Mesh infection was thoroughly monitored in the postoperative period and at 
premature death. Mesh infection was defined as any pus discharge from the 
wound resulting in wound dehiscence and uncovered mesh. After two months, 
animals were killed using carbon dioxide asphyxiation. The abdomen was opened
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Table 1. DIFFERENT TREATMENT GRO UPS IN AN ABDOM INAL WALL HERNIA MODEL IN RATS.
Group Rats (no.) Treatment Separate anti­
adhesive agent
Description
1 10 PPM No Control
2 10 PPM + ACP-gel ACP-gel Mesh + antiadhesive
3 10 PPM + FG FG Mesh + antiadhesive
4 10 PPM/ePTFE No Double layer mesh
5 10 PPM/HA/CMC No Mesh including antiadhesive
6 10 PPM/CPGG No Mesh including antiadhesive
PPM = polypropylene mesh 
ACP = auto-cross-linked polymers 
FG = fibrinogen glue
ePTFE = expanded polytetrafluoroethylene 
HA/CMC = sodium hyaluronate/ carboxymethylcellulose 
CPGG = collagen/ polyethylene-glycol/glycerol
using a lateral incision, aside from the mesh. The presence of reherniation was 
noted and the percentage of mesh covered by adhesions was scored. The 
severity of adhesion formation to the mesh was classified using the Zühlke 
criteria, whereby grade zero means no adhesions and grade 4 means very 
dense adhesions, only dissectable with sharp instruments with organ damage 
almost unavoidable14. Subsequently the mesh including 1,0 cm of surrounding 
fascia was harvested. Sutures were removed and tensile strength of the mesh- 
fascia specimen was determined.
Tensile testing
After collection of the mesh with surrounding tissue, the mesh was divided in 
two parts, leaving surrounding tissue on three sides. Subsequently the tissue on 
two sides was removed, and the width of the remaining mesh-tissue interface 
was measured (mm). Both ends of the mesh-tissue specimen were fixed in 
metal clips of a tensile tester (Instron, Canton, USA). Tension on the specimen 
was increased until rupture of the mesh-tissue interface or fascia itself occurred. 
Tests were performed with a rate of strain of 1 cm/min. Maximal tensile force 
was expressed in Newton per square mm of specimen.
117
Chapter 7
Statistical analysis
Statistical analysis between groups was performed using the Chi-squared test 
for independence for comparison of numbers of events, and the Kruskal-Wallis 
test (two-tailed) for comparison of continuous variables. The Kruskal-Wallis test 
was extended with post-tests in case of significant differences. P < 0.05 was 
considered significant.
R esults 
M esh infection
The total number of animals who developed mesh infection was 6; one rat in 
the PPM/ACP group, three rats in the PPM/ePTFE group and two rats in the 
PPM/CPGG group. Mesh infection led to premature death in one rat (PPM/ 
CPGG group). Differences between groups were not significant (p=0.114) 
(Table 2).
Adhesion formation
The percentage of the mesh covered by adhesions differed significantly 
between groups (p=0.03), with PPM/HA/CMC having the lowest percentage of 
adhesions (10%) (Table 2). Post-tests revealed that the difference in mesh 
coverage was significant for PPM/HA/CMC compared to control (PPM) 
(p<0.05). One rat in the PPM/HA/CMC group had zero adhesions. Severity of 
adhesion formation differed significantly between groups (p<0.002). Scores in 
the PPM/HA/CMC group (2, range 0-4) and PPM/ACP group (2, range 1-2) were 
significant lower than those in the PPM group (3, range 2-4; p<0.05 and 
p<0.01, respectively) (Table 2). The number of animals having dense adhesions 
(grade 3 and 4) differed between groups (p<0.002). One rat in the 
PPM/HA/CMC and in the PPM/FG group developed dense adhesions and zero 
rats in the PPM/ACP group (Table 2). Three PPM/ePTFE rats with infection had 
100% mesh coverage with dense adhesions (grade 3).
Reherniation and tensile strength
Reherniation rate was significantly higher in PPM/ACP rats (50%) compared to 
PPM/FG rats (10%) and rats in all other groups (0%) (p<0.001) (Table 2).
The interfaces between fascia and PPM/HA/CMC had the highest tensile 
strength (p<0.005) (Fig. 1). PPM/HA/CMC and PPM/ePTFE mesh-fascia interfaces 
demonstrated significantly higher maximal tensile strength (p<0.01 and p<0.05, 
respectively) than the PPM/ACP mesh interface.
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Table 2. INFECTION, A D H ESIO N S AN D  REHERNIATION AFTER 
RECONSTRUCTION W ITH  DIFFERENT MESHES IN A RAT MODEL.
A BD O M IN A L W ALL
Mesh No. of rats No. of rats %  of mesh Zühlke No. of rats No. of rats No. of rats
at end of with mesh covered by score with Zühlke with Zühlke with
study infection adhesions score 0-2 score 3-4 reherniation
median+range median+range t t t
PPM 10 0 40 (10-80) 3 (2-4) 3 7 0
PPM/ACP 10 1 35 (15-90) 2 (1-2)** 10 0 5
PPM/FG 10 0 30 (5-90) 2 (2-3) 9 1 1
PPM/ePTFE 10 3 22.5 (10-100) 3 (2-3) 4 6 0
PPM/HA/CMC 10 0 10 (0-35)* 2 (0-4)* 9 1 0
PPM/CPGG 9 2 40 (5-90) 2 (1-3) 6 3 0
*p<0.05 PPM/HA/CMC vs PPM
**p<0.01 PPM/ACP vs PPM
tp<0.002 between groups
tp<0.001 between groups
1,6
1 2 3 4 5 6
Groups
Group 1; PPM 
Group 2; PPM/ACP 
Group 3; PPM/FG 
Group 4; PPM/ePTFE 
Group 5; PPM/HA/CMC 
Group 6; PPM/CPGG
Figure 1. Tensile strenghts of the mesh-fascia interfaces.
1,4
1,2
1
0,8
0,6
0,4
0,2
0
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D isc u ss io n
Reconstruction of large incisional hernias, compelling the use of prosthetic 
material, is a challenge in general surgery. Mesh infection, adhesive bowel 
obstruction, fistula formation and hernia recurrence are devastating early and 
late postoperative complications. Much research has focused on finding the 
ideal mesh preventing these complications. The ideal mesh should well 
incorporate fibrocollagenous tissue and anchor firmly to adjacent fascia, be 
unsusceptible for infection and cause no adhesion formation. In the present 
study PPM/HA/CMC approached the demands of an ideal mesh most, having 
superior antiadhesive properties, good anchorage to the fascia and no infection 
in this rat model of incisional hernia.
There are several animal models to investigate mesh repair of incisional hernia 
including rat, rabbit and porcine model. No model has proven superiority 
mimicking the human situation. W e choose rats because of our large 
experience with these animals and the reproducible model of incisional hernia 
repair and evaluation of adhesions.
HA(/CMC) has demonstrated experimental and clinical efficacy reducing 
postoperative adhesion formation in various types of abdominal-pelvic 
operations15, 16. The adhesion reducing capacity is attributed to mechanical 
separation of injured serosal layers. A contributing biological effect of the 
hyaluronan component on peritoneal repair mechanisms has recently been 
suggested17, 18. Encouraged by the good clinical results, investigators used a 
HA/CMC sheet underlying a PP mesh in incisional hernia repair, leading to a 
reduction of adhesion formation4, 10. The composite mesh of PP, coated on the 
peritoneal side with a hyaluronan-based bioresorbable membrane demonstrated 
similar adhesion reduction but does not exhibit the difficult handling characteristics 
like the separate HA sheet5, 11. Adhesions that developed by using PPM/HA/ 
CMC were not only reduced in number but were more filmy, which is of 
clinical importance reducing enteric fistula formation and inadvertent 
enterotomy on re-entry of the abdomen. More filmy adhesions were also seen 
to the other meshes that were combined with antiadhesives. Nevertheless, this 
study did not reproduce the results of recent studies, in which the use of 
presumed antiadhesive substances as fibrinogen, collagen and hyaluronate gel, 
led to a marked reduction in amount and density of adhesions8, 12, 19-24.
The PPM/ePTFE mesh with very small pore size at the peritoneal side was 
designed to withhold ingrowth of cells involved in adhesion formation and yet 
failed to do so. Massive dense adhesions to the meshes were particularly seen 
in three animals with a mesh infection, a finding similarly done in the two 
animals with an infected PPM/CPGG mesh. Stimulation of the coagulation
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cascade by bacteria invading the mesh is a first step in fibrin deposition and 
adhesion formation. The overwhelming inflammatory response accompanying 
infection stimulates exudation of fibrinogen-rich fluid in the peritoneal fluid 
and attracts peritoneal inflammatory cells, processes known to be key factors in 
adhesion formation25, 26. An inflammatory response elicited by the foreign body 
as such, has been demonstrated with the use of ePTFE2 7 and is a possible 
additional factor inducing adhesions. With regard to prevention of adhesion 
formation to the mesh the concept of preventing inflammation-induced 
fibrinous attachments and rapid coverage with mesothelial cells might be more 
valid than that of small pore size or no pores at all preventing cell ingrowth. 
Hyaluronate, present in ACP gel and PPM/HA/CMC mesh has documented 
anti-inflammatory properties17, 18. Use of fibrinolytic agents or mesothelial cell 
layers are alternatives preventing deposition of products following peritoneal 
inflammatory response28, 29. Increased mesh infection in the present study is in 
concordance with the clinically known susceptibility of ePTFE to bacterial 
invasion and outgrowth giving infection that almost always require mesh 
excision. This might be explained by the size of host defence cells, which 
prevents their penetration of the microporous ePTFE structure, while bacteria, 
which are smaller in size, are able to invade the mesh.
Although auto-cross-linked hyaluronate showed great potential reducing the 
density of adhesions to the PP mesh, the high rate of reherniation makes it 
unsuitable for use in hernia repair. Protrusion of the visco-elastic substance 
when suturing the mesh to the fascial edges combined with the prolonged 
residence time may adversely affect the healing process at the mesh-fascia 
interface. Wound-healing problems reflected by fascial dehiscence or 
incisional hernia are not known from scarce data available on the gel.
Fibrin glue has shown beneficial effects reducing adhesions attributed to rapid 
sealing of lymph and blood vessels at traumatized peritoneal surfaces 
preventing ongoing fibrinogen exudation23, 24. In the present study, use of 
PPM/FG decreased adhesion density. The large clinical experience with fibrin 
glue in other surgeries and the easy handling of the spray form makes it an 
attractive alternative to HA/CMC in clinical hernia repair.
Although PPM/HA/CMC mesh was superior to other composite meshes and PP 
meshes combined with antiadhesives in this model, complete adhesion 
prevention was not achieved. Laparoscopic placement of the mesh could 
further decrease adhesion formation as laparoscopic surgery has been 
associated with diminished inflammatory reaction 0. For laparoscopic use a 
more versatile mesh (Sepramesh IP®, Genzyme Corporation, Cambridge, USA) 
has recently be designed because the one used in the experiments cracks when 
applied through laparoscopic trocars.
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Chapter 8
A bstract
Background: A relationship between postsurgical adhesion formation and 
peritoneal tumour implantation has been proposed. Hyaluronan (HA)-based 
agents reduce adhesion formation, but the effect on peritoneal tumour is not 
established. This study investigated the influence of a HA containing agent on 
intraperitoneal tumour in an experimental model.
Methods: 66 Balb/c mice underwent laparotomy and damage was inflicted to 
the parietal peritoneum. The animals were randomized into 5 groups. Groups 1 
and 2 received HA-carboxymethylcellulose bioresorbable membrane and no 
treatment, respectively. Mice in groups 3-5 were injected intraperitoneally with 
105 colon 26-B cells after the laparotomy. Treatment consisted of HA membrane, 
no HA agent and placement of HA membrane on the non-traumatized peritoneal 
wall, respectively. Animals were killed after 14 days; adhesions were scored in 
groups 1 and 2, and tumour mass in groups 3-5.
45 Wag/Rij rats underwent the same procedures and treatment as mice in groups 
3-5. In rats 106 CC-531 cells were injected. Rats were killed after 3 weeks and 
tumour mass was scored.
Results: HA membrane resulted in a significant reduction of adhesions, but had 
no major effect on intraperitoneal tumour mass in mice and rats.
Conclusion: HA-carboxymethylcellulose bioresorbable membrane has no major 
effect on intraperitoneal tumour implantation and growth in an experimental 
model.
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In tro d u c t io n
The most common sites for colorectal cancer recurrence are the resection site and 
the peritoneal surfaces 1 , 2. Peritoneal carcinomatosis is seen in approximately 
25-40% of all recurrences1' 2. In about 10 percent of patients, peritoneal 
dissemination is present at diagnosis of the primary tumour3. The prognosis of 
patients with peritoneal carcinomatosis is unfavourable, having a median survival 
of six months4.
Tumour penetration through the bowel wall and tumour spill during the primary 
operation are considered to be the causes of peritoneal metastasis5. The mechanism 
of tumour implantation in the peritoneum after surgery is presumed to be dominated 
by factors involved in wound healing and adhesion formation6-9.
In recent years, the experimental and clinical application of antiadhesive 
products has received much attention. Hyaluronan (HA) derivates reduce 
postsurgical adhesion formation i 0-12. The adhesion reducing capacity of this 
polyanionic polysaccharide seems to be the result of mechanical separation, as 
well as biological effects on peritoneal repair mechanisms12-14.
Based on the properties, it was hypothesized that HA reduces peritoneal 
tumour implantation and growth. The hypothesis was tested using both a mouse 
and rat model of peritoneal injury, tumour implantation and growth. In addition, 
adverse effects of HA on tumour growth were evaluated.
M aterials and  M ethods 
Study design
The effect of HA-carboxymethylcellulose on adhesion formation (mouse model) 
and implantation and growth of tumour cells (mouse and rat models) was studied 
in two rodent models of surgical peritoneal injury. Study protocols were approved 
by the Animal Ethics Review Committee of the Faculty of Medicine, University 
of Nijmegen, the Netherlands.
Animals
Balb/c mice (Charles River, Sulzfeld, Germany), weighing between 20 and 26 g 
and WAG/Rij rats (Charles River, Sulzfeld, Germany), weighing between 224 
and 282 gram were housed at 21°C with a day-night cycle of 12 hours. They 
had free access to water and standard rodent chow (Hope Farms BV, Woerden, 
the Netherlands).
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Tumour
Balb/c mouse model
A murine adenocarcinoma cell line colon 26-B, which is derived from a 
chemically induced colon carcinoma in a Balb/c mouse was used. Cells were 
grown in the thigh of a Balb/c mouse. The tumour nodulus was collected 
at growth of approximately 1 cm in diameter and sliced in pieces (<1 mm). 
RPMI medium (5 ml), Collagenase (20 mg) and DNase (5 pl of a 20 mg/ml 
solution) were added. The solution was rotated for 2 hours at 37°C, centrifuged 
(4 minutes at 1500 r.p.m.), washed twice with phosphate buffered saline (PBS), 
centrifuged again and resuspended in PBS. Viability was measured by trypan- 
blue exclusion. Viability of cells always exceeded 95%.
WAG/Rij rat model
CC-531 tumour is a moderately differentiated, weakly immunogenic colonic 
adenocarcinoma induced in WAG rats by 1,2dimethylhydrazine. The tumour 
was maintained in cell culture in RPMI-1640 medium, supplemented with 5%  
fetal calf serum, penicillin (100U/ml), streptomycin (100mcg/ml) and glutamin 
(200 mmol). All supplements were obtained from Life Technologies. Before 
their use in vivo, cells were trypsinized and washed with PBS. Viability of cells 
always exceeded 95%.
105 Colon 26-B cells in 0.5cc NaCl were used for the selected animals in 
experiment 1 (mice) and 106 CC-531 cells in 1cc NaCl were used in experiment 
2 (rats). These doses were based on dose-finding studies, aiming at about 80% of 
animals having macroscopic tumour load. In these studies, the aimed tumour 
loads were obtained after a period of two weeks in mice and three weeks in rats.
Hyaluronan derivate
The second generation HA-carboxymethylcellulose-USP glycerol bioresorbable 
membrane (Seprafilm IITM, Genzyme Corporation, Cambridge, USA) was used as 
antiadhesive agent. This membrane was kindly donated by Genzyme Corporation, 
Naarden, the Netherlands.
Control groups received no treatment. HA membrane on the non-traumatized 
peritoneum served as control for possible tumour stimulating activity of HA.
Experiment 1: Effect HA on intra-abdominal adhesion formation and 
growth of intraperitoneal tumour cells in mice
Sixty-six mice were anaesthetized with a fluothane (Zeneca, Cheshire, United 
Kingdom) nitrous-oxide oxygen mixture. After shaving and disinfection of the 
abdomen, a 2 cm midline laparotomy was performed. Peritoneal trauma was
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inflicted by a 1 cm incision on the right parietal peritoneum, 1.5 cm lateral from 
the midline incision. The peritoneal incision was closed using three Prolene 5/0 
(Ethicon, Norderstedt, Germany) sutures, dividing the trauma area in eight areas 
of 12.5%. Mice were randomized in 5 groups and treated as described in Table
1. The midline was closed using Prolene 4.0 (Ethicon, Norderstedt, Germany) for 
the fascia and staples for the skin. After the procedure, mice in groups 3-5 were 
injected with tumour cells intraperitoneally.
Fourteen days after the operative procedure mice were killed using CO2 
asphyxia. The extent and quality of the adhesions were scored in group 1 and 
2 mice. The extent was quantified by estimation of the involvement of the eight 
areas of 12.5% on the traumatized peritoneum, as previously described15. The 
quality of adhesions was scored using the Zühlke classification16; type 1 adhesion: 
filmy adhesion, easy to separate by blunt dissection; type 2: stronger adhesion; 
blunt dissection possible, partly sharp dissection necessary, beginning of 
vascularisation; type 3: strong adhesion, lysis possible by sharp dissection only, 
clear vascularisation; type 4: very strong adhesion, lysis possible by sharp 
dissection only, organs strongly attached with severe adhesions, damage of 
organs hardly preventable.
Table 1. D IFFERENT TREATMENT G RO U PS IN EXPERIMENT 1 AN D  2.
Group No. of Tumour HA membrane HA membrane HA membrane
animals cells traumatized laparotomy non-traumatized
peritoneum wound peritoneum
Exp. 1 colon 26b 0.7x1.5 cm 1x2.5 cm 0.7x1.5 cm
(mice)
1 15 no yes yes no
2 15 no no no no
3 12 105 yes yes no
4 12 105 no no no
5 12 105 no yes yes
Exp. 2 CC-531 1x2.5 cm 1x6 cm 1x2.5 cm
(rats)
1 15 106 yes yes no
2 15 106 no no no
3 15 106 no yes yes
131
Chapter 8
In group 3-5, the intraperitoneal tumour growth was scored by determining the 
percentage of the traumatized area occupied by tumour, using the peritoneal 
cancer index (PCI) according to Steller17 and by weighing the total tumour mass 
after excision. The PCI ranges from 0-5; a score of 0 means no tumour growth, 
a score of 1 indicates a tumour diameter less than 0.5 cm, a score of 2 a tumour 
diameter between 0.5 and 1 cm, a score of 3 a tumour diameter between 1 and 
2 cm, a score of 4 a tumour diameter between 2 and 3 cm and a score of 5 
a tumour diameter exceeding 3 cm.
Experiment 2: Effect HA on adhesion and growth of intraperitoneal tumour 
cells in rats
Forty-five rats received a similar peritoneal injury as described in experiment 1. 
However, the midline incision was 5 cm and the peritoneal incision was 2cm, 
2 cm lateral from the midline incision. Rats were randomized in three groups 
and treated as described in Table 1. The abdomen was closed in two layers, 
using Prolene 4/0 and staples. Afterwards tumour cells were injected 
intraperitoneally. In rats, no groups without tumour were included to control for 
the adhesion reducing capacity of the HA membrane.
Three weeks after the operative procedure the rats were killed by CO2 asphyxia. 
Intraperitoneal tumour growth was scored as described in experiment 1.
Statistical analysis
Statistical analysis between groups was performed using the Mann-Whitney U 
test (nonparametric, two-tailed). Statistical significance was defined as p < 0.05.
R esults
Experiment 1: Effect HA on intra-abdominal adhesion formation and 
growth of intraperitoneal tumour cells in mice
No mice died in group 1 and 2 before the end of the experiment. The use of HA 
membrane resulted in a significant reduction of the percentage of adhesions at 
the injured peritoneal wall (12.5% (range 0-100), vs 75% (0-100), p < 0.01). 
Zühlke score was also significant lower when a HA membrane was used 
compared to controls ( 2(0-4) vs 4(0-4), p < 0.05).
In group 3-5, no mice died before the end of the experiment. All mice but two 
(both in group 4; no HA membrane) developed tumour growth. As expected, 
tumour growth was almost exclusively located at the site of peritoneal trauma 
and the laparotomy wound. HA membrane at the traumatized area, the 
laparotomy wound, or the non-traumatized peritoneal wall did not significantly
132
Hyaluronan-based membrane and intraperitoneal tum our cells
affect the percentage of (traumatized) area covered by tumour, the PCI or the 
tumour weight (Table 2).
Table 2. RESULTS OF HA MEMBRANE TREATMENT IN A PERITONEAL DISSEMINATION MODEL 
IN MICE.
Group n %  tumour PCI R PCI L PCI ML tumour tumour tumour total tumour 
trauma area weight R weight L weight ML weight
3 12 62.5 (37.5-100) 2 (1-3) 0 (0-0) 3 (1-4) 273 (93-637) 0 (0-0) 537 (98-794) 769 (191-1431)
4 12 75 (0-100) 2 (0-4) 0 (0-0) 3 (0-4) 313 (0-793) 0 (0-0) 397 (0-1250) 697 (0-2043)
5 12 43.8 (0-100) 2 (0-3) 0 (0-3) 2 (1-4) 160 (0-627) 0 (0-943) 352 (1 18-751) 550 (118-1585) 
Values are median (range). Group 3; HA membrane, group 4; no additives, group 5; HA membrane contralateral. PCI R; 
peritoneal cancer index right peritoneum, L=left peritoneum, ML= peritoneum at the site of the midline incision.
Tumour weights are in milligrams. Differences between groups are not significant.
Experiment 2: Effect HA on adhesion and growth of intraperitoneal tumour 
cells in rats
Two of 45 rats died before the end of the experiment. One rat died on the second 
postoperative day due to peritonitis after accidental puncture of the colon. One rat 
was killed on the third postoperative day because of eventration. Eight of 43 rats 
did not develop tumour growth; three in group 1 (HA membrane), five in group 2 
(no HA) and one in group 3 (HA contralateral). As in mice, tumour growth was 
predominantly located at the traumatized peritoneum and the laparotomy wound. 
The results are shown in Table 3. There was no significant difference in tumour 
growth between rats treated with or without HA membrane, at any side of injury.
Table 3. RESULTS OF HA MEMBRANE TREATMENT IN A PERITONEAL DISSEMINATION MODEL
IN RATS
Group n %  tumour PCI R PCI L PCI ML tumour tumour total tumour
trauma area weight R+ML weight L weight
1 14 100 (0-100) 5(0-5) 0 (0-0) 5(0-5) 9.9 (0-16.5) 0 (0-0) 9.9 (0-16.5)
2 14 93.8 (0-100) 3.5 (0-5) 0 (0-0) 4 (0-5) 4.6 (0-20.1) 0 (0-0) 4.6 (0-20.1)
3 15 100 (0-100) 5 (0-5) 0 (0-1) 5 (0-5) 7.7 (0-20) 0 (0-4.7) 7.7 (0-20)
Values are median (range). Group 1; HA membrane, group 2; no additives, group 3; HA membrane contralateral. PCI R;
peritoneal cancer index right peritoneum, L=left peritoneum, ML= peritoneum at the site of the midline incision.
Tumour weights are in grams. Differences between groups are not significant.
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D isc u ss io n
Modified HA derivates are presently used to reduce the number and severity of 
postsurgical adhesions10-12. Question has been raised as whether these 
derivates would prevent tumour implantation and growth at the traumatized 
peritoneum, because of the presumed similarity between pathogenesis of 
adhesions and tumour implantation5, 8. The present study has shown that HA- 
carboxymethylcellulose bioresorbable membrane does not prevent tumour 
implantation and growth in a model of surgical trauma and peritoneal 
dissemination of colonic cancer cells, whereas adhesions were significantly 
reduced. Although the use of HA membrane did not result in a major reduction 
of tumour implantation and growth at the site of trauma, it neither seemed to 
promote tumour growth.
There are several possible explanations for the fact that adhesions were reduced 
by HA, while no evident reduction of tumour implantation and growth was 
found. First, HA reduced adhesions, but total prevention was not accomplished, 
leaving areas with adhesions and tumour cell implants. Second, tumour cells 
remain present in the peritoneal cavity in high concentrations and implantation 
takes place several days after tumour cell injection at a moment that the HA 
film has loosened from the injured peritoneal wall but healing of the peritoneal 
mesothelium is not complete18. The HA bioresorbable membrane is reported to 
remain in the abdominal cavity in gel form for about 7 days19. It is, however, 
uncertain whether active substance remains present for a sufficient long period, 
at the injured site where the HA membrane is initially placed.
In both mice and rats experiments some animals did not develop tumour 
growth. The most likely explanation is "metastatic inefficiency"; not all tumour 
cells lead to metastasis5. Both immunological defence mechanisms and other 
factors involved in wound healing and adhesion formation influence peritoneal 
tumour implantation and growth after surgery6-9. In dose-finding studies (data 
not shown), the number of animals without tumour growth increased when 
lower amounts of tumour cells were injected. There might be a critical amount 
of tumour cells needed to overcome the host defence mechanisms.
W e used both a rat and mouse model. Main reason was to control for inter­
species variability. Another reason was the concern that the results in mice were 
influenced by the limited intraperitoneal space. More tissue-handling and 
tissue-contact seems unavoidable in comparison with rats, which creates 
unintended large areas of serosal damage. Furthermore, the relatively greater 
mass of HA derivates in the smaller paracolic gutter of mice might influence the 
fluid movements in the abdominal cavity. Tumour cells follow these fluid
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movements from the pelvis via the paracolic gutters towards the subhepatic and 
subdiaphragmatic spaces18.
In contradiction to the hypothesis of this study, it has been suggested that HA 
derivates increase tumour implantation and growth. The design of the 
experiments, with placement of HA membrane on non-traumatized peritoneum, 
allowed to study this in addition. The effect of HA itself seems dualistic based 
on its interactions with the surface receptor CD44, which is present on a variety 
of cancer cells, including colon 26-B and CC-531 cells20, 21. Zeng et al. 
demonstrated that tumour growth can be inhibited in vivo by HA oligomers, 
probably due to an effect on the interaction of endogenous HA and CD4422. 
Through this interaction, exogenous HA may bind spilled tumour cells via their 
CD44 receptors, thereby prohibiting direct attachment to traumatized peritoneum, 
after which the immunologic system can clear these tumour cells. It is also 
possible that disruption of the endogenous HA-CD44 interactions leads to 
inhibition of signal transduction necessary for tumour cell proliferation. On the 
contrary, HA derivates may attract tumour cells to traumatized areas, bind the 
CD44 receptors and promote local implantation and growth. Our results show 
that HA membrane itself has no major tumour promoting effect, strongly 
suggesting that peritoneal trauma is a key factor in enhanced tumour growth. 
Only a few other experimental studies have been performed, with regard to the 
use of HA in an intra-abdominal tumour model23-26 (Table 4). Haverlag et al. 
studied whether the use of a 0.4% HA solution affected the adhesion of CC-531 
colonic carcinoma cells23. Their in vitro studies showed an inhibitory effect of HA 
solution on adhesion of tumour cells. However, experiments in rats showed a 
tendency towards higher tumour load when HA solution was used in an uterine 
abrasion model. In a laparotomy model, mean total tumour scores did not differ 
significantly. We feel that HA solution is unsuitable for studying tumour growth 
reduction, because of the short lifetime (<48-72 hours) in the abdominal cavity27. 
Underwood et al. examined the effects of a HA membrane on GW-39 human 
colon cancer implantation at surgical wound and laparoscopic trocar sites in a 
hamster model24. They concluded that HA membrane neither had a protective 
nor an adverse effect on tumour implantation and/or growth.
On the contrary, Tan and associates performed in vitro studies, using human 
colorectal tumour cell lines SW480, SW620 and SW707, and demonstrated 
that HA solution significantly increased tumour cell proliferation and motility25. 
In vivo, the use of HA solution resulted in a significantly higher total tumour 
nodule count in a laparotomy model in rats, using DHD/K12 tumour cells 
intraperitoneally. The use of a nodule count as method of tumour load 
assessment in this study is questionable.
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Table 4. STUDIES C O N C ER N IN G  THE EFFECT OF HA ON PERITONEAL DISSEM INATION (IN 
V IVO  RESULTS).
Reference Year Animal Model Tumour HA derivate Outcome
Haverlag 
et al.
1999 WAG rat Laparotomy and uterine horn 
abrasion or laparotomy only, 
i.p.seeding of tumour
CC-531 HA 0 .4%  
(Sepracoat™ )
No effect of HA
Underwood 
et al.
1999 Syrian hamster Laparotomy and trocar 
placement, i.p. seeding of 
tumour
GW-39 HA membrane 
(Seprafilm™)
No effect of HA
Tan 
et al.
2001 BD IX rat Laparotomy, i.p. seeding of 
tumour
DHD/K12 HA 0 .4% HA enhances 
tumour growth
Hubbard 
et al.
2002 BALB/c mouse Laparotomy, i.p. seeding of 
tumour
KM12-L4 HA membrane 
(Seprafilm™)
No effect of HA?
Sikkink 
et al.
2003 BALB/c mouse 
WAG rat
Laparotomy, peritoneal wall 
incision, i.p. seeding of tumour
colon 26-B 
CC-531
HA membrane 
(Seprafilm II™)
No major effect 
of HA
I.p.= intraperitoneal
Hubbard and Burns examined the effect of the first generation HA membrane 
on human colon cancer cell growth and metastasis in a nude mouse model26. 
They concluded that HA-carboxymethylcellulose did not affect tumour 
metastasis. However, placement of the membrane on non-traumatized 
peritoneum led to increased local tumour growth. They attributed this outcome 
to trauma, as result of placement of the biomaterial, and not to its composition. 
In our experience placement of the membrane is not a traumatic procedure and 
their explanation given is questionable.
A uniform conclusion can not be drawn from the results of these studies, due to 
the contradicting results, variability in models and tumour cell lines used. It is 
concluded from the present study that HA-carboxymethylcellulose membrane 
has no major effect on intraperitoneal tumour implantation and growth.
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S um m ary
In chapter 1 the clinical impact and pathophysiology of intra-abdominal adhesion 
and abscess formation, which have a common pathophysiological base via the 
fibrinogenesis and fibrinolysis pathway, are summarized. Postoperative adhesions 
cause considerable morbidity and even mortality. Readmissions for small bowel 
obstruction after abdominal surgery are frequent and lead to survival intervention 
in a considerable amount of cases. Adhesions complicate relaparotomies and 
increase the incidence of inadvertent enterotomy.
Adhesions develop after peritoneal trauma, which may be induced by surgery 
or inflammation. A fibrin matrix is formed on the damaged peritoneal areas. 
Normally the fibrinolytic system will lyse these clots, however, peritoneal 
fibrinolytic activity is impaired after surgery and infection. Many studies have 
focused on methods to diminish fibrin formation or increase fibrinolysis in 
order to reduce adhesions and intra-abdominal abscess formation.
Hyaluronan, a polysaccharide, is a frequently studied antiadhesive substance. 
The working mechanism of hyaluronan is twofold: mechanical separation of 
traumatized peritoneal surfaces and biological activity. Hyaluronan plays a role 
in tissue repair and wound healing, modifies the inflammatory response and 
facilitates cell migration and proliferation. Fibrin deposits may trap bacteria and 
thus form a nidus for abscess formation. Prevention of fibrin formation or early 
lysis of these deposits in patients with intra-abdominal infections may be an 
attractive method to prevent abscess formation. Since hyaluronan is effective in 
adhesion prevention and has distinct activity on the fibrinolytic cascade, its use 
in the treatment of intra-abdominal sepsis is most challenging. There is hardly 
any study on this topic.
In chapter 2 the literature of hyaluronan-based antiadhesive agents in abdominal 
surgery is reviewed. The urge to prevent adhesion formation has resulted in 
numerous experimental and clinical trials. Despite the effectiveness of hyaluronan, 
there is much debate on its clinical use and mechanisms of action. Various 
hyaluronan-containing products have been introduced but are withdrawn from the 
market. The application of hyaluronan in combination with meshes for hernia repair 
appears to be a promising concept. Not all different applications of hyaluronan are 
well studied and the use in patients with a malignancy or abdominal infection 
remains controversial. An overview is given on the effects of hyaluronan-based 
antiadhesive agents in abdominal surgery, the use in infectious conditions and in 
malignant disease. The different possible mechanisms of action of hyaluronan are 
discussed as well.
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Peritoneal mesothelial cells are involved in a variety of biological processes 
among which the formation of peritoneal adhesions. Cultures comprise an 
important tool to investigate human mesothelial cell behaviour and functions. 
The objective of the study in chapter 3 was to evaluate the effects of cell 
propagation and freezing and storing, when using mesothelial cells from 
different sources, and the effect of hyaluronan on cell function. Viable cell lines 
were obtained from both omentum and peritoneal lavage fluid of seven 
patients. Intercellular adhesion molecule-1 (ICAM-1) expression, by ELISA, and 
matrix metalloproteinase (MMP) bioactivity, by zymography, were measured in 
the second and fourth passage. MMP bioactivity was additionally measured 
after freezing and storage of cells in liquid nitrogen. The effects of different 
stimuli, including interleukin 1beta ( IL-1 ß), tumor necrosis factor-alpha (TNF-a), 
phorbol myristate acetate (PMA) with and without hyaluronan were determined. 
ICAM-1 was constitutively expressed and stimulated by IL-1 ß, TNF-a and PMA. 
All cell lines produced both MMP-2 and MMP-9. Only the latter activity was 
positively affected by TNF-a and, especially so, PMA. Differences were found 
between the second and fourth passage, and between cells of different lineage 
(i.e. lavage cells vs omental cells), mostly so if the relative stimulation by the 
various agents was compared. Addition of sodium hyaluronate either to control 
cultures or to cultures together with any of the three stimuli examined did not 
significantly change ICAM-1 expression and gelatinase activity. Freezing and 
storage of cells did not affect cell functions. From this study it was concluded 
that both the human omentum and peritoneal lavage fluid are good sources of 
mesothelial cells for in vitro culturing. Cells can be propagated, also after 
freezing, without qualitative changes in their ability to express ICAM-1 and to 
produce gelatinases. For omental cells there are differential effects of stimulation 
depending on whether the cells have been passaged 2 or 4 times. The presence 
of hyaluronan did not affect the expression of ICAM-1 or gelatinases.
The objective of the study in chapter 4 was to determine whether the presence 
of cells of the monocyte-macrophage system affects the fibrinolytic response of 
peritoneal mesothelial cells to lipopolysaccharide (LPS) in the presence and 
absence of sodium hyaluronate. Human peritoneal mesothelial cells were 
harvested from patients undergoing a laparotomy for non-infectious reasons and 
cultured in vitro. Co-cultures were formed by adding U-937 human monocyte­
like cells to a monolayer of mesothelial cells. After 24 hours, cultures were 
treated with 10 ng/ml LPS and sodium hyaluronate was added in a final 
concentration of 0.2%. Controls received medium without sodium hyaluronate. 
After 24 hours incubation, tissue Plasminogen Activator (tPA), urokinase 
Plasminogen Activator (uPA) and Plasminogen Activator Inhibitor-1 (PAI-1) levels
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were determined in medium and cell lysates using ELISA techniques. In medium 
of co-cultures, tPA and PAI-1 concentrations were significantly increased 
compared to monocultures (p<0.05 and p<0.005, respectively), while uPA 
concentration was significantly decreased (p<0.01). In cell lysates of co-cultures, 
PAI-1 concentration was significantly increased compared to monocultures 
(p<0.01), while tPA and uPA were unaffected. Sodium hyaluronate significantly 
decreased PAI-1 (p<0.05) and uPA (p<0.01) concentrations in medium of 
monocultures and uPA concentration only in medium of co-cultures (p<0.01). 
It was concluded that cells of the monocyte-macrophage system modulate the 
fibrinolytic capacity of LPS treated human peritoneal mesothelial cells and 
interfere dualistic in the hyaluronan associated changes in mesothelial fibrinolytic 
capacity.
From chapter 3 and 4 no unequivocal conclusions about the presumed 
biological properties of hyaluronan could be drawn, although results presented 
in chapter 4 confirmed earlier observations that hyaluronan may affect 
peritoneal fibrinolysis.
The aim of chapter 5 was to determine whether auto-cross-linked hyaluronic 
acid polysaccharide (ACP) gel could reduce adhesion and abscess formation in 
a rat peritonitis model. In the first experiment, bacterial peritonitis was induced 
in 24 Wistar rats, using a cecal ligation and puncture model. Animals were 
randomized to receive 4 ml ACP gel (4%) or 4 ml phosphate buffered saline 
(PBS). After two weeks animals were killed and adhesions and abscesses were 
scored. In the second experiment, 72 rats underwent the same procedure but 
were randomized to receive 2 ml ACP gel, 4 ml ACP gel or 4 ml PBS. After one 
and three weeks, respectively, half of the animals in each group were killed and 
adhesions and abscesses were scored. In the first experiment, the median total 
adhesion score was 12 (range 3-20) in the ACP group and was 9 (range 6-12) in 
the PBS group (not significant). 91% of rats in the ACP group and 90% in the 
control group developed abscesses. There were no significant differences in 
abscess size or number of abscesses between groups. In the second experiment, 
total adhesion scores after one week in the 2 ml ACP group, 4 ml ACP group and 
PBS group were 4 (range 2-20), 6 (range 1-11) and 6 (range 1-18) respectively 
(not significant), and 3.5 (range 1-8), 5 (range 2-15) and 4 (range 0-9), 
respectively (not significant) after three weeks. All rats in the 2 ml ACP group 
and the PBS group and 83% of the 4 ml ACP group had abscesses after one 
week. After three weeks these percentages were 80, 75 and 73, respectively. 
There were no significant differences in size or number of abscesses between 
groups both after one and three weeks. It was concluded that ACP gel does not 
reduce adhesion and abscess formation in a rat peritonitis model.
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In chapter 6, the use of 99mTc-polyethylene glycol (PEG)-liposomes for detection 
of early adhesion formation after peritonitis was studied. Additionally, the value 
of 99mTc-PEG-liposomes for therapy evaluation of hyaluronan solution was 
assessed. It was previously shown that this solution reduces both adhesions and 
abscesses in a model for secondary peritonitis. A bacterial peritonitis was 
induced in 24 rats by performing a cecal ligation and puncture procedure. 
The animals were treated with sodium chloride solution or 0.4% hyaluronan 
solution intra-abdominally. One week later, a scintigraphy was performed, using 
99mTc-PEG-liposomes and abnormal focal uptake in the abdomen was scored. 
Hereafter autopsy was performed and adhesions and abscesses were scored. 
A significant correlation was found between the total adhesion score and the 
scintigraphic score (p<0.01, r=0.65). Treatment with hyaluronan significantly 
reduced the total adhesion score (p=0.01). The size of abscesses significantly 
correlated with the scintigraphic score (p<0.01, r=0.62). Treatment with 
hyaluronan reduced the size of abscesses (p<0.05). It was concluded that 99mTc- 
PEG-liposomes are able to detect early adhesions and abscesses and may be 
used for therapy evaluation of agents that reduce adhesions and abscesses. 
It was, however, not possible to distinguish between adhesions or abscesses. 
The antiadhesive and abscess reducing capacity of hyaluronan was reconfirmed. 
After abdominal surgery, and especially after secondary peritonitis, incisional 
hernia is a frequent complication. Hernia repair usually requires the use 
of prosthetic mesh. The demands of an ideal mesh are conflicting; ingrowth 
at the mesh-fascia interface, without ingrowth at the visceral mesh surface 
by adhesions. In chapter 7, various antiadhesives combined with macroporous 
mesh and composite meshes were studied for prevention of adhesions to 
mesh and ingrowth into the fascia. An abdominal wall defect was created in 
60 rats and repaired with underlay mesh. Rats were divided in six groups for 
repair with polypropylene mesh (PPM, control), PPM with auto-cross-linked 
polymers gel (ACP), PPM with fibrinogen glue (FG), polypropylene/ expanded 
polytetrafluoroethylene (ePTFE) mesh, polypropylene/sodium hyaluronate/ 
carboxymethylcellulose (HA/CMC) mesh, and polypropylene-collagen/polyethylene- 
glycol/glycerol (CPGG) mesh. Endpoints were mesh infection, adhesions, 
reherniations and tensile strength of the mesh-tissue interface at sacrifice after 
two months. Six rats developed mesh infection, half of them after repair with 
PPM/ePTFE. The PPM/HA/CMC group showed a significant reduction in the 
amount and severity of adhesions. In the groups with PPM/ACP and PPM/FG, 
severity of adhesions was reduced as well. Reherniation rate was significantly 
higher in the PPM/ACP group (50%) compared to other. Rats in the PPM/HA/CMC
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had the highest tensile strength. It was concluded that PPM/HA/CMC approaches 
the demands of the ideal mesh best, in a rat model of incisional hernia.
A relationship between postsurgical adhesion formation and peritoneal tumor 
implantation has been suggested in previous studies1-3. The aim of the study 
described in chapter 8 was to investigate the influence of a hyaluronan 
containing agent on intraperitoneal tumor in an experimental tumor model. 
66 Balb/c mice underwent a laparotomy and damage was inflicted to the 
parietal peritoneum. Animals were randomized into 5 groups. Groups 1 and 2 
received hyaluronan-carboxymethylcellulose bioresorbable membrane and no 
treatment, respectively. Mice in groups 3-5 were injected intraperitoneally with
105 colon 26-B cells after the laparotomy. Treatment consisted of hyaluronan 
membrane, no hyaluronan agent and placement of hyaluronan membrane at 
the non-traumatized parietal peritoneum, respectively. Animals were killed after 
14 days; adhesions were scored in groups 1 and 2, and tumor mass in groups 
3-5. This tumor experiment was also performed in 45 Wag/Rij rats. In rats
106 CC-531 cells were injected. Rats were killed after 3 weeks and tumor mass 
was scored. Hyaluronan membrane resulted in a significant reduction of 
adhesions, but had no major effect on intraperitoneal tumor mass in both 
experimental models.
Future d irect io n s
Although progress has been made in the attempts to reduce postoperative 
adhesion formation, the problem is far from being resolved. The optimal 
antiadhesive agent should safely and completely prevent adhesions. 
Hyaluronan-based agents promote fibrinolysis and mesothelial healing 
processes, thereby possibly preventing adhesion formation. The (clinical) 
importance of these biological properties in adhesion prevention, however, 
remains unclear, and the barrier function of hyaluronan might be far more 
relevant. Various experimental studies have shown the capacity of hyaluronan- 
based agents to reduce adhesions, which was confirmed in this thesis. Clinical 
use of hyaluronan-based agents has shown a reduction of the incidence, 
severity and extent of adhesions as well4-10. There is, however, less evidence 
that hyaluronan-based agents reduce adhesion related complications11, 12. 
Studies on clinical endpoints of adhesive problems are difficult to design and 
carry out, and need large financial resources. Further experimental and clinical 
research should focus on prevention of postsurgical adhesions, without 
interference with the peritoneal healing processes and without side effects.
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Until now, it has been shown that hyaluronan-based film is able to prevent 
adhesions to the midline incision in at least 50% of patients undergoing 
midline laparotomy4. However, the increased risk of anastomotic leakage when 
these films are wrapped around anastomoses, is a major drawback, illustrating 
that hyaluronan may disturb the normal healing of bowel anastomosis6.
In experimental studies, the composition and the amount of the used 
hyaluronan-based agent seem important13-15. The use of membranes, gels and 
solutions, despite their base of hyaluronan, leads to different results. Addition of 
other substances, such as iron or glycerol, negatively affects safety of these 
antiadhesive agents8, 16-18. These observations give valuable information for 
further research regarding the effect of viscosity on adhesion prevention and on 
the safety profile. Antiadhesives should not potentiate infection, nor stimulate 
tumor adhesion and growth, nor impair healing.
Results of the in vitro study in chapter 4 shed light on a possible influence of 
timing of hyaluronan administration. It was noticed that hyaluronan decreased 
PAI-1 levels produced by mesothelial cells exposed to LPS. The presence of 
monocyte-like cells, however, abolished the reduction in PAI-1. Hypothesis is 
that hyaluronan is less efficient with regard to its fibrinolytic effects, when cells 
of the monocyte-macrophage system have already invaded the abdominal 
cavity. Consequence is to interfere early with hyaluronan-based products in the 
response to surgical trauma or peritonitis. This is feasible in elective surgery, but 
more difficult in peritonitis because the inflammatory response is well 
underway before treatment has commenced. Data from experimental studies 
only show moderate effect on intra-abdominal abcess formation5, 8, 13-20. These 
data combined with the data in chapter 5 make it questionable whether it is 
worthwhile to put much effort in further research on this subject.
As found in our study reported in chapter 6, intravenously administered liposomes 
accumulate in areas with an increased vascular permeability such as infiltrates, 
abscesses and adhesions. This finding gives the opportunity to use liposomes 
loaded with antiadhesive agents such as hyaluronan, tissue plasminogen activator 
(tPA), or anti-PAI antibodies for targeted therapy.
Prosthetic mesh repair is the gold standard for abdominal hernia repair. The 
demand to avoid adhesion formation to the mesh has led to the development of 
multiple meshes. In our model of incisional hernia, the polypropylene mesh 
combined with hyaluronan proved to be the best with regard to adhesion 
prevention. The combined mesh of polypropylene with hyaluronan not only 
showed the best antiadhesive properties, but optimal ingrowth at the mesh- 
fascia interface as well. The long-term effects of this mesh, however deserve 
attention. The presence of the hyaluronan part is only temporary and the
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presence of intra-abdominal polypropylene may be potentially harmful at the 
long run. It is obvious that randomized clinical trials comparing different 
meshes with antiadhesive properties are necessary in order to find out which 
one is best.
Few studies have focused on the use of hyaluronan during oncologic abdominal 
surgery9, 20, 21. Unfavorable oncologic effects of hyaluronan have not been 
reported until now. In our experimental study hyaluronan had no major effect 
on intraperitoneal tumor growth, either. The used number of animals, however, 
was chosen anticipating on a significant decrease of tumor growth. It is possible 
that negative side effects of hyaluronan in this experimental oncologic model 
were not found due to small numbers of animals. Widespread use of 
hyaluronan in oncologic abdominal procedures seems premature, as studies on 
safety are not available. Further studies are warranted to answer the question 
whether hyaluronan can be used without reserve in combination with various 
abdominal malignancies. The follow-up of patients in whom hyaluronan has 
been used under these circumstances seems of utmost importance.
In conclusion hyaluronan has undeniable antiadhesive properties. Not all 
hyaluronan-based agents are equally successful. Future challenges lie in a 
further unraveling of the different mechanisms involved in adhesion formation 
and finding more effective ways to reduce adhesions. Further progress in this 
field might lay in optimalization of the composition of the hyaluronan-based 
agents, combinations with other agents and more sophisticated ways of 
administration.
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Sam envatting
In hoofdstuk 1 zijn de klinische impact en de pathophysiologie van intra­
abdominale verklevingen en abcessen, welke een gemeenschappelijke basis 
hebben via de fibrinogenese en fibrinolyse route, samengevat. Postoperatieve 
verklevingen resulteren in een aanzienlijke morbiditeit en zelfs mortaliteit. 
Heropnames in verband met darm-obstructie na abdominale chirurgie zijn veel 
voorkomend en leiden niet zelden tot chirurgische reïnterventie. Verklevingen 
compliceren relaparotomieën en verhogen de incidentie van iatrogeen darmletsel. 
Verklevingen ontstaan door peritoneaal letsel, hetgeen kan ontstaan door 
trauma of ontsteking. Op de beschadigde oppervlakken wordt een fibrine- 
neerslag gevormd. Ofschoon normaliter het fibrinolytische systeem deze 
neerslagen oplost, kunnen chirurgie en infectie leiden tot een verminderde 
fibrinolyse. Veel onderzoek heeft zich gericht op het vinden van manieren om 
fibrinevorming te verminderen of fibrinolyse te versterken, om zo verklevingen 
en intra-abdominale abcessen te verminderen.
Hyaluronzuur, een polysaccharide, is een veelvuldig onderzochte anti-adhesieve 
substantie. Het werkingsmechanisme van hyaluronzuur lijkt terug te voeren op 
mechanische scheiding van beschadigde peritoneale oppervlakken, en is verder 
terug te voeren op biologische eigenschappen van hyaluronzuur. Hyaluronzuur 
speelt een rol bij weefselherstel en wondgenezing, beïnvloedt de inflammatoire 
respons en faciliteert cel migratie en proliferatie. Fibrine deposities kunnen 
bacterieën afkapselen en zo een bron voor abcedering vormen. Preventie 
van fibrinevorming of vroeg oplossen van deze deposities bij patiënten met 
intra-abdominale infecties zou een aantrekkelijk methode kunnen zijn om 
abcesvorming te voorkomen. Aangezien hyaluronzuur effectief is in het 
voorkomen van verklevingen en duidelijke invloed heeft op de fibrinolytische 
cascade, is het gebruik ervan bij de behandeling van intra-abdominale sepsis 
het meest uitdagend. Er is vrijwel geen enkele studie op dit gebied.
Hoofdstuk 2 bestaat uit een review van de literatuur over op hyaluronzuur- 
gebaseerde anti-adhesieve middelen, toegepast in abdominale chirurgie. 
De noodzaak om verklevingen tegen te gaan heeft geresulteerd in vele 
experimentele en klinische trials. Ondanks de effectiviteit van hyaluronzuur bestaat 
er nog veel discussie over de klinische toepassing en het werkingsmechanisme. 
Verschillende hyaluronzuur-bevattende producten zijn geïntroduceerd en ook 
weer teruggetrokken van de markt. De toepassing van hyaluronzuur in 
combinatie met matjes bij herstel van buikwandbreuken lijkt een veelbelovend 
concept te zijn. Niet alle toepassingen van hyaluronzuur zijn uitgebreid 
onderzocht en het gebruik ervan onder infectieuze condities of bij patiënten
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met een maligniteit blijft controversieel. Een overzicht wordt geschetst van de 
effecten van hyaluronzuur-bevattende anti-adhesieve middelen toegepast in 
abdominale chirurgie, het gebruik ervan onder infectieuze omstandigheden en 
bij maligne ziekte. De verschillende mogelijke werkingsmechanismen van 
hyaluronzuur worden eveneens besproken.
Peritoneale mesotheelcellen zijn betrokken bij verschillende biologische 
processen, waaronder de vorming van peritoneale verklevingen. Kweken van 
humane peritoneale mesotheelcellen vormen een belangrijk middel om het 
gedrag en de functies van mesotheelcellen te onderzoeken. Het doel van de 
studie in hoofdstuk 3 was om de effecten te onderzoeken van het opkweken van 
cellen en het invriezen en opslaan ervan, gebruikmakend van mesotheelcellen 
van verschillende bronnen. De invloed van hyaluronzuur op celfuncties werd 
eveneens bekeken. Vitale cellijnen werden verkregen van zowel omentum als 
peritoneale lavagevloeistof van zeven patiënten. Intercellulair adhesie molecuul-1 
(ICAM-1) expressie, middels ELISA, en matrix metalloproteïnase (MMP) bio- 
activiteit, middels zymographie, werden gemeten in de tweede en vierde passage. 
MMP bio-activiteit werd ook gemeten na invriezen en opslag van cellen in 
vloeibare stikstof. De effecten van verschillende stimuli, te weten interleukine 
1beta (IL-1 ß), tumor necrosis factor-alpha (TNF-a) en phorbol myristaat acetaat 
(PMA), met en zonder hyaluronzuur werden geanalyseerd. ICAM-1 werd tot 
expressie gebracht en gestimuleerd door IL-1 ß, TNF-a en PMA. Alle cellijnen 
produceerden zowel MMP-2 als MMP-9. Alleen de laatste activiteit werd positief 
beïnvloed door TNF-a en met name PMA. Verschillen werden gevonden tussen de 
tweede en de vierde passage, en tussen cellen van verschillende afkomst 
(lavagevloeistof cellen versus omentale cellen), met name als de relatieve 
stimulatie door de verschillende middelen vergeleken werd. Toevoeging van 
hyaluronzuur aan controle kweken of aan kweken samen met een van de drie 
onderzochte stimulantia resulteerde niet in een significante verandering van 
ICAM-1 expressie of gelatinase activiteit. Invriezen en opslag van cellen 
beïnvloedde hun functies niet. Op grond van deze studie werd geconcludeerd dat 
zowel humaan omentum als peritoneale lavagevloeistof goede bronnen vormen 
om mesotheliale cellijnen te verkrijgen, die kunnen worden opgekweekt, ook na 
invriezen, zonder kwalitatieve veranderingen in hun vermogen om ICAM-1 tot 
expressie te brengen en gelatinasen te produceren. Voor omentumcellen bestaat 
er een verschillend effect van stimulatie, afhankelijk van het feit of de cellen uit 
passage 2 of 4 kwamen. De aanwezigheid van hyaluronzuur beïnvloedde de 
expressie van ICAM-1 of de gelatinasen niet.
Het doel van de studie in hoofdstuk 4 was om uit te zoeken of de aanwezigheid 
van cellen van het monocyt-macrophaag systeem de fibrinolytische respons
158
Samenvatting en plannen voor de toekomst
van peritoneale mesotheelcellen op lipopolysaccharide (LPS) in de aan- en 
afwezigheid van hyaluronzuur beïnvloedt. Humane peritoneale mesotheelcellen 
werden verkregen bij patiënten die een laparotomie ondergingen voor niet- 
infectieuze redenen en werden in vitro gekweekt. Co-culturen werden gevormd 
door U-937 humane monocyt-achtige cellen toe te voegen aan een monolaag 
van mesotheelcellen. Na 24 uur werden kweken behandeld met 10 ng/ml LPS 
en hyaluronzuur werd toegevoegd in een uiteindelijke concentratie van 0.2%. 
Controles kregen medium zonder hyaluronzuur. Na 24 uur incubatie werden 
de waarden bepaald van tissue Plasminogeen Activator (tPA), urokinase 
Plasminogeen Activator (uPA) en Plasminogeen Activator Inhibitor-1 (PAI-1) 
in medium en cellysaten, gebruikmakend van ELISA technieken. In medium 
van co-culturen waren de tPA en PAI-1 concentraties significant verhoogd 
vergeleken met monoculturen (p<0.05 en p<0.005, respectievelijk), terwijl de 
uPA concentratie significant verlaagd was (p<0.01). In cellysaten van co- 
culturen, was de PAI-1 concentratie significant verhoogd vergeleken met 
monoculturen (p<0.01), terwijl tPA en uPA onveranderd waren. Behandeling 
met hyaluronzuur gaf een significante verlaging van PAI-1 (p<0.05) en uPA 
(p<0.01) concentraties in medium van monoculturen, maar verlaagde alleen de 
uPA concentratie in medium van co-culturen (p<0.01). Geconcludeerd werd 
dat cellen van het monocyt-macrophaag systeem de fibrinolytische capaciteit 
van met LPS behandelde humane peritoneale mesotheelcellen moduleren en 
dualistisch interfereren in de hyaluronzuur-gerelateerde veranderingen in 
mesotheliale fibrinolytische capaciteit.
Uit hoofdstuk 3 en 4 kunnen geen eenduidige conclusies over de veronderstelde 
biologische eigenschappen van hyaluronzuur getrokken worden, hoewel de 
resultaten uit hoofdstuk 4 eerdere bevindingen ondersteunen over de mogelijke 
invloed van hyaluronzuur op peritoneale fibrinolyse.
In hoofdstuk 5 was het doel om te bepalen of auto-cross-linked hyaluronzuur 
polysaccharide (ACP) gel verklevingen en abcesvorming zou kunnen 
verminderen in een peritonitismodel bij ratten. In het eerste experiment werd 
een bacteriële peritonitis geïnduceerd bij 24 Wistar ratten, gebruikmakend van 
een model waarbij het coecum wordt geligeerd en gepuncteerd. Dieren 
werden gerandomiseerd en ontvingen 4 ml ACP gel (4%) of 4 ml phosphate 
buffered saline (PBS). Na 2 weken werden de dieren gedood en werden 
verklevingen en abcessen gescoord. In een tweede experiment ondergingen 
72 ratten dezelfde procedure, maar ontvingen nu na randomisatie 2 ml ACP 
gel, 4 ml ACP gel of 4 ml PBS. Na 1 en 3 weken respectievelijk werd de helft 
van de dieren in iedere groep gedood en werden verklevingen en abcessen 
gescoord. In het eerste experiment was de mediane totale adhesie-score 12
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(range 3-20) in de ACP groep en 9 (range 6-12) in de PBS groep (niet 
significant). 91% van de ratten in de ACP groep en 90% van de controle groep 
ontwikkelde abcessen. Er waren geen significante verschillen in abcesgrootte of 
aantal abcessen. In het tweede experiment waren de totale adhesie-scores in de 
2 ml ACP groep, 4 ml ACP groep en PBS groep 4 (range 2-20), 6 (range 1-11) 
en 6 (range 1-18) respectievelijk (niet significant) na 1 week en 3.5 (range 1-8),
5 (range 2-15) en 4 (range 0-9), respectievelijk (niet significant) na 3 weken. 
Alle ratten in de 2 ml ACP groep en de PBS groep en 83% van de 4 ml ACP 
groep hadden abcessen na 1 week. Na 3 weken waren deze percentages 80, 75 
en 73, respectievelijk. Er bestonden geen significante verschillen wat betreft de 
grootte of het aantal abcessen tussen de groepen na 1 en 3 weken. Geconcludeerd 
werd dat ACP gel verklevingen en abcesvorming in een peritonitis model in 
ratten niet vermindert.
In hoofdstuk 6 werd het gebruik van 99mTc-polyethylene glycol (PEG)-liposomen 
voor de detectie van vroege verklevingen na peritonitis bestudeerd. Verder werd de 
waarde van 99mTc-PEG-liposomen voor therapie-evaluatie van hyaluronzuur- 
oplossing geëvalueerd. Bij 24 ratten werd een bacteriële peritonitis geïnduceerd 
middels het ligeren en puncteren van het coecum. De dieren werden behandeld 
met natrium/chloride oplossing of 0.4% hyaluronzuur-oplossing, intra-abdominaal 
toegediend. Een week later werd scintigraphie verricht, gebruikmakend van 99mTc- 
PEG-liposomen en werd abnormale focale uptake in het abdomen gescoord. 
Hierna werd autopsie uitgevoerd en werden verklevingen en abcessen beoordeeld. 
Een significante correlatie werd vastgesteld tussen de totale adhesie-score en de 
scintigraphie-score (p<0.01, r=0.65). Behandeling met hyaluronzuur leidde 
tot een significante vermindering van de totale adhesie-score (p=0.01). Ook was 
er sprake van een significante correlatie tussen de grootte van abcessen 
en de scintigraphie-score (p<0.01, r=0.62). Behandeling met hyaluronzuur 
verminderde de grootte van abcessen (p<0.05). Geconcludeerd werd dat 99mTc- 
PEG-liposomen in staat zijn om vroege verklevingen en abcessen te detecteren en 
gebruikt zouden kunnen worden voor therapie evaluatie van middelen met een 
adhesie- en abcesverminderend effect. Het was evenwel niet mogelijk om 
verklevingen en abcessen van elkaar te onderscheiden. Verder werd de capaciteit 
van hyaluronzuur om verklevingen en abcessen te verminderen wederom 
bevestigd.
Na abdominale chirurgie, en met name na secundaire peritonitis, is het 
optreden van een littekenbreuk een veel voorkomende complicatie. Het herstel 
van breuken vereist doorgaans het gebruik van een kunststof mat. De vereisten 
van de ideale mat lijken tegenstrijdig; ingroei op de overgang mat - fascie, 
zonder het ontwikkelen van verklevingen aan het viscerale oppervlak van de
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mat. In hoofdstuk 7 worden verschillende anti-adhesieve middelen gecombineerd 
met een macroporeuze mat en samengestelde matten onderzocht, waarbij 
gekeken werd naar het vermogen om verklevingen aan de mat te voorkomen en 
tevens gelet werd op de ingroei ter plaatse van de fascie. Bij 60 ratten werd een 
buikwanddefect gemaakt en hersteld met een underlay mat. Ratten werden 
verdeeld in 6 groepen en behandeld met polypropylene mesh (PPM, controle), 
PPM met auto-cross-linked polymers gel (ACP), PPM met fibrinogen glue (FG), 
polypropylene/ expanded polytetrafluoroethylene (ePTFE) mesh, polypropylene/ 
sodium hyaluronate/ carboxymethylcellulose (HA/CMC) mesh, en polypropylene- 
collagen/polyethylene-glycol/glycerol (CPGG) mesh. Mat-infecties werden gedurende 
het postoperatieve beloop bijgehouden, verklevingen en reherniaties werden 
gescoord na het termineren na 2 maanden, waarbij ook de trekkracht van de mat- 
weefsel overgang werd gemeten. Zes ratten ontwikkelden een mat-infectie, waarbij de 
helft hiervan behandeld werd met PPM/ePTFE. In de PPM/HA/CMC groep werd een 
significante reductie gezien van de hoeveelheid verklevingen, alsook van de ernst 
ervan. In de groepen met PPM/ACP en PPM/FG, was de ernst van de verklevingen 
eveneens verminderd. Het aantal reherniaties was significant hoger in de PPM/ACP 
groep (50%). De mat-weefsel overgangen van ratten in de PPM/HA/CMC groep 
hadden de hoogste trekkracht. Geconcludeerd werd dat PPM/HA/CMC de vereisten 
van de ideale mat het dichtst benadert, in een littekenbreukmodel in ratten.
Een relatie tussen postchirurgische vorming van verklevingen en peritoneale 
tumorimplantatie is geopperd1-3. Het doel van de studie in hoofdstuk 8 was om de 
invloed van een hyaluronzuurbevattend middel op intraperitoneale tumor te 
onderzoeken in een experimenteel model. 66 Balb/c muizen ondergingen een 
laparotomie en schade werd gemaakt op het pariëtale peritoneum. Dieren werden 
gerandomiseerd in 5 groepen. Groepen 1 en 2 kregen behandeling met een 
hyaluronzuurbevattende, oplosbare membraan en geen behandeling, respectievelijk. 
Muizen in de groepen 3-5 werden intraperitoneaal geïnjecteerd met 105 colon 26-B 
cellen na de laparotomie. Behandeling bestond uit hyaluronzuur membraan, geen 
hyaluronzuurbevattend middel en plaatsing van de hyaluronzuur membraan op de 
niet beschadigde peritoneale wand, respectievelijk. Dieren werden gedood na 
14 dagen; verklevingen werden gescoord in de groepen 1 en 2 en tumormassa in 
groepen 3-5. Het tumorexperiment werd ook uitgevoerd, gebruikmakend van 
45 Wag/Rij ratten. Bij de ratten werden 106 CC-531 cellen geïnjecteerd. Ratten 
werden gedood na 3 weken en de tumormassa werd gescoord. Gebruik van 
hyaluronzuur membraan resulteerde in een significante reductie van verklevingen, 
maar had geen evident effect op de intraperitoneale tumormassa bij muizen en ratten 
in deze experimentele modellen.
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Ondanks de vooruitgang die is geboekt bij het reduceren van postoperatieve 
verklevingen, is het probleem verre van opgelost. Het optimale anti-adhesieve 
middel zou veilig en volledig verklevingen moeten voorkomen. Middelen op basis 
van hyaluronzuur stimuleren fibrinolyse en mesotheliale genezingsprocessen, 
waardoor ze mogelijk verklevingen voorkomen. Het (klinische) belang van deze 
biologische eigenschappen bij adhesie-preventie blijft evenwel onduidelijk, en de 
barrière functie van hyaluronzuur zou veel relevanter kunnen zijn. Verschillende 
experimentele studies hebben het vermogen van middelen op hyaluronzuur-basis 
om verklevingen te verminderen aangetoond, hetgeen bevestigd werd in dit 
proefschrift. De klinische toepassing van middelen op hyaluronzuur-basis heeft 
eveneens geleid tot een reductie van incidentie, ernst en uitgebreidheid van 
verklevingen4-10. Er is echter minder bewijs dat middelen op hyaluronzuur-basis 
adhesie-gerelateerde complicaties verminderen11' 12. Studies die zich richten op 
klinische eindpunten van problemen gerelateerd aan verklevingen zijn moeilijk op 
te zetten en uit te voeren, en hebben royale financiële ondersteuning nodig. 
Toekomstige experimentele en klinische onderzoeken zouden zich moeten richten 
op preventie van postchirurgische verklevingen, zonder beïnvloeding van de 
peritoneale genezingsprocessen en zonder bijwerkingen. Tot nu toe is aangetoond 
dat een hyaluronzuur membraan in staat is om verklevingen met de midline incisie 
te voorkomen bij ten minste 50% van de patiënten die een midline laparotomie 
ondergingen4. Echter, het verhoogde risico op naadlekkage wanneer deze 
membranen rondom anastomosen worden gelegd, is een groot nadeel, dat laat 
zien dat hyaluronzuur de normale genezing van een darmnaad kan verstoren6.
In de experimentele studies lijkt de samenstelling en hoeveelheid van het 
gebruikte middel op hyaluronzuur-basis van belang13-15. Het gebruik van 
membranen, gels en oplossingen kan, ondanks de gemeenschappelijke basis 
van hyaluronzuur, leiden tot verschillende resultaten. Het toevoegen van 
andere substanties, zoals ijzer of glycerol, heeft een negatieve invloed op de 
veiligheid van deze anti-adhesieve middelen8, 16-18. Deze bevindingen geven 
waardevolle informatie voor verder onderzoek gericht op de invloed van 
viscositeit op adhesiepreventie en op het veiligheidsprofiel. Anti-adhesieve 
middelen zouden infectie niet moeten verergeren, zouden tumor-adhesie en 
-groei niet moeten stimuleren en zouden genezing niet moeten belemmeren. 
De in vitro studie in hoofdstuk 4 suggereert dat de timing van hyaluronzuur 
toediening ook cruciaal zou kunnen zijn. Er werd vastgesteld dat hyaluronzuur 
zorgt voor een verlaging van PAI-1 levels, geproduceerd door mesothelcellen 
die werden blootgesteld aan LPS. Echter, de aanwezigheid van monocyt-
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achtige cellen, deed de reductie van PAI-1 teniet. Dit zou erop kunnen duiden 
dat hyaluronzuur minder effectief is wat betreft de fibrinolytische effecten, 
wanneer cellen van het monocyt-macrophaag systeem al aangekomen zijn in 
de buikholte. Dit betekent dat men vroeg zou moeten interveniëren met 
middelen op hyaluronzuur-basis in de respons op chirurgisch trauma of 
peritonitis. Dit is haalbaar bij electieve chirurgie, maar moeilijker bij peritonitis, 
daar de inflammatoire respons al op gang is, voordat de behandeling begint. 
De data van experimentele studies laten slechts bescheiden effecten zien op 
intra-abdominale abcesvorming5, 8, 13-20. Deze data gecombineerd met de data 
uit hoofdstuk 5 maken het discutabel of het de moeite waard is om veel energie 
te steken in verdere onderzoeken naar dit onderwerp.
Zoals werd aangetoond in onze studie in hoofdstuk 6, accumuleren liposomen 
na intraveneuze injectie in gebieden met een toegenomen vasculaire 
permeabiliteit zoals infiltraten, abcessen en verklevingen. Deze bevinding biedt 
de kans om liposomen met daaraan gekoppeld anti-adhesieve middelen zoals 
hyaluronzuur, tissue plasminogeen activator (tPA), of anti-PAI antilichamen, te 
gebruiken voor doelgerichte therapie.
Herstel middels een kunststof mat is de gouden standaard bij de behandeling 
van littekenbreuken. Met het doel om verklevingen aan de mat te voorkomen 
zijn vele matten ontwikkeld. In ons model van littekenbreuken bleek de 
polypropyleen mat gecombineerd met hyaluronzuur de beste te zijn. De 
gecombineerde mat van polypropylene met hyaluronzuur liet niet alleen de 
beste anti-adhesieve eigenschappen zien, maar had ook de beste ingroei op de 
mat-fascie overgang. De lange termijn resultaten van deze mat verdienen 
desalniettemin aandacht. De aanwezigheid van het hyaluronzuur deel is slechts 
tijdelijk en de aanwezigheid van polypropyleen in de buikholte is potentieel 
schadelijk. Het is duidelijk dat gerandomiseerde klinische trials nodig zijn, 
waarin verschillende matten met anti-adhesieve eigenschappen worden 
vergeleken, om erachter te komen welke het beste is.
Slechts enkele studies zijn gericht op het gebruik van hyaluronzuur tijdens 
oncologische abdominale chirurgie9, 20, 21. Ongunstige oncologische effecten 
van hyaluronzuur zijn tot op heden niet gemeld. In onze experimentele studie 
had hyaluronzuur evenmin een evident effect op intraperitoneale tumorgroei. 
Het gebruikte aantal dieren was echter gekozen uitgaande van een significante 
vermindering van tumorgroei. Het is mogelijk dat negatieve bijwerkingen van 
hyaluronzuur in dit experimentele oncologische model niet werden vastgesteld 
door te kleine aantallen dieren. Wijdverbreid gebruik van hyaluronzuur tijdens 
oncologische abdominale procedures lijkt prematuur, gezien het feit dat er nog 
geen veiligheidsstudies beschikbaar zijn. Verdere studies zijn noodzakelijk om
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de vraag te beantwoorden of hyaluronzuur zonder terughoudendheid gebruikt 
kan worden in combinatie met abdominale maligniteiten. De follow-up van 
patiënten, bij wie hyaluronzuur onder deze omstandigheden gebruikt is, lijkt 
van groot belang.
Geconcludeerd kan worden dat hyaluronzuur ontegenzeggelijk anti-adhesieve 
eigenschappen heeft. Toekomstige uitdagingen liggen in een verdere ontrafeling 
van de verschillende mechanismen die betrokken zijn bij adhesievorming en in 
het vinden van effectievere manieren om verklevingen tegen te gaan. Verdere 
vooruitgang op dit gebied zou geboekt kunnen worden door optimalisatie van 
de samenstelling van de middelen op hyaluronzuur-basis, combinaties met 
andere middelen en meer geavanceerde manieren van toediening.
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Een proefschrift komt er niet zomaar. Dat je bij een promotie afhankelijk bent 
van vele anderen is onmiskenbaar. Ik wil dan ook een poging doen om zo 
volledig mogelijk diegenen te bedanken, die bij mijn studies en promotie 
betrokken zijn geweest.
Hooggeleerde Bleichrodt, beste Rob, de betrokkenheid bij mijn proefschrift stamt al 
vanuit de tijd waarin je zelf in Nijmegen begon. In kritische wetenschapsbesprekingen 
werd ik gedwongen om na te denken over de opzet van mijn experimenten. Dank ook 
voor je hulp bij mijn introductie en met name het omvormen van de losse stukken tot 
een compleet geheel.
Harry, toen ik als AGNIO naar Nijmegen kwam werd ik door Michel getipt om met 
jou te gaan praten over onderzoek. Jij wist me voor het experimentele onderzoek 
te enthousiasmeren en al snel liep het treintje. Heel wat brainstormsessies volgden, 
waarbij het bij de experimenten zeker niet altijd heeft meegezeten. Desondanks 
heeft het geleid tot mooie artikelen. Dank voor je tijd en (mee)denken!
Michel/ Baasje, we gaan al heel wat jaren terug! W e kennen elkaar al uit de 
collegebankjes en zijn daarna goede vrienden gebleven. Opvallend is de 
overeenkomst in onze carrièrekeuzes. Het bereiken van de afronding van dit 
proefschrift heeft heel wat geduld gevergd, van mij, maar zeker ook van jou. 
Nadat je me in het begin op het vervolg van jouw studies had gezet ben je het 
geheel nauwlettend blijven volgen. Met name op momenten dat er zand in de 
raderen zat heb je je nadrukkelijk laten zien. Dank je voor je aanhoudende 
enthousiasme en het "pushen". Ofschoon ik dat laatste op de betreffende 
momenten niet altijd kon waarderen, moet ik achteraf toch erkennen dat het 
anders niet was afgekomen. Dank!!!
Ben de Man, we hebben menig uurtje samen in het lab doorgebracht. Ik heb 
deze uren altijd als erg gezellig ervaren en wil je bedanken voor al je werk en 
je flexibiliteit, met name als er weer eens even iets snel moest gebeuren.
Thijs Hendriks, van het researchlab Heelkunde, je weet zelf waar ik je dank 
verschuldigd ben.
Victor Postma, Tammo de Vries Reilingh, Manuel Koppe, Arian Malyar en Joris Joosten, 
dank voor jullie bijdrage aan verschillende experimenten. De onverschrokkenheid
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waarmee enkelen zich omwille van de wetenschap in hun vingers hebben laten 
bijten door de knaagdiertjes kan ik nog steeds zeer waarderen.
Bram Duffhues en Roger Lomme wil ik bedanken voor hun bijdrage aan 
hoofdstuk 3.
Peter Falk and Lena Holmdahl, the Swedish connection. Thank you for your 
contributions to this thesis. I have always been very impressed by the enormous 
amount of scientific presentations of your departement on congresses and your 
scientific publications. I was, however, most impressed by the enthousiasm and 
familial atmosphere of your team.
Dr. Laverman en professor Oyen, dank voor jullie bijdrage aan hoofdstuk 6. 
Professor Jansen, dank voor de bijdrage in hoofdstuk 7.
Clark Zeebregts, dank voor je hulp bij het review stuk (hoofdstuk 2). Tijdens het 
schrijven met jou en Michel was treuzelen onmogelijk. Dank voor je aanstekelijke 
enthousiasme. Gefeliciteerd met je recente benoeming tot hoogleraar!
Medewerkers van afdeling "kleine dieren" van het centraal dieren laboratorium, 
bedankt voor jullie hulp en het faciliteren van vele zaken.
Leden van de manuscriptcommissie; professor Feitz, professor Lange en dr 
Walboomers, dank voor de snelle beoordeling van mijn proefschrift.
Hans Coveliers en John Paas, mijn paranimfen. Hans, ik heb enorm prettig met je 
samengewerkt in het VUMC. In die tijd ben je een erg goede vriend geworden. Ik 
heb bewondering voor je positieve houding en je ondernemingslust. Ik heb op 
vele gebieden veel van je opgestoken en waardeer onze wederzijdse bezoeken 
(net als de rest van de familie) zeer.
John, mijn oom, en een van mijn eerste werkgevers. Mijn baantje als telefonische 
achterwacht tijdens jouw diensten als huisarts (in de tijd van de semafoons!), was 
mijn eerste echte introductie in de medische wereld. Ik heb veel bewondering 
voor de rust die je altijd uitstraalt en op mijn spreekuren zijn je patiënten unaniem 
lovend over je. Het is een mooi streven om dat ook te bereiken.
Mijn huidige maten, allen bedankt voor de ruimte die ik heb gekregen om me 
voor te bereiden op mijn verdediging. Na de drukte en onrust rond de verhuizing
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met de oude maatschap naar het Orbis Medisch Centrum in Sittard-Geleen, en de 
recente fusie met de Heerlense maatschap, ga ik ervan uit dat de Maatschap 
Heelkunde Zuid-Limburg een mooie tijd tegemoet gaat!
Mijn moeder, die veel te jong is overleden. Mam, ik vind het heel erg dat je 
zoveel hebt moeten missen, waar ik je zo graag bij aanwezig had gezien; mijn 
huwelijk, de geboorte en het opgroeien van mijn kinderen, mijn chirurgische 
carrière en nu weer het verdedigen van mijn proefschrift. Ik had graag die trotse 
kop van je gezien en hoop mijn kinderen hetzelfde mee te geven, als jij mij.
Veer, we zijn al ruim 20 jaar samen. Alles waarvoor ik je moet bedanken valt 
niet in een paar woorden te vangen. Door je niet aflatende steun en geloof in 
mij ben ik altijd verder kunnen gaan, ook in moeilijke tijden. Dankzij je 
nuchtere kijk ben ik nooit gaan zweven. Door jou heb ik kunnen bereiken wat 
ik bereikt heb en kan ik doen wat ik doe!
Tuur, Fleur en Rosa, mijn prachtige kinderen. Nergens ben ik trotser op dan op 
jullie. Ik hoop dat we nog veel leuke dingen samen gaan doen!
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